,Trade Name,Generic/Proper Name(s),Active Ingredient(s),DICT _ Concern,Standardized_SMILES,Standardized_InChI,DICTrank,name,Cardiotoxicity,CT label,Mutagenicity,Blood-Brain Barrier Penetration,Oral Bioavailability,CYP1A2 Inhibition,CYP2C19 Inhibition,CYP2C9 Substrate,CYP2C9 Inhibition,CYP2D6 Substrate,CYP2D6 Inhibition,CYP3A4 Substrate,CYP3A4 Inhibition,Carcinogenicity,Clinical Toxicity,Drug Induced Liver Injury,Human Intestinal Absorption,Androgen Receptor (Ligand Binding Domain),Androgen Receptor (Full Length),Aryl Hydrocarbon Receptor,Aromatase,Estrogen Receptor (Ligand Binding Domain),Estrogen Receptor (Full Length),Peroxisome Proliferator-Activated Receptor Gamma,PAMPA Permeability,P-glycoprotein Inhibition,Nrf2-Antioxidant Responsive Element,ATPase Family AAA Domain-Containing Protein 5 (ATAD5),Heat Shock Factor Response Element,Mitochondrial Membrane Potential,Tumor Protein p53,Skin Reaction,hERG Blocking,Cell Effective Permeability,Drug Clearance (Hepatocyte),Drug Clearance (Microsome),Half Life,Hydration Free Energy,Acute Toxicity LD50,Lipophilicity,Plasma Protein Binding Rate,Aqueous Solubility,Volume of Distribution at Steady State,atc_name_1,atc_name_2,atc_name_3,atc_name_4
0,flurbiprofen,flurbiprofen,flurbiprofen,most,CC(C(=O)[O-])c1ccc(-c2ccccc2)c(F)c1,"InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)/p-1",1,Flurbiprofen,Heart Damage,bw,0.0560511492192745,0.8144097924232483,0.9883896350860596,0.0865292742848396,0.2741449147462845,0.7378433585166931,0.2470630317926407,0.0302443049848079,0.0012975349585758,0.2801136344671249,0.0026204651454463,0.4881897687911987,0.004111284809187,0.9543150782585144,0.9998334288597108,0.0019407502550166,0.0327787986025214,0.0296265034005045,0.0117824491113424,0.0096737910993397,0.2119463592767715,0.1360779508948326,0.8136821389198303,0.0099996878183446,0.0267918091267347,0.0177850762382149,0.0012367982300929,0.0037776462384499,0.0018949843011796,0.1854963541030883,0.0115430916659533,-4.2642527996440975,17.276201377027057,25.59143622943734,-21.932289979459863,-7.38200224714997,2.539729802089905,0.0602321396471254,92.186895833029,-3.454159069145516,1.3147610673835608,MUSCULO-SKELETAL SYSTEM;RESPIRATORY SYSTEM;SENSORY ORGANS,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;OPHTHALMOLOGICALS;THROAT PREPARATIONS;TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,"ANTIINFLAMMATORY AGENTS;ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS;THROAT PREPARATIONS;TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN","Antiinflammatory agents, non-steroids;Antiinflammatory preparations, non-steroids for topical use;Other throat preparations;Propionic acid derivatives"
1,ketoprofen,ketoprofen,ketoprofen,most,CC(C(=O)[O-])c1cccc(C(=O)c2ccccc2)c1,"InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)/p-1",1,Ketoprofen,Heart Damage,bw,0.0042574523482471,0.5063201487064362,0.9590898394584656,0.0161412801593542,0.0774077117443084,0.6026883125305176,0.1028131395578384,0.0166576698422431,0.0018433789140544,0.1634778916835784,0.0013063594698905,0.2533854782581329,0.0028686473262496,0.924104142189026,0.9972925782203674,0.0033537514158524,0.0338588401675224,0.0074317159131169,0.0035088753327727,0.0095211282372474,0.2596444949507713,0.0602031402289867,0.6118586361408234,0.0124536765739321,0.0162643575109541,0.0059085253626108,0.0013830306124873,0.0039000053424388,0.0008387907641008,0.2393446564674377,0.0028042820049449,-4.2713232090853,14.339313544485126,6.009712600294347,-5.790000725783121,-9.29297170775869,2.192214188451836,-0.4654115970757158,88.31709134469314,-3.148045600445901,2.3798665372635783,MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS;TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN","Antiinflammatory preparations, non-steroids for topical use;Propionic acid derivatives"
2,ketoconazole,ketoconazole,ketoconazole,most,CC(=O)[NH+]1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,"InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/p+1",1,Ketoconazole,Arrhythmia,bw,0.2685363382101059,0.1441240016371011,0.3788057863712311,0.2735614269971848,0.9121931314468384,0.1067651256918907,0.7556535124778747,0.1351008847355842,0.7509427189826965,0.7972268104553223,0.967118227481842,0.1830479681491851,0.0336855811066925,0.7400897383689881,0.9702046036720277,0.0100950744003057,0.0161318704951554,0.4103022903203964,0.4725169241428375,0.036022600531578,0.1052468165755271,0.0586452724412083,0.6297025442123413,0.6803457498550415,0.8697991013526917,0.0130561773432418,0.1859008163213729,0.3595242142677307,0.1367344588041305,0.4098720431327819,0.9217434525489808,-5.267285728494621,35.58454086291887,42.485820396593226,-27.81117220493603,-11.081198400820792,2.97506371350988,2.392775047016866,93.19014975935866,-3.2860891493184154,3.2224592941383703,"ANTIINFECTIVES FOR SYSTEMIC USE;DERMATOLOGICALS;GENITO URINARY SYSTEM AND SEX HORMONES;SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",ANTIFUNGALS FOR DERMATOLOGICAL USE;ANTIMYCOTICS FOR SYSTEMIC USE;CORTICOSTEROIDS FOR SYSTEMIC USE;GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,"ANTIADRENAL PREPARATIONS;ANTIFUNGALS FOR TOPICAL USE;ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;ANTIMYCOTICS FOR SYSTEMIC USE",Anticorticosteroids;Imidazole and triazole derivatives;Imidazole derivatives
3,omnipaque,iohexol,iohexol,most,CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I,"InChI=1S/C19H26I3N3O9/c1-8(29)25(4-11(32)7-28)17-15(21)12(18(33)23-2-9(30)5-26)14(20)13(16(17)22)19(34)24-3-10(31)6-27/h9-11,26-28,30-32H,2-7H2,1H3,(H,23,33)(H,24,34)",1,Iohexol,Mixed,bw,0.1099081020802259,0.1416790693998336,0.2403117626905441,0.0062690430204384,0.0202309099957346,0.0629936039447784,0.0191709702834486,0.046157725341618,0.0629238229244947,0.3854814529418945,0.0556565104052424,0.3140124022960663,0.0340370143763721,0.1671941429376602,0.1264968432486057,0.0449472408741712,0.0487845834344625,0.0067249786516185,0.002091894345358,0.0086295114830136,0.0862346574664116,0.0012414571101544,0.1721734419465065,0.0492994390428066,0.0359546557068824,0.0010320581524865,0.0070216258522123,0.0059268637327477,0.0096878437325358,0.176881156861782,0.3924498260021209,-5.823325189465398,3.303638508722243,14.630280949247853,6.119342106859688,-14.089819156197578,1.7760929149565587,-0.2786932887485487,57.76076461141749,-1.0155614345664314,-0.6470747230136848,VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media"
4,visipaque,iodixanol,iodixanol,most,CC(=O)N(CC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I,"InChI=1S/C35H44I6N6O15/c1-13(52)46(30-26(38)20(32(59)42-3-15(54)9-48)24(36)21(27(30)39)33(60)43-4-16(55)10-49)7-19(58)8-47(14(2)53)31-28(40)22(34(61)44-5-17(56)11-50)25(37)23(29(31)41)35(62)45-6-18(57)12-51/h15-19,48-51,54-58H,3-12H2,1-2H3,(H,42,59)(H,43,60)(H,44,61)(H,45,62)",1,Iodixanol,Mixed,bw,0.0757766429334878,0.1227945610880851,0.2417455732822418,0.0028893894894281,0.017108862940222,0.063530258461833,0.019348655687645,0.0451035255566239,0.0675996432080865,0.5503421664237976,0.084822567179799,0.2607945919036865,0.0278994610533118,0.248116797208786,0.1021894015371799,0.0228760404512286,0.0365305751562118,0.0035339055699296,0.0011077027767896,0.0033576356014236,0.0492316961288452,0.0008532811814802,0.1569333180785179,0.0581233441829681,0.024992211908102,0.0007462173205567,0.0032938850868958,0.0052206176216714,0.0066449536476284,0.1119041942059993,0.541856586933136,-5.6580780093076335,-17.32930235281103,17.788754729235137,109.796656094959,-14.29943070092296,2.0961490153363407,-0.2681098931484412,60.38728635655366,-1.2479557764266094,-0.7082947274647353,VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media"
5,sertraline,sertraline,sertraline hydrochloride,most,C[NH2+]C1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21,"InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/p+1",1,Sertraline,Arrhythmia,wp,0.0531794365495443,0.9231932520866394,0.8403810381889343,0.8171025276184082,0.572120749950409,0.2909669280052185,0.0561496332287788,0.6601293981075287,0.9217450022697448,0.7171007215976715,0.3336423620581626,0.0979324273765087,0.0021391295129433,0.0857118792831897,0.998110830783844,0.002568777045235,0.0126559262163937,0.2007592499256134,0.23100546002388,0.0968976616859436,0.2457538515329361,0.0024109631980536,0.9483792185783386,0.2158311754465103,0.1303497299551964,0.0012509724241681,0.0309583629015833,0.7363853573799133,0.0142573321703821,0.757529079914093,0.9001338720321655,-4.873065014311472,76.70835022022308,28.150938007121614,28.607765056937616,-6.9434298156186,3.310707933004666,2.712099454305671,86.82181955130974,-4.576635082851995,21.86807923778369,NERVOUS SYSTEM,PSYCHOANALEPTICS,ANTIDEPRESSANTS,Selective serotonin reuptake inhibitors
6,ondansetron,ondansetron,ondansetron hydrochloride,most,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,"InChI=1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3",1,Ondansetron,Arrhythmia,wp,0.6932569146156311,0.9918163418769836,0.9211130023002624,0.8500489950180053,0.5851952910423279,0.5066412270069123,0.1277566738426685,0.5821727812290192,0.7400703430175781,0.8050288677215576,0.8484123587608338,0.040345549955964,0.2628321796655655,0.3853941291570663,0.99999737739563,0.0203989577013999,0.0273713331669569,0.5555933475494385,0.2205318927764892,0.0171475814655423,0.0787383634597063,0.0066570514813065,0.979223120212555,0.8165587067604065,0.2677078068256378,0.0234161026775836,0.0404065096750855,0.0371324805542826,0.0133049431256949,0.4555206358432769,0.7869835615158081,-4.788094385176159,32.97483099317051,20.63861574381362,1.3656320875991164,-9.32533869432262,2.492181193295223,1.8014880547909795,63.35367716541987,-1.917557214011724,-4.770555447468467,ALIMENTARY TRACT AND METABOLISM,ANTIEMETICS AND ANTINAUSEANTS,ANTIEMETICS AND ANTINAUSEANTS,Serotonin (5HT3) antagonists
7,praziquantel,praziquantel,praziquantel,most,O=C(C1CCCCC1)[NH+]1CC(=O)[NH+]2CCc3ccccc3C2C1,"InChI=1S/C19H24N2O2/c22-18-13-20(19(23)15-7-2-1-3-8-15)12-17-16-9-5-4-6-14(16)10-11-21(17)18/h4-6,9,15,17H,1-3,7-8,10-13H2/p+2",1,Praziquantel,Arrhythmia,wp,0.1125808909535408,0.7156448900699616,0.2634871944785118,0.0128777306061238,0.1366058369167149,0.3329917468130589,0.0132041361386654,0.5092569828033447,0.0967532277107238,0.7016741871833801,0.0633897769264876,0.0357321807183325,0.0034238701249705,0.1057214749976992,0.6108306393027305,0.0328956563025713,0.0743811428546905,0.0241089448332786,0.0153041797690093,0.0305602139793336,0.3021348595619201,0.00213184574568,0.5218989968299865,0.0840800405479967,0.1894187152385711,0.0054492244613356,0.007532059442019,0.0311202082782983,0.0111521288868971,0.6660142421722413,0.4575425744056701,-4.982904102993712,49.25962910326253,35.95612583407246,-18.282731512804123,-9.2203133024245,2.733295906605904,1.83143094515464,65.53821484845737,-2.5581271360621907,5.863317641232111,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTHELMINTICS,ANTITREMATODALS,Quinoline derivatives and related substances
8,cilostazol,cilostazol,cilostazol,most,O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1,"InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26)",1,Cilostazol,Mixed,wp,0.6428141415119171,0.9585274934768676,0.891150426864624,0.165581639111042,0.830184257030487,0.1690424442291259,0.3904157549142837,0.1698458582162857,0.2673731453716755,0.8398657202720642,0.8540888547897338,0.1469117656350135,0.2613549411296844,0.64925457239151,0.99994637966156,0.0076846021460369,0.0333298500627279,0.0596538237296044,0.0726962111890316,0.0242458036169409,0.1734180852770805,0.0541612898930907,0.9147895932197572,0.7829505443572998,0.6761696398258209,0.0571259640157222,0.0666793171316385,0.1843943133950233,0.1219931423664093,0.3778491675853729,0.3134311452507973,-5.1924425271869765,78.41268215025003,79.03589593440309,-4.451358901551018,-8.167648323656026,2.939755208671021,2.605583029988836,94.06637669927274,-3.2186864619012305,0.288150533224529,BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Platelet aggregation inhibitors excl. heparin
9,thalomid,thalidomide,thalidomide,most,O=C1CCC([NH+]2C(=O)c3ccccc3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)/p+1",1,Thalidomide,Mixed,wp,0.1151621710509061,0.7940812110900879,0.7093425452709198,0.0197831666097044,0.0058861484285444,0.1602316305041313,0.0030125529621727,0.0452350176870822,0.0005425724655651,0.2035854153335094,0.0006586521922145,0.0941781222820282,0.0097556059714406,0.9172988295555116,0.8188847303390503,0.0123507961630821,0.0288281070068478,0.0077348355669528,0.0056703083682805,0.0037348285724874,0.0751697778701782,0.0014881143230013,0.1704306453466415,0.0037651010323315,0.0304993918165564,0.0034264675574377,0.006346860108897,0.0103165379958227,0.0393028538674116,0.7427643060684204,0.0349106283858418,-5.204574676534118,-14.551540148007012,-19.71278410040274,13.348338136314457,-14.823260351128102,2.324891710222452,-1.5348092159110702,53.42969851061273,-2.3062212972085634,3.9584106040737823,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Other immunosuppressants
10,scemblix,asciminib,asciminib hydrochloride,most,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CCC(O)C2)c(-c2cc[n-]n2)c1,"InChI=1S/C20H18ClF2N5O3/c21-20(22,23)31-15-3-1-13(2-4-15)26-19(30)12-9-16(17-5-7-25-27-17)18(24-10-12)28-8-6-14(29)11-28/h1-5,7,9-10,14,29H,6,8,11H2,(H2,25,26,27,30)/p-1",1,Asciminib,Mixed,wp,0.3419530153274536,0.2770618766546249,0.8819587349891662,0.3163211405277252,0.4762796550989151,0.3177780032157898,0.5603321611881256,0.1290110006928443,0.1290135860443115,0.3183202296495437,0.4775393843650818,0.3686002612113953,0.4794262409210205,0.9599551677703856,0.9980658531188964,0.0079450739081949,0.01239650612697,0.4139949709177017,0.1596513226628303,0.0098523137625306,0.0923358969390392,0.0440681226551532,0.8052674770355225,0.4702849447727203,0.4283271670341492,0.039613839611411,0.0835125021636486,0.6919724464416503,0.3461424857378006,0.1374301955103874,0.7325069665908813,-5.194394970894591,-4.213147599861874,16.58899292486684,17.897321790553885,-13.135486779631655,2.9429845226321585,3.002547779247465,94.43875517344236,-4.1320522470102645,1.8324756207741144,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,BCR-ABL tyrosine kinase inhibitors
11,,terfenadine,terfenadine,most,CC(C)(C)c1ccc(C(O)CCC[NH+]2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,"InChI=1S/C32H41NO2/c1-31(2,3)26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33)32(35,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29-30,34-35H,10,15,20-24H2,1-3H3/p+1",1,Terfenadine,Arrhythmia,Withdraw,0.0112836375366896,0.1809731729328632,0.2936777517199516,0.0104485120158642,0.0206861845450475,0.067877060174942,0.0105649761972017,0.5137606382369995,0.8823698282241821,0.6020148515701294,0.0926129460334777,0.0619485553354024,0.0036565035115927,0.0129763310309499,0.5745070800185204,0.004894028417766,0.0051246656104922,0.0107492352835834,0.0175275546964257,0.0118106234818696,0.1097829550504684,0.0006260201036639,0.6871536016464234,0.8912559628486634,0.0985257804393768,8.603214046161156e-05,0.0441864904016256,0.1161393381655216,0.0011281400627922,0.5735566347837449,0.9611151814460754,-5.643061024723654,39.81461003995936,46.22668203637302,-1.5759890215660337,-7.819861909405023,2.797321928549583,2.847589779320816,92.2296588050058,-4.483243366810156,3.947323961592427,RESPIRATORY SYSTEM,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,Other antihistamines for systemic use
12,ibuprofen,ibuprofen,ibuprofen,most,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)/p-1",1,Ibuprofen,Heart Damage,bw,0.0043339031981304,0.6717815577983857,0.9517009973526,0.002645226707682,0.0689291164278984,0.5203382492065429,0.0570043295621871,0.0332005258649587,0.0026990340673364,0.2655077636241912,0.00105589304585,0.382071778178215,0.0010152020899113,0.4523905515670776,0.999660849571228,0.0001222672253788,0.0037595351692289,0.0023257041699253,0.0006745804683305,0.0047015874646604,0.1015677258372306,0.0111972265876829,0.7147624969482422,0.002244599442929,0.0040073449956253,0.0002597204693302,0.0025861634174361,0.0052927975077182,0.0001922326307976,0.3764037132263184,0.0048125551315024,-4.329864978181598,27.36432899886153,10.268279968651608,-4.610028363932393,-6.417423979261704,2.080762383779581,0.368098636737406,83.58970118778116,-2.7764871797952644,3.11821877175092,CARDIOVASCULAR SYSTEM;GENITO URINARY SYSTEM AND SEX HORMONES;MUSCULO-SKELETAL SYSTEM;NERVOUS SYSTEM;RESPIRATORY SYSTEM,ANALGESICS;ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;CARDIAC THERAPY;OTHER GYNECOLOGICALS;THROAT PREPARATIONS;TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS;OPIOIDS;OTHER CARDIAC PREPARATIONS;OTHER GYNECOLOGICALS;THROAT PREPARATIONS;TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN","Antiinflammatory preparations, non-steroids for topical use;Antiinflammatory products for vaginal administration;Opioids in combination with non-opioid analgesics;Other cardiac preparations;Other throat preparations;Propionic acid derivatives"
13,,sibutramine,sibutramine,most,CC(C)CC([NH+](C)C)C1(c2ccc(Cl)cc2)CCC1,"InChI=1S/C17H26ClN/c1-13(2)12-16(19(3)4)17(10-5-11-17)14-6-8-15(18)9-7-14/h6-9,13,16H,5,10-12H2,1-4H3/p+1",1,Sibutramine,Heart Damage,Withdraw,0.0077903669327497,0.8997412919998169,0.7966413974761963,0.0990950478240847,0.199993497133255,0.3044293791055679,0.0020105848787352,0.5311040759086609,0.8364283800125122,0.7941566586494446,0.2731202930212021,0.0575192257761955,0.0015689859865233,0.0100574766751378,0.992660903930664,9.826945470194914e-05,0.0024892513873055,0.0082921010442078,0.036546080186963,0.024354282207787,0.0692107137292623,0.0001729320950516,0.95763258934021,0.0350088972598314,0.0495570845436304,7.745038092252799e-05,0.0082485284423455,0.1417804524302482,0.0004189161107206,0.8131236672401428,0.6097328722476959,-4.431725772223782,70.97735949746003,13.51497181971238,30.13762430484477,-5.3886953233973145,3.064088443522225,2.0982020085904445,65.95500798350211,-3.4723598398019506,17.58706446615449,ALIMENTARY TRACT AND METABOLISM,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS","ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",Centrally acting antiobesity products
14,maraviroc,maraviroc,maraviroc,most,Cc1nnc(C(C)C)n1C1CC2CCC(C1)[NH+]2CCC(NC(=O)C1CCC(F)(F)CC1)c1ccccc1,"InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/p+1",1,Maraviroc,Heart Damage,wp,0.3282349944114685,0.5896391093730926,0.4815944910049438,0.0005604530218988,0.0079284039558842,0.0240610440261662,0.0036213752871844,0.2127193883061409,0.2729563385248184,0.8301589250564575,0.1576193578541279,0.1526723831892013,0.0188462927937507,0.0474866380915045,0.5450273171067238,0.0069690217263996,0.0230890571139752,0.0072013727505691,0.0117838643491268,0.0272874826565384,0.1482642695307731,0.0002399803121079,0.5344917953014374,0.384094214439392,0.1040634915232658,0.0017718681599944,0.0074083969579078,0.0219117585103958,0.0034635261865332,0.4185184210538864,0.792129397392273,-5.919300576063245,-4.306283582624833,22.360686995081867,18.98192311017249,-7.872642533976827,4.055718654084208,1.905280324442948,75.00969829726492,-2.4707944922057687,3.960878958675973,ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,Other antivirals
15,propofol,propofol,propofol,most,CC(C)c1cccc(C(C)C)c1[O-],"InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3/p-1",1,Propofol,Mixed,wp,0.0041794828372076,0.928351902961731,0.7990841746330262,0.7247099280357361,0.3020824953913689,0.3517409447580576,0.0442097077146172,0.4671035625040531,0.0263411864638328,0.5438431024551391,0.0842615414410829,0.5405651777982712,0.0003076913308177,0.1488817926496267,0.9999929904937744,2.065246981146629e-05,0.001770364830736,0.0027880880283191,0.0085159121081233,0.0049062381032854,0.0276434823870658,0.0004522246061242,0.993578028678894,0.011634914111346,0.0179316724650561,7.832363535271724e-05,0.0036649034824222,0.1507699891924858,0.0003558967728167,0.5491544246673584,0.1239807896316051,-4.145334345986618,101.15472392096464,73.12803174864077,-0.410144297472663,-1.8875981498524552,1.76717995083724,3.9051321440182174,92.68037278615112,-3.903332658639432,2.1141138182100065,NERVOUS SYSTEM,ANESTHETICS,"ANESTHETICS, GENERAL",Other general anesthetics
16,kyprolis,carfilzomib,carfilzomib,most,CC(C)CC(NC(=O)C(CCc1ccccc1)NC(=O)C[NH+]1CCOCC1)C(=O)NC(Cc1ccccc1)C(=O)NC(CC(C)C)C(=O)C1(C)CO1,"InChI=1S/C40H57N5O7/c1-27(2)22-32(36(47)40(5)26-52-40)42-39(50)34(24-30-14-10-7-11-15-30)44-38(49)33(23-28(3)4)43-37(48)31(17-16-29-12-8-6-9-13-29)41-35(46)25-45-18-20-51-21-19-45/h6-15,27-28,31-34H,16-26H2,1-5H3,(H,41,46)(H,42,50)(H,43,48)(H,44,49)/p+1",1,Carfilzomib,Mixed,wp,0.219791755080223,0.0278788160532712,0.444449120759964,0.001061180423494,0.249929341673851,0.0554747324436903,0.0796675726771354,0.0490145083516836,0.0299411652609705,0.8397065877914429,0.8848189830780029,0.3084670901298523,0.0086436978308483,0.5016757905483246,0.4300109565258026,0.0176556279882788,0.0183634685352444,0.0171259007416665,0.0200635829009115,0.040482772886753,0.0890965431928634,0.041530826035887,0.5417643159627914,0.7543841242790222,0.5280982613563537,0.0296277247369289,0.0615662895143032,0.1067996501922607,0.053962942585349,0.2613167941570282,0.5157280266284943,-5.675562064519532,74.18212066318374,64.61889346240078,28.849961647724804,-10.625311492807286,3.5047054794709043,1.4260147941943997,81.87949675632315,-2.467801204412884,7.538529326965985,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Proteasome inhibitors
17,velcade,bortezomib,bortezomib,most,CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)",1,Bortezomib,Mixed,wp,0.270402181148529,0.4463025838136673,0.8639366865158081,0.0450088173151016,0.406062239408493,0.5055738806724548,0.480181473493576,0.1242116458714008,0.0393707766197621,0.5276498079299927,0.7575278282165527,0.2771667540073395,0.4255257084965705,0.7996421813964844,0.987175679206848,0.0123880453873425,0.015375221055001,0.1389478251338005,0.0699295447207987,0.0480321664363145,0.0678921852260828,0.0308847211301326,0.5441941320896149,0.121473079919815,0.1975829631090164,0.0233781799441203,0.0742486387491226,0.055687138158828,0.0555586232803761,0.3317975103855133,0.2350705444812774,-5.427990633265841,53.13679577386421,35.79056634101644,20.82933324729581,-11.4536353142499,2.8357781159182864,1.1430899765183988,76.203101249318,-2.6354811592662983,4.5925410795904416,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Proteasome inhibitors
18,pregabalin,pregabalin,pregabalin,most,CC(C)CC(C[NH3+])CC(=O)[O-],"InChI=1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)",1,Pregabalin,Arrhythmia,wp,0.0084007113240659,0.6415725409984588,0.801030695438385,0.0003220215949113,0.0015592921583447,0.1746213749051094,0.0006409290945157,0.2426081776618957,0.0079692800063639,0.232111582159996,2.201461084041512e-05,0.1687527358531952,0.0001616979092432,0.01488390667364,0.7958389401435852,0.0001881501848401,0.0050042526563629,0.0005355162837076,3.6710306085296905e-05,0.00118982240092,0.1267009951174259,0.0002902763611928,0.2610798578709364,0.0008096061996184,0.0015881717030424,2.797591478156392e-05,0.0003397370310267,6.01798794377828e-05,2.810253326970269e-05,0.654904967546463,0.012742580845952,-4.626914108525819,30.033897503822992,-8.804612675389171,-21.24376858560167,-9.103193260714855,1.8264157812317945,-2.126300404721493,42.26933432577882,-0.8597206194565693,-0.1760813457197909,NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Other antiepileptics
19,ritonavir,ritonavir,ritonavir,most,CC(C)c1nc(C[NH+](C)C(=O)NC(C(=O)NC(Cc2ccccc2)CC(O)C(Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/p+1",1,Ritonavir,Mixed,wp,0.0475402370095252,0.0656373348087072,0.353362375497818,0.1533780060708522,0.943280792236328,0.4248389959335327,0.9347243905067444,0.1720899134874343,0.3699412286281586,0.7136601090431214,0.9887149572372436,0.1420804373919963,0.0035706457565538,0.7310382723808289,0.9783475995063782,0.0040810582228004,0.0090360086876899,0.1315669164061546,0.0438325520604848,0.008565354719758,0.0547883436083793,0.0185394030064344,0.555729079246521,0.8020664334297181,0.2931253641843795,0.0036771862767636,0.0394413657486438,0.3909627616405487,0.0162416419014334,0.1140414267778396,0.8779894948005676,-5.540537616728978,59.582622994151656,104.7782143939135,53.35976328918044,-12.059858149661755,2.747090550782896,3.175644354009667,98.51357532104072,-4.269295582256033,0.3861515018431964,ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,"Antivirals for treatment of HCV infections;Antivirals for treatment of HIV infections, combinations;Protease inhibitors"
20,,probucol,probucol,most,CC(C)(Sc1cc(C(C)(C)C)c([O-])c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c([O-])c(C(C)(C)C)c1,"InChI=1S/C31H48O2S2/c1-27(2,3)21-15-19(16-22(25(21)32)28(4,5)6)34-31(13,14)35-20-17-23(29(7,8)9)26(33)24(18-20)30(10,11)12/h15-18,32-33H,1-14H3/p-2",1,Probucol,Arrhythmia,Withdraw,0.0008013562877749,0.4089588910341263,0.3586093358695507,0.0144321149215102,0.1717673912644386,0.2733968138694763,0.0457572975195944,0.0669994368217885,0.0107626073528081,0.9294410347938538,0.1443697715178132,0.7089638531208038,0.0005181699118111,0.3786123514175415,0.9991159558296204,3.2713053815314194e-05,0.0001201725272949,0.0026661739335395,0.0156537187751382,0.0107126280665397,0.016244500176981,0.0071331347891828,0.9582125663757324,0.6231654107570648,0.1924036979675293,2.1159182688279545e-05,0.1194650419056415,0.4121351897716522,0.0022825290448963,0.5729284405708313,0.6256057143211364,-4.696995391060836,60.128213182656886,110.67676168603292,49.98828306355957,-1.667339754364778,2.20607358322354,5.5372710355617984,111.42542029971146,-7.547476694594853,-0.2827657755267644,CARDIOVASCULAR SYSTEM,LIPID MODIFYING AGENTS,"LIPID MODIFYING AGENTS, PLAIN",Other lipid modifying agents
21,,phentermine,phentermine,most,CC(C)([NH3+])Cc1ccccc1,"InChI=1S/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H3/p+1",1,Phentermine,Heart Damage,Withdraw,0.0067157394485548,0.9437402725219728,0.6700852155685425,0.007327642844757,0.027506949706003,0.0941536217927932,0.0005309108833898,0.491280996799469,0.2403425872325897,0.3002913117408752,0.0006680183019852,0.1087546400725841,0.0001584734718562,0.001754054237972,0.9741220474243164,3.3708138198562664e-05,0.0009500204934738,0.0009366761165438,0.0005281816753267,0.006564122159034,0.1505552284419536,2.689480737565475e-05,0.9095522165298462,0.0019170851679518,0.0029661782551556,5.326888334877822e-06,0.001035305204823,0.0031329486489994,2.1073274470495563e-05,0.9442301273345948,0.2653050065040588,-4.112936825330941,55.03021467134067,20.03000802854003,-15.930563634102125,-5.381513777241347,2.165820180709786,1.0316694976228586,43.427204796464025,-1.294892672058772,-2.2817148316986904,ALIMENTARY TRACT AND METABOLISM,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS","ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",Centrally acting antiobesity products
22,mitoxantrone,mitoxantrone,mitoxantrone hydrochloride,most,[O-]c1ccc([O-])c2c([O-])c3c(NCC[NH2+]CCO)ccc(NCC=NCCO)c3c([O-])c12,"InChI=1S/C22H28N4O6/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32/h1-5,24-32H,6-12H2/p-3",1,Mitoxantrone,Heart Damage,bw,0.7198339641094208,0.0777615159749984,0.2098242439329624,0.4160902142524719,0.0458672657608985,0.028434675745666,0.0199484219774603,0.2200968630611896,0.1848910421133041,0.2079369723796844,0.1170040436089038,0.3875194549560546,0.0251944764517247,0.5712756097316742,0.1605633175000548,0.1504334300756454,0.0718118675053119,0.602835190296173,0.0634351156651973,0.0789892554283142,0.0772298477590084,0.0031603814160916,0.1200607597827911,0.138600705564022,0.1167704418301582,0.1195697050541639,0.0167641372419893,0.1497339710593223,0.1661502756178379,0.6823886632919312,0.8853936076164246,-5.5752558429770165,-4.971834570011692,-1.0767681464626768,-32.81795315829869,-12.417244353948233,1.8716187476793096,0.1313643145109888,67.97383619739507,-1.930126310414845,-1.4516172756992802,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Anthracyclines and related substances
23,carbamazepine,carbamazepine,carbamazepine,most,NC(=O)N1c2ccccc2C=Cc2ccccc21,"InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)",1,Carbamazepine,Arrhythmia,wp,0.2852039128541946,0.9883072972297668,0.9687445878982544,0.5308002889156341,0.0997061822563409,0.6829455852508545,0.0678145987913012,0.2718908786773681,0.0162746758200228,0.4507008254528045,0.0177745297551155,0.4004929587244987,0.1516181036829948,0.9050757169723512,0.9998132705688476,0.0424343153834343,0.1269435122609138,0.3050075531005859,0.0117223218083381,0.0133650694042444,0.1698457539081573,0.0146541418507695,0.886593246459961,0.0333785437978804,0.1142039097845554,0.0435080733150243,0.0095598808955401,0.2497852444648742,0.0699248649179935,0.4180476784706116,0.2260460287332534,-4.272991412914807,2.18470531256456,17.695740336013706,26.22031234924813,-9.85044266131042,2.0825039173362248,1.868215134714281,71.03987747306186,-3.547368511921265,1.727952733701454,NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Carboxamide derivatives
24,onglyza,saxagliptin,saxagliptin hydrochloride,most,N#CC1CC2CC2[NH+]1C(=O)C([NH3+])C12CC3CC(CC(O)(C3)C1)C2,"InChI=1S/C18H25N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h10-15,23H,1-7,9,20H2/p+2",1,Saxagliptin,Heart Damage,wp,0.0365471305325627,0.7420609951019287,0.3804539054632186,0.0002917258468642,0.0919219945790246,0.0740621861070394,0.0065664299298077,0.3292374044656753,0.0167869590222835,0.7629757523536682,0.0123749260470503,0.0136450577061623,0.0097410365240648,0.0186453334405086,0.7711484745144844,0.0153108754195272,0.0633846048265695,0.0034049444133415,0.0079163880698615,0.0109138664091005,0.1076224833726882,0.0003537487262974,0.5337470442056655,0.0134251761657651,0.0168270784895867,0.0007765528192976,0.0011563338326595,0.0044072466727811,0.0063429951580474,0.3250121653079986,0.3930070281028747,-5.292597309356645,12.437904854038871,-27.79079104461082,8.910267542707029,-11.336848160939644,3.424293458108492,-0.1360741889649063,42.63502502050543,-1.7696068253971695,2.733441517776202,ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",Combinations of oral blood glucose lowering drugs;Dipeptidyl peptidase 4 (DPP-4) inhibitors
25,diflunisal,diflunisal,diflunisal,most,O=C([O-])c1cc(-c2ccc(F)cc2F)ccc1[O-],"InChI=1S/C13H8F2O3/c14-8-2-3-9(11(15)6-8)7-1-4-12(16)10(5-7)13(17)18/h1-6,16H,(H,17,18)/p-2",1,Diflunisal,Heart Damage,bw,0.4375418484210968,0.7112826704978943,0.9855542540550232,0.270335803925991,0.0626861713826656,0.4375866711139679,0.2006347432732582,0.0606423191726207,0.0067854058928787,0.1965573951601982,0.0061566279735416,0.4824292421340942,0.0093181337695568,0.9813477635383606,0.9995839715003968,0.0104660185519605,0.0931371763348579,0.1287599943578243,0.0144435939379036,0.0080700547434389,0.1233452349901199,0.0326392985880374,0.5185810327529907,0.0372949691489338,0.0659723438322544,0.0402420630678534,0.00303794615902,0.017370924912393,0.0089867082424461,0.2886824488639831,0.0278544365428388,-4.239270709987598,20.45713281457488,13.11033474456956,-19.404072698750745,-8.176819997631304,2.3491539536991803,0.0180337853710911,84.79983551014774,-3.78788575314219,1.8415816573364368,NERVOUS SYSTEM,ANALGESICS,OTHER ANALGESICS AND ANTIPYRETICS,Salicylic acid and derivatives
26,xalkori,crizotinib,crizotinib,most,CC(Oc1cc(-c2cnn(C3CC[NH2+]CC3)c2)c[n-]c1=N)c1c(Cl)ccc(F)c1Cl,"InChI=1S/C21H21Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H-,25,27)/q-1/p+1",1,Crizotinib,Arrhythmia,wp,0.141961170732975,0.3428947895765304,0.6213953256607055,0.3275355279445648,0.4268513083457946,0.0637144923210144,0.2915095388889313,0.4397002220153808,0.657577520608902,0.6467612504959106,0.8669680595397949,0.190953180193901,0.0869722008705139,0.4240575551986694,0.963481605052948,0.028784054890275,0.0178449742496013,0.2871027499437332,0.4952815949916839,0.1191212266683578,0.1412619546055794,0.017951162578538,0.8476956248283386,0.5820299625396729,0.3901257753372192,0.021016832999885,0.0756814464926719,0.2890180796384811,0.0768034130334854,0.2884023308753967,0.871142041683197,-5.604130896869816,1.3923846161458726,6.946321060536059,7.5863668237099775,-11.248635037740744,2.817239493471713,1.4310058516877648,81.7051840949094,-3.1308015602817463,4.000269146181914,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Anaplastic lymphoma kinase (ALK) inhibitors
27,braftovi,encorafenib,encorafenib,most,COC(=O)NC(C)CN=c1nc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)cc[n-]1,"InChI=1S/C22H27ClFN7O4S/c1-12(2)31-11-16(17-6-7-25-21(28-17)26-10-13(3)27-22(32)35-4)20(29-31)15-8-14(23)9-18(19(15)24)30-36(5,33)34/h6-9,11-13,30H,10H2,1-5H3,(H2,25,26,27,28,32)/p-1",1,Encorafenib,Arrhythmia,wp,0.0728913452476263,0.6637199401855469,0.8974883794784546,0.3234118223190307,0.3089844897389412,0.3254792347550392,0.2757228791713714,0.1296783916652202,0.1493552029132843,0.670536208152771,0.9830747246742249,0.156414745748043,0.3273616969585419,0.9512035489082336,0.9995221376419068,0.0585234582424163,0.082586495578289,0.1280285149812698,0.0694783374667167,0.0156603392213583,0.0399681944400072,0.0267306793481111,0.9516780853271484,0.2638277292251587,0.1698446407914161,0.0135461038444191,0.007605032576248,0.0885827228426933,0.0432423617690801,0.050818271562457,0.5944211184978485,-5.1137434576168905,37.47389448327963,61.12239105441439,62.1877346751196,-10.098782886701647,2.289688191508941,1.7566047333944514,88.58983515418177,-4.092239760518799,2.935928547557581,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,B-Raf serine-threonine kinase (BRAF) inhibitors
28,voriconazole,voriconazole,voriconazole,most,CC(c1ncncc1F)C(O)(Cn1cncn1)c1ccc(F)cc1F,"InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3",1,Voriconazole,Arrhythmia,wp,0.0696482257917523,0.8495968103408813,0.9714248180389404,0.1791121006011962,0.8027027010917663,0.3220323607325553,0.6498418360948562,0.0308367818593978,0.0531614250969141,0.4071048229932785,0.9661835432052612,0.0606490515172481,0.1240143291652202,0.861838948726654,0.999998140335083,0.0003927241406927,0.0016146158915944,0.0767011195421218,0.4161521971225738,0.0023678085184656,0.0074723917990922,0.0010410669725388,0.922067666053772,0.0704833478666842,0.0441776029765605,0.000168704825046,0.0020297140697948,0.0052210223861038,0.000501421726949,0.3282167837023735,0.3488441914319992,-4.920038711873608,33.558000376064854,7.881416431249207,17.224703376104653,-10.507968617714996,2.710883293763632,1.2169806898965372,44.45088564321,-3.198079375390689,2.4006528789770147,ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Triazole and tetrazole derivatives
29,citalopram,citalopram,citalopram hydrobromide,most,C[NH+](C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,"InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/p+1",1,Citalopram,Arrhythmia,wp,0.1570392429828643,0.7155000567436218,0.7017849564552308,0.053535964526236,0.0245744977146387,0.1310836005955934,0.0054205173044465,0.6890237033367157,0.4646813869476318,0.7909445285797119,0.2753825068473816,0.1456599928438663,0.0104362437501549,0.0547125743702054,0.7785122752189636,0.0154189527966082,0.0556450679898262,0.0178690362721681,0.1043404087424278,0.0967707969248294,0.1012894079089164,0.0019113209156785,0.8829428553581238,0.4160337746143341,0.0306826455518603,0.0019157484988681,0.0031740049773361,0.0590908743441104,0.0210857525002211,0.4116487383842468,0.9495713710784912,-4.6263660139738745,70.64637176607636,9.28390347307256,23.660035151005623,-8.315375152870148,3.19625343031958,1.1819006837080714,56.09855495435288,-3.25732874123007,5.411263747109327,NERVOUS SYSTEM,PSYCHOANALEPTICS,ANTIDEPRESSANTS,Selective serotonin reuptake inhibitors
30,cyclophosphamide,cyclophosphamide,cyclophosphamide anhydrous,most,O=P1([NH+](CCCl)CCCl)[NH2+]CCCO1,"InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)/p+2",1,Cyclophosphamide,Mixed,wp,0.9928946733474732,0.441714134812355,0.7890768051147461,0.0100620075216284,0.0490150489669758,0.1451134473085403,0.0024158914166946,0.2516585603356361,0.0056723004243394,0.3453542709350586,0.0031558693561237,0.7398471713066102,0.0156094047152691,0.1493753522634506,0.4112234255298972,0.0107412267825566,0.0021970783476717,0.0137296561006223,0.0033481027396192,0.0191511973273009,0.0876240774989128,0.0062611685299998,0.4175500916317105,0.0009086480596806,0.1150456320494413,0.0114234090549871,0.0044368820519594,0.0019846912447064,0.0726040692068636,0.9792523860931396,0.1800709761679172,-5.355411290537892,21.41039232658204,-26.858879994128834,-26.91804530752497,-10.795781678650377,3.710933934500072,0.1813475048043846,-2.709947356724712,-0.0820354862154023,10.819389488420192,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues
31,abacavir,abacavir,abacavir sulfate,most,N=c1[n-]c(=NC2CC2)c2ncn(C3C=CC(CO)C3)c2[n-]1,"InChI=1S/C14H16N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1,4,7-10,21H,2-3,5-6H2,(H-2,15,17,18,19)/q-2",1,Abacavir,Heart Damage,wp,0.3766878247261047,0.608366584777832,0.8100519776344299,0.1230281271040439,0.0495363060384988,0.2040709763765335,0.0234103440539911,0.0980036571621894,0.0347895633662119,0.228590777516365,0.0121424866141751,0.0898226365447044,0.1214740611612796,0.671734070777893,0.9993651270866394,0.0062608226668089,0.009040117659606,0.2054869815707206,0.012474213639507,0.005996541515924,0.0569919742643833,0.0057922919047996,0.3472314268350601,0.0298848866019397,0.0991170417517423,0.0211288434453308,0.0847817476838827,0.0406268822960555,0.075926149636507,0.4405357658863068,0.0913295783102512,-5.405382533564071,-4.217712664445564,-25.53692645483698,20.022045064219583,-13.629959803198972,2.1746400421067693,0.4139513583094029,59.30791169801876,-2.0288905206526184,-7.279730171371999,ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,"Antivirals for treatment of HIV infections, combinations;Nucleoside and nucleotide reverse transcriptase inhibitors"
32,nitroglycerin,nitroglycerin,nitroglycerin,most,O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-],"InChI=1S/C3H5N3O9/c7-4(8)13-1-3(15-6(11)12)2-14-5(9)10/h3H,1-2H2",1,Nitroglycerin,Heart Damage,wp,0.4935662738978862,0.9833620309829711,0.8494808435440063,0.3554869652725756,0.4613977044820785,0.1663712680339813,0.1149357147281989,0.1176330734044313,0.103856826107949,0.7055695533752442,0.0059893722762353,0.3532628059387207,0.020735800312832,0.6631500065326691,0.9920459270477296,0.0098282567341811,0.0035245756502263,0.0023768000976701,0.0016090713790617,0.0185270209331065,0.0433290392626076,0.006035777467332,0.8199585258960724,0.0454217777121812,0.3216638440266252,0.0080544418044155,0.0187132487044436,0.0124698337516747,0.0033413101744372,0.9334155440330504,0.0349958300823345,-4.556233611153013,62.62217405079925,21.92813928038169,-1.7034770248129103,-6.109317773440754,2.794267771874972,0.531860811863681,53.13280869139535,-2.1014926164050127,5.532709468491585,CARDIOVASCULAR SYSTEM,CARDIAC THERAPY;VASOPROTECTIVES,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;VASODILATORS USED IN CARDIAC DISEASES,Muscle relaxants;Organic nitrates
33,xeljanz; xeljanz xr,tofacitinib,tofacitinib citrate,most,CC1CC[NH+](C(=O)CC#N)CC1[NH+](C)c1ncnc2[nH]ccc12,"InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/p+2",1,Tofacitinib,Heart Damage,bw,0.0692441143095493,0.5436754405498505,0.3126459777355194,0.0175136261153966,0.0042318378575146,0.06291482783854,0.0010523085176828,0.3138010323047638,0.0145449145697057,0.4257477819919586,0.0097739255987107,0.0208281104918569,0.0122609757119789,0.215108223259449,0.8119381725788116,0.0130601740442216,0.0112061937339603,0.0491364784538745,0.0037724923575297,0.0149842260871082,0.0763010710477829,9.207176790368977e-05,0.3488056719303131,0.0022413316881284,0.0103365797083824,0.004510549083352,0.0006049943825928,0.000809474941343,0.003986680181697,0.4267373889684677,0.3432062357664108,-5.420624931194544,18.892302910046645,-29.314123485198003,-4.374722814291906,-16.74735474591868,3.049647931515404,-0.0429001727302214,52.083878364224304,-1.838247747387251,13.909767961997142,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants
34,depo-estradiol,estradiol cypionate,estradiol cypionate,most,CC12CCC3c4ccc([O-])cc4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/p-1",1,Estradiol cypionate,Heart Damage,bw,0.0948655970394611,0.7935231566429138,0.8345089673995971,0.0391094873193651,0.3364515781402588,0.3966237902641296,0.0948973797261714,0.2202550992369651,0.072929996997118,0.8356279611587525,0.2678294956684112,0.2481456696987152,0.0218622174113988,0.1534237220883369,0.9998817086219788,0.0362792626954615,0.2619186133146286,0.0183339420706033,0.0132901651784777,0.175482827425003,0.5024250328540802,0.0197432643733918,0.9397403597831726,0.8868612051010132,0.227982884645462,0.0079722692724317,0.0637175183743238,0.2997729495167732,0.0235885366797447,0.3963670372962952,0.5294651716947556,-4.858760766106303,109.81295667303198,112.8300368502513,1.8563343507833203,-2.0160614631981857,2.2452364961081366,5.332164514804636,106.9661343203176,-6.741738990210616,2.148973876339773,,,,
35,lorbrena,lorlatinib,lorlatinib,most,CC1Oc2cc(c[n-]c2=N)-c2c(nn(C)c2C#N)C[NH+](C)C(=O)c2ccc(F)cc21,"InChI=1S/C21H18FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H-,24,25)/q-1/p+1",1,Lorlatinib,Mixed,wp,0.4377397865056991,0.1751181632280349,0.7702165246009827,0.0531736232340335,0.0275890037417411,0.1480607375502586,0.0357545102015137,0.1067655682563781,0.0317343529313802,0.7076846241950989,0.2576068893074989,0.2036975264549255,0.0328184281475842,0.8032100796699524,0.8444718599319458,0.0298216883093118,0.03426597379148,0.0612868025898933,0.0502005852758884,0.0397790607064962,0.0492210235446691,0.0099171383772045,0.7131370425224304,0.2545615002512932,0.0416088130325078,0.0493301818147301,0.0080288412049412,0.0559296488761901,0.1218953035771846,0.0998137541115284,0.6590412139892579,-5.104888595405569,-15.653630684835912,13.17163792282405,36.665949466823214,-12.690018629877232,3.758738310723336,1.1090043936049114,74.33487270068227,-3.435117477854361,-3.3603738153923017,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Anaplastic lymphoma kinase (ALK) inhibitors
36,digoxin,digoxin,digoxin,most,CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(c7coc([O-])c7)CCC65O)C4)OC3C)OC2C)CC(O)C1O,"InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,18-21,23-31,33-38,42-48H,6-11,13-17H2,1-5H3/p-1",1,Digoxin,Arrhythmia,wp,0.2286392323672771,0.2933084577322006,0.7434658348560333,0.0008019950228572,0.078308654949069,0.0618497278541326,0.0739997964352369,0.0375127799808979,0.0069831251807045,0.8164989233016968,0.1789950303733349,0.0398863295093178,0.0483623538166284,0.5633757472038269,0.956287944316864,0.0092529949499294,0.0264165971428155,0.0112556988373398,0.1828024663031101,0.047898956015706,0.1473556295037269,0.0561287919059395,0.4147085130214691,0.635737293958664,0.3557959765195846,0.0303613923490047,0.0918148189783096,0.4856266736984252,0.1142098896205425,0.1180236954241991,0.5615688920021057,-5.904786293013808,17.031746446496754,38.00470718940311,68.28942521069199,-8.63623551567754,5.001820444836133,2.052875061545552,90.85959700294042,-3.28314773841727,4.54319603143291,CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC GLYCOSIDES,Digitalis glycosides
37,naratriptan,naratriptan,naratriptan hydrochloride,most,CNS(=O)(=O)CCc1ccc2[nH]cc(C3CC[NH+](C)CC3)c2c1,"InChI=1S/C17H25N3O2S/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14/h3-4,11-12,14,18-19H,5-10H2,1-2H3/p+1",1,Naratriptan,Mixed,wp,0.0677981669083237,0.6417497158050537,0.2969668954610824,0.0060577580356039,0.0058543523424305,0.0703178942203521,0.0013944516700576,0.5252283632755279,0.0626790275797248,0.6013056337833405,0.0031549228937365,0.0213979727588593,0.0060948402504436,0.0656336084008216,0.4844570443034172,0.0099543221294879,0.0321033213287591,0.0441503459587693,0.0033285648329183,0.0186133648268878,0.1442409485578537,0.0001208965722071,0.3311487317085266,0.0115522203966975,0.0140286606969311,0.0005476361548062,0.0031786547391675,0.0029654811602085,0.0023589180549606,0.5446535170078277,0.4795665442943573,-5.5618643189099215,23.73541883950886,-5.161450077467188,-50.70780066221747,-12.515016158479508,2.932509880587713,-0.1545871490152789,48.238834234084486,-2.201077931983741,-3.9556938046160974,NERVOUS SYSTEM,ANALGESICS,ANTIMIGRAINE PREPARATIONS,Selective serotonin (5HT1) agonists
38,levofloxacin,levofloxacin,levofloxacin,most,CC1COc2c(N3CC[NH+](C)CC3)c(F)cc3c(=O)c(C(=O)[O-])cn1c23,"InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)",1,Levofloxacin,Arrhythmia,wp,0.6066332876682281,0.0758986160159111,0.6442325711250305,0.0024547031265683,0.0058678438887,0.0614760488271713,0.004970960819628,0.0248795224353671,0.0159898501355201,0.1150189332664013,0.0077946758363395,0.2971286177635193,0.0056830491172149,0.8246302604675293,0.1434017971158027,0.0460657808929681,0.0986783891916275,0.0082026599440723,0.0086623737588524,0.0254650760442018,0.1774978354573249,0.0018244954801048,0.0832761995494365,0.0151177264750003,0.0291947351768612,0.0063196996925398,0.0016437685815617,0.0021908468334004,0.0085566672962158,0.4022615790367126,0.0663300096988677,-4.756790219279037,-12.827708721778686,-15.214247749362055,-6.09101561117388,-12.428417385168158,1.871853887172104,-1.429769662097253,46.10210404892983,-2.234705115080884,4.44777078538409,ALIMENTARY TRACT AND METABOLISM;ANTIINFECTIVES FOR SYSTEMIC USE;SENSORY ORGANS,ANTIBACTERIALS FOR SYSTEMIC USE;DRUGS FOR ACID RELATED DISORDERS;OPHTHALMOLOGICALS,ANTIINFECTIVES;COMBINATIONS OF ANTIBACTERIALS;DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);QUINOLONE ANTIBACTERIALS,Combinations for eradication of Helicobacter pylori;Combinations of antibacterials;Fluoroquinolones
39,alvimopan,alvimopan,alvimopan,most,CC1C[NH+](CC(Cc2ccccc2)C(=O)NCC(=O)[O-])CCC1(C)c1cccc([O-])c1,"InChI=1S/C25H32N2O4/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30)/p-1",1,Alvimopan,Heart Damage,bw,0.0175122753717005,0.1254241526126861,0.3543886214494705,0.0019943228166084,0.0199424029327929,0.0819148957729339,0.0042837389511987,0.2261976331472396,0.3725760817527771,0.677900207042694,0.0453108813613653,0.037314074486494,0.0014576993678929,0.0622697088867425,0.1212594512850046,0.008076199889183,0.0402175676077604,0.0131451845169067,0.0009580935060512,0.0117606185376644,0.191283044219017,0.0014905241841915,0.1094673097133636,0.0428577844053506,0.0393618255853652,0.0006487690436188,0.0036577563965693,0.0004528820645646,0.0005554993433179,0.3409715831279755,0.2004191190004348,-5.841236474706747,4.5607160301627845,4.00981208027046,-43.40724564374358,-10.058488773909568,2.482239125269377,-0.9479857624246166,63.7041436367022,-1.7472369866217186,-4.599828355971136,ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Peripheral opioid receptor antagonists
40,,sparfloxacin,sparfloxacin,most,CC1CN(c2c(F)c(N)c3c(=O)c(C(=O)[O-])cn(C4CC4)c3c2F)CC(C)[NH2+]1,"InChI=1S/C19H22F2N4O3/c1-8-5-24(6-9(2)23-8)17-13(20)15(22)12-16(14(17)21)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6,22H2,1-2H3,(H,27,28)",1,Sparfloxacin,Arrhythmia,Withdraw,0.5372728705406189,0.1308954790234565,0.7510369062423706,0.0004785902405274,0.0034481746552046,0.0155220252461731,0.0036658577388152,0.0088640897534787,0.0100562151521444,0.1455056585371494,0.0108503819443285,0.2414392799139023,0.0064681513933464,0.8401521444320679,0.4505508840084076,0.1262657217681408,0.3383633643388748,0.0260626446455717,0.0429171487689018,0.0223941315896809,0.1405260801315307,0.0012188640350359,0.0848977915942668,0.0044589322060346,0.0449269266799092,0.0108030724804848,0.0015463046962395,0.0094873674679547,0.011902154260315,0.2772071033716202,0.1391200333833694,-5.299011778544958,-10.273036293528047,12.353951744283568,-42.3863773067165,-12.030475554971606,2.233695442250643,-0.9897100986011482,46.80766580749306,-2.9664355559991096,3.409676325173849,ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones
41,xospata,gilteritinib,gilteritinib fumarate,most,CCc1nc(C(N)=O)c(=Nc2ccc(N3CCC([NH+]4CC[NH+](C)CC4)CC3)c(OC)c2)[n-]c1[NH2+]C1CCOCC1,"InChI=1S/C29H44N8O3/c1-4-23-28(31-20-9-17-40-18-10-20)34-29(26(33-23)27(30)38)32-21-5-6-24(25(19-21)39-3)37-11-7-22(8-12-37)36-15-13-35(2)14-16-36/h5-6,19-20,22H,4,7-18H2,1-3H3,(H4,30,31,32,34,38)/p+2",1,Gilteritinib,Arrhythmia,wp,0.1697376050055027,0.1915811091661453,0.2252013772726059,0.0013724409524002,0.0046609982469817,0.0339832670986652,0.001257173011254,0.2587848573923111,0.1067142099142074,0.7026712656021118,0.0093505285447463,0.0354234692640602,0.0228643402457237,0.2361825350672006,0.1037146711722016,0.0049977417569607,0.0234106671065092,0.0145196474390104,0.0047689170809462,0.0304050235077738,0.1041118770837783,0.0003921367939256,0.4308699160814285,0.1573697909712791,0.02474649194628,0.0026893275207839,0.0055012459983117,0.0074712191475555,0.0134583936072885,0.267176154255867,0.7777468919754028,-5.719795930864134,-19.462520231517782,23.90510064273126,-11.489433984465114,-11.632263844615704,2.42430259370412,0.2324921378149254,62.137553113018384,-0.9598976981586272,9.982953281334662,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors
42,capecitabine,capecitabine,capecitabine,most,CCCCCOC(=O)N=c1[n-]c(=O)n(C2OC(C)C(O)C2O)cc1F,"InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/p-1",1,Capecitabine,Mixed,wp,0.3840014368295669,0.856698751449585,0.8381099939346314,0.0445254545658826,0.2133069097995758,0.2701949909329414,0.3401074081659317,0.0299539979547262,0.0032953089626971,0.4581103980541229,0.0154885270632803,0.0739901438355445,0.2979074746370315,0.9378056168556214,0.9979700088500976,0.0092082333518192,0.0512911826372146,0.0298027504235506,0.0836097784340381,0.0151734308339655,0.0467120084911584,0.0171174342744052,0.7994723916053772,0.1942145973443985,0.2052563115954399,0.0286059755831956,0.0144807506352663,0.0237875962164253,0.1512765280902385,0.1390950575470924,0.1812941133975982,-4.787047017068993,58.77044647040448,19.78346879052389,-4.84922265725155,-13.607367790958216,2.6343891415308107,0.954051205183631,58.48244784128557,-1.957363854155336,6.8049327421900045,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ANTIMETABOLITES,Pyrimidine analogues
43,isovue 200; isovue 250; isovue 300; isovue 370,iopamidol,iopamidol,most,CC(=O)C(O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I,"InChI=1S/C17H22I3N3O8/c1-6(28)15(29)23-14-12(19)9(16(30)21-7(2-24)3-25)11(18)10(13(14)20)17(31)22-8(4-26)5-27/h7-8,15,23-27,29H,2-5H2,1H3,(H,21,30)(H,22,31)",1,Iopamidol,Mixed,wp,0.0530362658202648,0.1446393072605133,0.4682662665843963,0.0068707866133991,0.028521002526395,0.101526865363121,0.0295294609328266,0.0347919976338744,0.0363931455183774,0.339610755443573,0.0390154682332649,0.3491993904113769,0.0255268545821309,0.2643624383956194,0.2749877955764532,0.0919451616704463,0.0996996983885765,0.0109389315824955,0.0018071796774165,0.0033312900573946,0.0680536948144436,0.0033557119058968,0.1735675603151321,0.070834681391716,0.0355885912664234,0.0021967014268739,0.0085890199698042,0.0181223587016575,0.0111890168394893,0.1255121521651744,0.1670110538601875,-5.956938276538311,11.523898927648665,1.4042016893170526,33.63109210940519,-13.934910493702883,1.842308515585212,-0.2003284392033311,64.23522553654044,-0.8335247941743509,1.72213728206983,VARIOUS,CONTRAST MEDIA,"X-RAY CONTRAST MEDIA, IODINATED","Watersoluble, nephrotropic, low osmolar X-ray contrast media"
44,corlanor,ivabradine,ivabradine hydrochloride,most,COc1cc2c(cc1OC)CC(=O)[NH+](CCC[NH+](C)CC1Cc3cc(OC)c(OC)cc31)CC2,"InChI=1S/C27H36N2O5/c1-28(17-21-11-20-14-25(33-4)26(34-5)16-22(20)21)8-6-9-29-10-7-18-12-23(31-2)24(32-3)13-19(18)15-27(29)30/h12-14,16,21H,6-11,15,17H2,1-5H3/p+2",1,Ivabradine,Arrhythmia,wp,0.151743833720684,0.3353487640619278,0.4429725438356399,0.0215104386676102,0.0118728942237794,0.0640159271657467,0.0014854802808258,0.5652970790863037,0.3099733114242554,0.861134672164917,0.2297065109014511,0.0564832653850317,0.0054026389378122,0.1031151665374636,0.1703440304845571,0.0087611556053161,0.045245849341154,0.0509638674557209,0.0061756333801895,0.0155176790431141,0.0762667581439018,0.0007234458709717,0.6489140272140503,0.2346991062164306,0.0280110366642475,0.0059228367405012,0.0040932189673185,0.0169978909194469,0.0071943836985155,0.3824947565793991,0.8331809997558594,-5.883103327740035,-6.96733922144882,69.48419208498224,-2.3192776596491065,-9.654758167450463,2.904426783264669,0.0863115648111489,44.15255761638421,-0.3118690822596467,2.591011590301721,CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS;CARDIAC THERAPY,"BETA BLOCKING AGENTS, OTHER COMBINATIONS;OTHER CARDIAC PREPARATIONS","Beta blocking agents, other combinations;Other cardiac preparations"
45,phenytoin,phenytoin,phenytoin,most,O=C1[N-]C(=O)C(c2ccccc2)(c2ccccc2)N1,"InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)/p-1",1,Phenytoin,Arrhythmia,wp,0.0822696313261985,0.9854945302009582,0.9707534074783324,0.0036940306541509,0.0303209712728858,0.4765032768249512,0.0095750416629016,0.0314977467060089,9.873303206404672e-05,0.1317425832152366,0.0008126747809001,0.3624975115060806,0.0246390609070658,0.8290023088455201,0.9939503073692322,0.0020703389542177,0.0240499864332377,0.0037745755864307,0.0015987133956514,0.0011507914226967,0.05678631067276,0.0010974709934089,0.5552842289209365,0.0096508861053735,0.0321200540289282,0.0008996894073789,0.0020789949223399,0.0060347795370034,0.0057205955439712,0.587396627664566,0.007046848651953,-4.543467711174971,26.90810061616371,5.986906293398917,40.70333178360068,-9.392347936942963,2.421761266942261,1.827501574806924,90.9613187443122,-3.840996481804183,-1.9341924640491608,NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Hydantoin derivatives
46,sotalol,sotalol,sotalol,most,CC(C)[NH2+]CC(O)c1ccc(NS(C)(=O)=O)cc1,"InChI=1S/C12H20N2O3S/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17/h4-7,9,12-15H,8H2,1-3H3/p+1",1,Sotalol,Mixed,wp,0.0122346214950084,0.1718005046248436,0.6076123952865601,0.0139292158186435,0.003625951334834,0.1139067038893699,0.0010204393431195,0.1934422820806503,0.1000292427837848,0.173539936542511,0.00360590047203,0.1888098776340484,0.0029799569107126,0.1068057514727115,0.7148327946662902,0.0338269475847482,0.1920510418713092,0.0061010706704109,0.001018370433303,0.0015318882244173,0.0732115633785724,6.775570269610399e-05,0.3961097836494446,0.0050852525746449,0.0065752951079048,9.672433930063562e-05,0.0006354005672619,0.0040642390958964,0.0006699012566969,0.2080650374293327,0.1556807354092598,-5.832055367931014,-14.99639543151264,-32.49994910963678,-29.06515952540543,-13.531244282558664,1.6715928023319215,-1.4487270841344848,10.615034068874376,-1.0478024067725094,1.451857326263965,CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,"BETA BLOCKING AGENTS;BETA BLOCKING AGENTS AND THIAZIDES;BETA BLOCKING AGENTS, OTHER COMBINATIONS","Beta blocking agents, non-selective;Beta blocking agents, non-selective, and thiazides;Beta blocking agents, other combinations"
47,etodolac,etodolac,etodolac,most,CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)[O-])OCC3,"InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)/p-1",1,Etodolac,Heart Damage,bw,0.1829160302877426,0.8987784028053284,0.8537858843803405,0.0743542792275548,0.1067452549934387,0.3357754990458488,0.0358336629346013,0.1318283110857009,0.0300432613119483,0.5927664458751678,0.0153033670969307,0.048150385916233,0.0266416508704423,0.6737344145774842,0.9991045832633972,0.0027858470974024,0.0117776347324252,0.2279392421245575,0.0421756600961089,0.0125374276190996,0.0717430926859378,0.0785517632961273,0.5713314175605774,0.1266329683363437,0.0595833357423543,0.0071771897841244,0.0792798459529876,0.0177139145322144,0.0460950145497918,0.3588869541883469,0.0501405619084835,-5.1196191192445,21.27865027362328,11.169587010316032,7.038874183080269,-10.27858192991251,2.53083207340351,0.1176958273133285,90.0830716402578,-3.053615417515453,0.4755237343929598,MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Acetic acid derivatives and related substances
48,katerzia,amlodipine,amlodipine benzoate,most,CCOC(=O)C1=C(COCC[NH3+])N=C(C)C(C(=O)OC)C1c1ccccc1Cl,"InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,16-17H,4,9-11,22H2,1-3H3/p+1",1,Amlodipine,Heart Damage,wp,0.0203830221667885,0.4094882056117058,0.4529435783624649,0.1219408571720123,0.7162941634654999,0.0740505848079919,0.3914998918771744,0.1208276338875293,0.2651261791586876,0.8774073004722596,0.8937132120132446,0.0609942376613616,0.001375345751876,0.341808396577835,0.9755337119102478,0.0052798138465732,0.0070967464707791,0.1451430357992649,0.0541755540296435,0.018984605744481,0.0294322673231363,0.0120927773416042,0.9513360857963562,0.4444597482681274,0.043417577818036,0.0032048280583694,0.0280180547386407,0.0200481403619051,0.013154920656234,0.3870715975761413,0.6439344823360443,-4.783493677810801,102.40543143046678,74.90643175068746,-2.1137426364194702,-7.759118729327161,2.574967642034683,1.706352221883182,77.62341839241472,-3.2106318574113764,9.257154828292736,CARDIOVASCULAR SYSTEM,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;BETA BLOCKING AGENTS;CALCIUM CHANNEL BLOCKERS;LIPID MODIFYING AGENTS,"ACE INHIBITORS, COMBINATIONS;ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS;BETA BLOCKING AGENTS, OTHER COMBINATIONS;CALCIUM CHANNEL BLOCKERS AND DIURETICS;LIPID MODIFYING AGENTS, COMBINATIONS;OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS","ACE inhibitors and calcium channel blockers;ACE inhibitors, other combinations;Angiotensin II receptor blockers (ARBs) and calcium channel blockers;Angiotensin II receptor blockers (ARBs), other combinations;Beta blocking agents and calcium channel blockers;Calcium channel blockers and diuretics;Dihydropyridine derivatives;Lipid modifying agents in combination with other drugs;Renin-inhibitors"
49,flumazenil,flumazenil,flumazenil,most,CCOC(=O)c1ncn2c1C[NH+](C)C(=O)c1cc(F)ccc1-2,"InChI=1S/C15H14FN3O3/c1-3-22-15(21)13-12-7-18(2)14(20)10-6-9(16)4-5-11(10)19(12)8-17-13/h4-6,8H,3,7H2,1-2H3/p+1",1,Flumazenil,Arrhythmia,wp,0.3948123514652252,0.8948714017868042,0.6762500166893005,0.7928884625434875,0.0653583541512489,0.1573535993695259,0.0184530464466661,0.1245566442608833,0.0295475531369447,0.6109319686889648,0.0243609838187694,0.0400013238191604,0.0014811213128268,0.7898094177246093,0.9966220259666444,0.0229548462666571,0.0203235922381281,0.1628042235970497,0.0269025698304176,0.0132991849444806,0.0775346908718347,0.0022370119600964,0.9471866011619569,0.0998271085321903,0.0263426519930362,0.0178911170456558,0.0041662230039946,0.0027784119243733,0.0087199407164007,0.3146616607904434,0.2639227420091629,-4.023121263554284,70.74462695985737,67.58880558455556,-24.742113861888523,-13.080635238356418,2.949101249110812,1.0578657923526895,60.81720040292423,-2.113358780359998,-3.471011304060938,VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Antidotes
50,ethyol,amifostine,amifostine,most,[NH3+]CCC[NH2+]CCS[P](=O)(=O)O,"InChI=1S/C5H14N2O3PS/c6-2-1-3-7-4-5-12-11(8,9)10/h7H,1-6H2,(H,8,9,10)/p+2",1,Amifostine,Mixed,wp,0.0544414843199774,0.3333505645394325,0.1781667910516262,9.170554258162156e-05,0.00550064171548,0.0354392655193805,0.0004142840029089,0.0952013827860355,0.0055831254809163,0.1169738620519638,1.0511121388390166e-05,0.0352537961676716,0.0016441582822153,0.008737793075852,0.0102330731569963,0.0040305903938133,0.0105887234210968,0.0009921138727804,8.381569448090431e-05,0.0086136046564206,0.1394176796078682,3.163422186727161e-05,0.056251116230851,0.0009510364336165,0.0532838933169841,0.0001330458234406,0.0003348176373037,0.0001856198450695,0.000468801613897,0.8647145509719849,0.045290132984519,-5.381852630723299,15.001368192527854,-38.305726355027005,-5.226326400905353,-12.06467194892148,2.71564108081284,-0.2448623131760534,9.20777832559167,0.9681187828932902,-4.60800617887158,VARIOUS,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,Detoxifying agents for antineoplastic treatment
51,olumiant,baricitinib,baricitinib,most,CCS(=O)(=O)[NH+]1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,"InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)/p+1",1,Baricitinib,Heart Damage,bw,0.1588259570300579,0.2021417737007141,0.543428635597229,0.0728944677859544,0.0094048615777865,0.2106026962399482,0.0100562588078901,0.1688775651156902,0.0050359165179543,0.4277186572551727,0.1666148826479911,0.0538499481976032,0.0239354759920388,0.8929500818252564,0.9046830892562866,0.0272337779402732,0.0187944035977125,0.0216665265150368,0.0326803606003522,0.0329880455508828,0.0580968379974365,0.0024406188633292,0.4208420693874359,0.0075138110201805,0.0210279684513807,0.0050691291224211,0.0039627795107662,0.0116949117276817,0.0321309831924736,0.4834878742694855,0.5274536192417145,-5.756327316081494,19.825430245165503,5.790088368419443,-45.55333032194634,-15.801010397202202,3.031481267782529,-0.4997944653293178,76.26887522002355,-3.323744128162301,-7.320790615202766,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants
52,ofev,nintedanib,nintedanib esylate,most,COC(=O)c1ccc2c(C(=Nc3ccc(N(C)C(=O)C[NH+]4CC[NH+](C)CC4)cc3)c3ccccc3)c([O-])[n-]c2c1,"InChI=1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19H,15-18,20H2,1-3H3,(H2,32,33,38,39)",1,Nintedanib,Heart Damage,wp,0.1172857232391834,0.1040895216166973,0.3120520621538162,0.0684723515063524,0.0966261595487594,0.2058510079979896,0.0581404683180153,0.2084636867046356,0.2621394827961921,0.5741107881069183,0.3804255694150925,0.2306484460830688,0.0244145464152097,0.7884782671928405,0.1508177723735571,0.0499575387686491,0.0561179725453257,0.0773078724741935,0.0302716745063662,0.020789374038577,0.0573036424815654,0.007079450978199,0.4910863637924194,0.6211357951164246,0.1304771035909652,0.0356555799022316,0.0157770456513389,0.1191271886229515,0.040287471935153,0.2625841215252876,0.8951866149902343,-5.302984960610528,14.81959951566031,39.750473363809085,0.4912437133900162,-12.099287087409872,2.258909173617683,1.3163684605716273,77.44869655789171,-2.7160270028525924,7.212419277173358,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors
53,minoxidil,minoxidil,minoxidil,most,N=c1[n-]c(N2CCCCC2)cc(N)[n+]1[O-],"InChI=1S/C9H14N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6H,1-5,10H2,(H-,11,12)/q-1",1,Minoxidil,Heart Damage,bw,0.8252965569496155,0.8666568756103515,0.8791175127029419,0.1601576482877135,0.1870991833508014,0.036351965367794,0.0591409131884574,0.1719148993492126,0.2011306419968605,0.1489960372447967,0.0166110295278485,0.1214149609208107,0.0927488826215267,0.3930371284484863,0.998158061504364,0.0090292613022029,0.0096919272560626,0.1611969172954559,0.0282828393392264,0.0172240222338587,0.1807631999254226,0.002143745261128,0.4629245698451996,0.0117539929284248,0.1731225036084652,0.0175817852839827,0.0223332975292578,0.0683662693947553,0.0760459810495376,0.7141534686088562,0.2097105972468853,-5.330710819231342,45.21146894617976,15.030781631000526,9.222092568366882,-12.791334234595228,2.100896890987797,0.4370227388855812,58.33907153661987,-1.7084032785770695,0.9161681565379296,CARDIOVASCULAR SYSTEM;DERMATOLOGICALS,ANTIHYPERTENSIVES;OTHER DERMATOLOGICAL PREPARATIONS,"ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON;OTHER DERMATOLOGICAL PREPARATIONS",Other dermatologicals;Pyrimidine derivatives
54,,grepafloxacin,grepafloxacin,most,Cc1c(F)c(N2CC[NH2+]C(C)C2)cc2c1c(=O)c(C(=O)[O-])cn2C1CC1,"InChI=1S/C19H22FN3O3/c1-10-8-22(6-5-21-10)15-7-14-16(11(2)17(15)20)18(24)13(19(25)26)9-23(14)12-3-4-12/h7,9-10,12,21H,3-6,8H2,1-2H3,(H,25,26)",1,Grepafloxacin,Arrhythmia,Withdraw,0.6328488349914551,0.20319794267416,0.8414742231369019,0.00203845576616,0.0030828328104689,0.0250795565545558,0.0019446752092335,0.0216961186379194,0.0107393815182149,0.1378875076770782,0.0112618693150579,0.1825688451528549,0.00334548947867,0.807530152797699,0.8580156803131104,0.1160762429237365,0.2978330165147781,0.0273502856492996,0.0348076160997152,0.0153747290372848,0.1623695313930511,0.0019982766738394,0.1532086536288261,0.0151072574779391,0.0380686979740858,0.0116462275385856,0.0017248067539185,0.0082987286383286,0.0066543483408167,0.2359399273991584,0.0949580878019333,-5.114396777332075,14.246563733899944,16.945512293543874,-23.86125221984401,-11.937604402443768,2.103556004918862,-0.9610398054298642,50.09122841416959,-3.080097001282398,-0.4407407502888595,ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,QUINOLONE ANTIBACTERIALS,Fluoroquinolones
55,,etoricoxib,etoricoxib,most,Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1,"InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3",1,Etoricoxib,Heart Damage,Withdraw,0.1294198624789714,0.8784817457199097,0.9527098298072816,0.8051114439964294,0.6994561791419983,0.6282093465328217,0.2008504673838615,0.2579169660806656,0.0654353093355894,0.7288668632507325,0.7728928923606873,0.397493451833725,0.2771210342645645,0.9359428286552428,0.9996583938598632,0.0253651585429906,0.0222180316224694,0.0948778893798589,0.1213533297181129,0.0339450918138027,0.0676307022571563,0.0291779205203056,0.9775277614593506,0.4307547867298126,0.2478562697768211,0.0161014423705637,0.0355229180306196,0.060801799967885,0.0200027639046311,0.1543528571724891,0.3117253988981247,-4.831167665259354,18.21711866426096,21.454320990835143,23.087668382743946,-8.538787607743167,2.138351036101433,2.5024642556797816,91.55532703263552,-4.741713532897999,-0.3182346324019567,MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Coxibs
56,revlimid,lenalidomide,lenalidomide,most,Nc1cccc2c1C[NH+](C1CCC(=O)NC1=O)C2=O,"InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)/p+1",1,Lenalidomide,Heart Damage,bw,0.5344311177730561,0.959589147567749,0.6914218306541443,0.0181390132289379,0.0079255633056163,0.079498641192913,0.002364681000472,0.0396562691777944,0.0012886509648524,0.2553571462631225,0.0017138223804067,0.0572538867592811,0.015105971135199,0.6836895942687988,0.9545816659927367,0.028195722028613,0.0674354575574398,0.0248172760009765,0.0145526930689811,0.0068471401697024,0.2026420593261718,0.0006226688812603,0.177461189776659,0.0013291294148075,0.0398795146495103,0.0037731753196567,0.0047787960793357,0.0065494181821122,0.0324100121855735,0.744871997833252,0.0894741103053093,-5.703427153381995,-3.985628788324374,-32.44823746741319,-14.4664817907159,-15.509576399355282,2.416543112967424,-0.6936437831227054,48.660162936164575,-2.581857962506745,2.490787576729015,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Other immunosuppressants
57,tasigna,nilotinib,nilotinib,most,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(N=c4nc(-c5cccnc5)cc[n-]4)c3)cc(C(F)(F)F)c2)cn1,"InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H2,33,35,36,37,39)/p-1",1,Nilotinib,Arrhythmia,bw,0.334622237086296,0.6507661700248718,0.9192399382591248,0.37500821352005,0.6928628802299499,0.374766480922699,0.5725484669208527,0.2174105077981948,0.3908226519823074,0.7161530971527099,0.9674459099769592,0.5108048498630524,0.6030576586723327,0.8841060400009155,0.9992396116256714,0.006806645495817,0.0157944347709417,0.3519100546836853,0.2313424319028854,0.0080007766373455,0.0539434358477592,0.0239627562463283,0.8518123269081116,0.893703031539917,0.4476864337921142,0.0364160288125276,0.0762149576097726,0.5693491041660309,0.080343310534954,0.1202755562961101,0.9554873704910278,-5.148446259291895,5.343349190550331,6.751898093930132,70.6457417111042,-9.793610042353038,2.65349837446982,2.8520129571486184,93.23859090408466,-5.65379499573461,-2.2384069318385507,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,BCR-ABL tyrosine kinase inhibitors
58,cinacalcet,cinacalcet,cinacalcet hydrochloride,most,CC([NH2+]CCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12,"InChI=1S/C22H22F3N/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3/p+1",1,Cinacalcet,Arrhythmia,wp,0.1894111350178718,0.9290061235427856,0.6513578057289123,0.943327021598816,0.5056962609291077,0.1360593557357788,0.0287488704547286,0.7181173205375672,0.9520044445991516,0.6516204237937927,0.5541231334209442,0.5564342856407165,0.0191285613924264,0.084020772576332,0.9966406345367432,0.0179314102977514,0.0104716037400066,0.0883994914591312,0.38595030605793,0.0620208792388439,0.1868542030453682,0.0076208848506212,0.8722067475318909,0.9659030795097352,0.2553523540496826,0.0010982145089656,0.0234768750146031,0.6194510102272034,0.033198082819581,0.6084987342357635,0.9965960264205932,-5.260711323518089,61.01997657873194,38.75057799754308,23.9307529693804,-5.50850518704546,3.552830166732298,3.52912233861811,103.9342531096407,-4.17394414559872,13.65642039979508,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CALCIUM HOMEOSTASIS,ANTI-PARATHYROID AGENTS,Other anti-parathyroid agents
59,pomalyst,pomalidomide,pomalidomide,most,Nc1cccc2c1C(=O)[NH+](C1CCC(=O)NC1=O)C2=O,"InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18)/p+1",1,Pomalidomide,Heart Damage,bw,0.3294009521603584,0.8804209113121033,0.6561372697353363,0.030876397062093,0.008347512083128,0.0964270822703838,0.0088345831260085,0.0338823737576603,0.0012038594519253,0.1415215358138084,0.003548156551551,0.0803028665482998,0.0284607743844389,0.910497295856476,0.9366893529891968,0.0213669375516474,0.0581224657595157,0.0323556274175643,0.020587795227766,0.0084589450154453,0.1373747989535331,0.0010869931371416,0.1154646258801221,0.0023834330262616,0.0607200592756271,0.003489233169239,0.0071262364974245,0.0328847954049706,0.0523537822067737,0.7544723212718963,0.0973811514675617,-5.62942822849744,-5.219430013680986,-25.78689505892417,-0.7737382463128679,-16.277194906431376,1.9558033820057936,-1.2225559065175646,54.991316236361726,-3.287831424293479,5.637357612737495,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Other immunosuppressants
60,pioglitazone,pioglitazone,pioglitazone,most,CCc1ccc(CCOc2ccc(Cc3sc(=O)[n-]c3[O-])cc2)nc1,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12H,2,9-11H2,1H3,(H2,21,22,23)/p-2",1,Pioglitazone,Heart Damage,bw,0.1446884930133819,0.5488020658493042,0.9092617154121398,0.2938372105360031,0.9001543998718262,0.4521897733211517,0.7770179271697998,0.1506678745150566,0.0891800690442323,0.6608059287071228,0.8107845187187195,0.2087368227541446,0.0744785636663436,0.8114572644233704,0.9992908358573912,0.0099968983093276,0.0369648873805999,0.1133702293038368,0.1000058226287365,0.0355893807485699,0.1701744735240936,0.0914582215249538,0.89736008644104,0.6666388273239136,0.4206098437309265,0.0330608555115759,0.2394793748855591,0.1176353424787521,0.0535987820476293,0.2201111584901809,0.2359604984521865,-4.866208723304158,58.49883546874052,27.480322286412765,-30.45576289262597,-8.285800734145527,2.173920288264981,2.387481088881368,90.96175564999436,-3.934584451737008,-4.751263245175553,ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",Combinations of oral blood glucose lowering drugs;Thiazolidinediones
61,cabergoline,cabergoline,cabergoline,most,C=CC[NH+]1CC(C(=O)[NH+](CCC[NH+](C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,"InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/p+3",1,Cabergoline,Heart Damage,wp,0.0562543591484427,0.8272366523742676,0.0932599503546953,0.0154037794098258,0.01865547420457,0.0474725989624857,0.0029635949176736,0.7650653839111328,0.5070872843265534,0.5734062969684601,0.1124261230230331,0.0642315486213192,0.0198664870345965,0.061426477599889,0.4890795081853866,0.008886638469994,0.0230098847299814,0.0915409535169601,0.004289598937612,0.007972227782011,0.0707238532602787,7.7910733398312e-05,0.2724715188145638,0.0551643528044223,0.0322951860725879,0.0009076428133994,0.0022838994045741,0.0088268304942175,0.0044360104016959,0.5039394199848175,0.8919163346290588,-6.012480006868902,11.926249624179269,4.872132303186709,20.714134692677213,-12.39001105520814,3.507995904602777,0.9948409867651976,69.55338840838849,-1.7385859441115143,11.809174327929174,GENITO URINARY SYSTEM AND SEX HORMONES;NERVOUS SYSTEM,ANTI-PARKINSON DRUGS;OTHER GYNECOLOGICALS,DOPAMINERGIC AGENTS;OTHER GYNECOLOGICALS,Dopamine agonists;Prolactine inhibitors
62,,tegaserod,tegaserod,most,CCCCC[NH+]=C(N)NN=Cc1c[nH]c2ccc(OC)cc12,"InChI=1S/C16H23N5O/c1-3-4-5-8-18-16(17)21-20-11-12-10-19-15-7-6-13(22-2)9-14(12)15/h6-7,9-11,19H,3-5,8H2,1-2H3,(H3,17,18,21)/p+1",1,Tegaserod,,sp,0.9017343282699584,0.6215284883975982,0.8084343194961547,0.9330597400665284,0.3295662075281143,0.0580928325653076,0.0579605167731642,0.7853053450584412,0.6388926595449448,0.4362362414598465,0.4830020546913147,0.1675608269870281,0.0812470291741192,0.4384815573692321,0.9995341062545776,0.0066807746887207,0.0156886203214526,0.951772713661194,0.0727486765012145,0.0957033969461917,0.1203652754426002,0.0055403182399459,0.8568913340568542,0.2268122017383575,0.1422364562749862,0.2720560237765312,0.1048928126692771,0.2915359303355217,0.2421116113662719,0.6673241436481476,0.7430926978588104,-5.369237278403291,14.392958626114602,-0.6544944880272731,-22.50940237239424,-11.598782120876134,3.0083699161445443,1.1663763407919123,77.36142183221955,-3.065325940390514,10.488404857928698,ALIMENTARY TRACT AND METABOLISM,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,Other drugs for constipation
63,asclera,polidocanol,polidocanol,most,CCCCCCCCCCCCOCCO,"InChI=1S/C14H30O2/c1-2-3-4-5-6-7-8-9-10-11-13-16-14-12-15/h15H,2-14H2,1H3",1,Polidocanol,Heart Damage,wp,0.0044461529352702,0.983234429359436,0.6343567073345184,0.6112839221954346,0.0875865310430526,0.067678016424179,0.0447462857700884,0.3492586452513933,0.0180870579089969,0.2880475968122482,0.0024768269155174,0.5423817723989487,0.0009253862837795,0.0980403162539005,0.9999616384506226,0.0003793893894908,0.0242476407438516,0.0031990109771868,0.0118157390505075,0.0023628855939023,0.0384357824921608,0.0027227577520534,0.94362576007843,0.6075621485710144,0.014557927660644,0.0001653396677284,0.0237963795661926,0.0119930269196629,0.0025242773583158,0.6981129050254822,0.6363703727722168,-4.113389194542849,116.5903299712503,59.48257151394769,124.95138556365949,-4.284711727632801,1.4091914626300068,2.831636392533363,80.97049519764968,-3.4661492491237893,47.97229150526821,CARDIOVASCULAR SYSTEM,VASOPROTECTIVES,ANTIVARICOSE THERAPY,Sclerosing agents for local injection
64,mavenclad,cladribine,cladribine,most,N=c1[n-]c(Cl)nc2c1ncn2C1CC(O)C(CO)O1,"InChI=1S/C10H11ClN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H-,12,14,15)/q-1",1,Cladribine,Heart Damage,wp,0.3859288036823273,0.4627760410308837,0.8479526042938232,0.0533950863638892,0.0167528351768851,0.0662613598629832,0.0122457793797366,0.0200156359933316,0.0009405438308021,0.1514508098363876,0.0011959286895944,0.0662713412195444,0.1710857927799224,0.97320294380188,0.9953031420707704,0.008327486179769,0.0033642801514361,0.1029348962008953,0.0471701367758214,0.0099680418148636,0.0322632443159818,0.0218682914972305,0.2674540162086486,0.0124491015449166,0.2110673695802688,0.0300576949492096,0.065828488022089,0.0076844676979817,0.2740671575069427,0.4520499587059021,0.0393850801512598,-5.692276875642688,0.4714962433795577,-21.31948716800732,38.76107365205124,-17.77717768100791,1.87235904048476,-0.6133106454752404,43.73573000035357,-1.847703143751796,2.760880412069384,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS;IMMUNOSUPPRESSANTS,ANTIMETABOLITES;IMMUNOSUPPRESSANTS,Purine analogues;Selective immunosuppressants
65,permax,pergolide,pergolide,most,CCC[NH+]1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,"InChI=1S/C19H26N2S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3/p+1",1,Pergolide,Heart Damage,bw,0.1877312391996383,0.9641787886619568,0.4742795944213867,0.350660166144371,0.075279994867742,0.0879740208387374,0.0066502526053227,0.8198930382728576,0.8893014430999756,0.3843453586101532,0.1664390198886394,0.0144841137807816,0.0073954386170953,0.0776738360524177,0.9912750482559204,0.0063717531505972,0.0112982282415032,0.6311084747314453,0.0323272204492241,0.0130237745121121,0.0855088420212268,0.0002351761388126,0.6153095781803131,0.0770115729421377,0.0383004955947399,0.0017767014331184,0.0090732857352122,0.0292655305936932,0.0088024451397359,0.748211658000946,0.9196710586547852,-5.479921320614968,41.664978297407686,10.858703245582712,2.350186971486772,-10.72870667120225,3.020159978824273,1.4072331801408484,70.20230715759772,-2.8815879059257514,19.751936478699392,NERVOUS SYSTEM,ANTI-PARKINSON DRUGS,DOPAMINERGIC AGENTS,Dopamine agonists
66,imbruvica,ibrutinib,ibrutinib,most,C=CC(=O)[NH+]1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(=N)[n-]cnc32)C1,"InChI=1S/C25H23N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H-,26,27,28,29)/q-1/p+1",1,Ibrutinib,Mixed,wp,0.1998681753873825,0.321125316619873,0.2904397964477539,0.1422486655414104,0.3418220847845077,0.1242673113942146,0.1985942706465721,0.3364523559808731,0.1818046748638153,0.6761730670928955,0.5280396461486816,0.1030146162956953,0.0708505764603614,0.7233573079109192,0.7268802344799041,0.0320282313972711,0.0269266530871391,0.1219328075647354,0.0876301184296608,0.0943373166024685,0.2414912343025207,0.0327919462695717,0.7296136260032654,0.5191938221454621,0.5897850275039673,0.045346700400114,0.1199051201343536,0.1058302655816078,0.1641441375017166,0.2844082832336426,0.7208302021026611,-5.85437897405933,7.816524546362144,17.120916343236694,23.0035091073794,-11.82106756678665,2.9364201689704608,1.3857311155868377,81.4577655190739,-3.214446176426809,-7.989844380282136,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Bruton's tyrosine kinase (BTK) inhibitors
67,aveed,testosterone undecanoate,testosterone undecanoate,most,CCCCCCCCCCC(=O)OC1CCC2C3CC=C4CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C30H48O3/c1-4-5-6-7-8-9-10-11-12-28(32)33-27-16-15-25-24-14-13-22-21-23(31)17-19-29(22,2)26(24)18-20-30(25,27)3/h13,24-27H,4-12,14-21H2,1-3H3",1,Testosterone undecanoate,Heart Damage,wp,0.0416497562080621,0.9507434606552124,0.6551416158676148,0.005867443117313,0.1877655923366546,0.1059192530810833,0.1327844031155109,0.0931584080681204,0.0811522347852587,0.8160707950592041,0.2044231332838535,0.1537577658891677,0.0197841750457882,0.1386462472379207,0.9998717665672302,0.0437293216586113,0.2219865947961807,0.007474313955754,0.0167131300084292,0.0368431843817234,0.2322382718324661,0.0144336705096065,0.9665884137153624,0.979738962650299,0.3744838088750839,0.0026587188011035,0.082911766692996,0.142872092872858,0.0164454605430364,0.501367163658142,0.5896066427230835,-4.995449390659653,152.3281498633033,122.6886287410864,23.878678475294,-1.2539355356334494,2.428190426205545,5.124251125372845,111.0998613645883,-6.352193509136866,-0.0381308732460996,,,,
68,cerdelga,eliglustat,eliglustat,most,CCCCCCCC(=O)NC(C[NH+]1CCCC1)C(O)c1ccc2c(c1)OCCO2,"InChI=1S/C23H36N2O4/c1-2-3-4-5-6-9-22(26)24-19(17-25-12-7-8-13-25)23(27)18-10-11-20-21(16-18)29-15-14-28-20/h10-11,16,19,23,27H,2-9,12-15,17H2,1H3,(H,24,26)/p+1",1,Eliglustat,Arrhythmia,wp,0.0346437491476535,0.1930149555206299,0.1739907048642635,0.0550268009305,0.0645783439278602,0.0202703548595309,0.0065085471607744,0.6467230319976807,0.8415892243385314,0.5710255622863769,0.375447478890419,0.0561234142631292,0.0035723641980439,0.028864303138107,0.4686554074287414,0.021310856193304,0.0752879343926906,0.0706410910934209,0.0123909284360706,0.0160916030406951,0.2273371383547782,0.0007201365428045,0.4821323931217193,0.6681396245956421,0.1209142461419105,0.0010315451741917,0.0099894893355667,0.0236048331484198,0.003267144691199,0.5220968306064606,0.8582170009613037,-5.589423229248359,33.39323712646162,47.20008892718487,8.918704263206745,-11.404661195694748,2.871747963238432,0.7557278914860532,66.19281489580558,-2.356880145661382,7.234224571192473,ALIMENTARY TRACT AND METABOLISM,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,Various alimentary tract and metabolism products
69,adenosine,adenosine,adenosine,most,N=c1[n-]cnc2c1ncn2C1OC(CO)C(O)C1O,"InChI=1S/C10H12N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H-,11,12,13)/q-1",1,Adenosine,Arrhythmia,wp,0.3921630918979645,0.3808294415473938,0.667283034324646,0.0024361176547245,0.0022098231391282,0.0637600990012288,0.0027335948921972,0.0111765671521425,0.0003917180699204,0.0572177596390247,0.0001477085261228,0.0587744580581784,0.1816364411264658,0.938190257549286,0.8238984823226929,0.005939874658361,0.0035485365020576,0.024049870762974,0.0106406894512474,0.0097674061544239,0.0415643971413373,0.0041415384621359,0.0248236399143934,0.0049443790921941,0.1534180454909801,0.0083991304622031,0.0184651264455169,0.0017192271538078,0.2142096251249313,0.3763487249612808,0.0227515369653701,-6.266200309253129,-2.53462984801932,-15.606831241887445,40.03992222527214,-20.62572206689878,1.9152823799978989,-1.8212336931943784,20.25342079374556,-1.285228634430433,-1.911848001656073,CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,OTHER CARDIAC PREPARATIONS,Other cardiac preparations
70,zelboraf,vemurafenib,vemurafenib,most,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,"InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)",1,Vemurafenib,Arrhythmia,wp,0.0669984832406044,0.5787067532539367,0.8790834546089172,0.713450139760971,0.560532984137535,0.237308868765831,0.5544551104307175,0.1477122094482183,0.3086699888110161,0.5216188967227936,0.8759684920310974,0.2966039329767227,0.1500398382544517,0.9681617379188536,0.9992436051368714,0.1799388915300369,0.177028340101242,0.5492954194545746,0.4271560788154602,0.0362306360155344,0.1286807730793953,0.1268376670777797,0.9097020983695984,0.5793312430381775,0.4585414439439773,0.0849005043506622,0.0481708737090229,0.700368058681488,0.2462889224290848,0.1071711190044879,0.7532822608947753,-4.913017993526912,31.589687312883257,42.77164798887519,145.42437330710362,-11.384296658328235,2.638280462729471,3.024276846384488,107.0843634764055,-5.823052720023782,23.69249362536072,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;GENITO URINARY SYSTEM AND SEX HORMONES,ANTINEOPLASTIC AGENTS;GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;PROTEIN KINASE INHIBITORS",B-Raf serine-threonine kinase (BRAF) inhibitors;Sulfonamides
71,brilinta,ticagrelor,ticagrelor,most,CCCSc1nc(=NC2CC2c2ccc(F)c(F)c2)c2nnn(C3CC(OCCO)C(O)C3O)c2[n-]1,"InChI=1S/C23H27F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3/q-1",1,Ticagrelor,Arrhythmia,wp,0.3157423257827759,0.7668794631958008,0.8631255507469178,0.1131841614842414,0.3727281272411346,0.2187841087579727,0.5985411942005158,0.1097953766584396,0.0494313091039657,0.652055412530899,0.8446420550346374,0.0920048587024211,0.0856256172060966,0.8736872196197509,0.9995857000350952,0.0223956358619034,0.0252188315615057,0.1755051627755165,0.1419830292463302,0.0125073704868555,0.0659355640411376,0.0983166832476854,0.7329729199409485,0.6985934376716614,0.3752636253833771,0.1621895715594291,0.0822665527462959,0.3674085050821304,0.1506622776389122,0.0922347731888294,0.5850003302097321,-5.411894498334999,32.8978699228028,4.074904364032147,51.78678385843487,-10.475834055700757,2.6401216522312416,2.789133051635371,84.10312599750613,-2.4038165040938693,4.2674890133114,BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Platelet aggregation inhibitors excl. heparin
72,,dexfenfluramine,dexfenfluramine,most,CC[NH2+]C(C)Cc1cccc(C(F)(F)F)c1,"InChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3/p+1",1,Dexfenfluramine,Heart Damage,Withdraw,0.0154479790478944,0.9703799605369569,0.8663139462471008,0.398514574766159,0.0319050726946443,0.1595027148723602,0.0002289130175995,0.7528031587600708,0.7567662596702576,0.2622572034597397,0.0310570450499653,0.3206067502498627,0.0017088514665374,0.0088053478626534,0.9983878374099732,0.0010760414181277,0.0142104230821132,0.0031677737482823,0.0018053602296276,0.0026460809865966,0.0665074240416288,2.4240393406671502e-05,0.9240350008010864,0.0503033133223652,0.0032520939595997,4.672814875448239e-05,0.0001389662980727,0.0032195008010603,0.0001081264171261,0.5764674454927444,0.6499358594417572,-4.4015338083270885,32.54215450573798,9.27564343041235,-8.79541740661737,-5.927407749992197,2.889828208235389,1.2947798621980215,47.34114771871971,-1.164645738648768,7.782638345389661,ALIMENTARY TRACT AND METABOLISM,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS","ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",Centrally acting antiobesity products
73,qinlock,ripretinib,ripretinib,most,CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2c[n-]c(=NC)cc21,"InChI=1S/C24H21BrFN5O2/c1-3-31-21-12-22(27-2)28-13-14(21)9-17(23(31)32)16-10-20(19(26)11-18(16)25)30-24(33)29-15-7-5-4-6-8-15/h4-13H,3H2,1-2H3,(H3,27,28,29,30,32,33)/p-1",1,Ripretinib,Heart Damage,wp,0.383283519744873,0.7126739263534546,0.9211881041526796,0.2499699145555496,0.4335353136062622,0.6153566718101502,0.3457143068313598,0.2277958065271377,0.1536576181650161,0.6022680282592774,0.4683039844036102,0.6252886950969696,0.4971701443195343,0.9436833500862122,0.9930128574371336,0.0241401324048638,0.0366666000336408,0.4399545311927795,0.0888652741909027,0.0084731414914131,0.060693222284317,0.06458157338202,0.8226044535636902,0.8572847247123718,0.385039359331131,0.0651157550513744,0.0691332012414932,0.5624741971492767,0.1734278112649917,0.174890786409378,0.8390370368957519,-4.907360388203836,40.32052112479021,68.68884096536578,147.6262739203031,-11.208223335422783,3.161360278126339,3.245968474341061,97.71857484627212,-5.796670949223662,-2.661545180408344,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors
74,barhemsys,amisulpride,amisulpride,most,CC[NH+]1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,"InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)/p+1",1,Amisulpride,Arrhythmia,wp,0.3291569441556931,0.4811379194259643,0.3839316844940185,0.0078238693997263,0.0072556921513751,0.0908505156636238,0.0007499001265387,0.296661826968193,0.1977482423186302,0.3936229377985,0.1490324109792709,0.1242479778826236,0.0126944408286362,0.1097140371799469,0.4654259696602821,0.0074528893455863,0.0221212295815348,0.0104157675988972,0.0046494340291246,0.0124046987853944,0.0632857490330934,0.0001059909696778,0.2736998490989208,0.0084930469747632,0.0154744405299425,0.0004899900333839,0.0004608332325005,0.0011877378332428,0.00059457179741,0.3677886664867401,0.5793605208396911,-5.694022612677005,4.122841501650099,-21.92052200600142,-12.360032095511432,-14.900190438891418,2.086437964165024,-1.540871519934104,23.38291778352333,-1.5504740545924642,-1.997009078675757,NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Benzamides
75,sprycel,dasatinib,dasatinib,most,Cc1nc(=Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CC[NH+](CCO)CC2)[n-]1,"InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H2,24,25,26,27,28,32)",1,Dasatinib,Mixed,wp,0.1667035117745399,0.1696037597954273,0.333974140882492,0.0403023794293403,0.16068065315485,0.2345720887184143,0.0550062257796526,0.2373206973075866,0.231576132774353,0.6532850503921509,0.2876032024621963,0.1817781209945678,0.0498399171978235,0.7645609378814697,0.8041456460952758,0.0173657013103365,0.0294165004044771,0.282204657793045,0.0324534378945827,0.0143538627773523,0.0798856027424335,0.0060698069108184,0.5181152641773223,0.5262390613555908,0.2437163427472114,0.0076959691010415,0.0279726000502705,0.2011766761541366,0.0574699331074953,0.3424419343471527,0.8584277391433716,-5.470853700029684,18.747348690465813,25.533864196221856,18.54718759693472,-11.655382953969257,2.497725059233393,1.2446431808279734,81.74683181341203,-1.877377565082344,17.091591446177766,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,BCR-ABL tyrosine kinase inhibitors
76,,lidoflazine,lidoflazine,most,Cc1cccc(C)c1NC(=O)C[NH+]1CC[NH+](CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,"InChI=1S/C30H35F2N3O/c1-22-5-3-6-23(2)30(22)33-29(36)21-35-19-17-34(18-20-35)16-4-7-28(24-8-12-26(31)13-9-24)25-10-14-27(32)15-11-25/h3,5-6,8-15,28H,4,7,16-21H2,1-2H3,(H,33,36)/p+2",1,Lidoflazine,Arrhythmia,Withdraw,0.0620723992586135,0.3367419257760048,0.4201611280441284,0.0383625415153801,0.1811432860791683,0.1586308948695659,0.0829436514526605,0.4369223415851593,0.9469671845436096,0.6276973366737366,0.4405048877000809,0.4303572058677673,0.0109699534717947,0.108254399523139,0.4444695711135864,0.0126222666352987,0.01767951361835,0.0047133597079664,0.0278065150603652,0.0068793346639722,0.0497373312711715,0.0025551728696882,0.5862476229667664,0.8489173173904419,0.1344387799501419,0.0002226121498097,0.0103475636336952,0.101549819111824,0.002281658258289,0.6337592124938964,0.9932178020477296,-5.88803708807081,28.7795048289485,10.645453810691572,37.35292983560661,-7.901566278027246,2.972419356170256,1.8212746201497911,88.52508730945297,-2.2367738909511763,13.52660460650084,CARDIOVASCULAR SYSTEM,CALCIUM CHANNEL BLOCKERS,NON-SELECTIVE CALCIUM CHANNEL BLOCKERS,Other non-selective calcium channel blockers
77,lupkynis,voclosporin,voclosporin,most,C=CC=CCC(C)C(O)C1C(=O)NC(CC)C(=O)[NH+](C)CC(=O)[NH+](C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)[NH+](C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)[NH+](C)C(CC(C)C)C(=O)[NH+](C)C(CC(C)C)C(=O)[NH+](C)C(C(C)C)C(=O)[NH+]1C,"InChI=1S/C63H111N11O12/c1-25-27-28-29-41(15)53(76)52-57(80)66-44(26-2)59(82)68(18)34-49(75)69(19)45(30-35(3)4)56(79)67-50(39(11)12)62(85)70(20)46(31-36(5)6)55(78)64-42(16)54(77)65-43(17)58(81)71(21)47(32-37(7)8)60(83)72(22)48(33-38(9)10)61(84)73(23)51(40(13)14)63(86)74(52)24/h25,27-28,35-48,50-53,76H,1,26,29-34H2,2-24H3,(H,64,78)(H,65,77)(H,66,80)(H,67,79)/p+7",1,Voclosporin,Mixed,wp,0.1948371596634387,0.0119979262817651,0.1412089511752128,0.0001975177187887,0.0049674117646645,0.0264823195524513,0.0011523476001457,0.0107397746760398,0.004228111426346,0.6264705777168273,0.319523860514164,0.1984108664095401,0.0048869562742765,0.400296339392662,0.111475103511475,0.0443379843607544,0.1685577735304832,0.0045837042620405,0.0098413688130676,0.0282216077088378,0.0620053712278604,0.0032922166283242,0.2672091513872147,0.1267707586288452,0.1031018450856208,0.0050433304611942,0.0080278264998923,0.0183902698568999,0.0077725091017782,0.3411657691001892,0.2184558734297752,-6.073940294831028,57.45237151812499,104.46029960062852,6.231685580071883,-13.56105508006365,3.169909319455105,0.7093432591922149,66.10271052550358,-2.954277797138246,11.786225690615932,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Calcineurin inhibitors
78,noxafil,posaconazole,posaconazole; posaconazole,most,CCC(C(C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O,"InChI=1S/C37H42F2N8O4/c1-3-35(26(2)48)47-36(49)46(25-42-47)31-7-5-29(6-8-31)43-14-16-44(17-15-43)30-9-11-32(12-10-30)50-20-27-19-37(51-21-27,22-45-24-40-23-41-45)33-13-4-28(38)18-34(33)39/h4-13,18,23-27,35,48H,3,14-17,19-22H2,1-2H3",1,Posaconazole,Arrhythmia,wp,0.0833415523171424,0.165929889678955,0.8191481828689575,0.0273566763848066,0.6791779041290283,0.3546166718006134,0.8225252151489257,0.0850824512541294,0.0138387405313551,0.8299827456474305,0.9118831515312196,0.2340273961424827,0.1567782193422317,0.9828796982765198,0.9991246581077576,0.0026869780151173,0.0175582398194819,0.0942095659673214,0.2700989842414856,0.0084797728573903,0.0251220699399709,0.0989228699356317,0.6170358419418335,0.8896100997924805,0.7702882051467895,0.0249453702941536,0.0465215217322111,0.6198383152484894,0.1705124095082283,0.0553025610744953,0.9092100262641908,-5.02233287955385,17.22853551760632,74.21029757241129,2.639266850191912,-10.839455810073725,3.381769758133675,3.279520078237532,98.05812907419345,-5.058384644460667,0.8049244636426016,ANTIINFECTIVES FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,Triazole and tetrazole derivatives
79,farydak,panobinostat,panobinostat lactate,most,Cc1[nH]c2ccccc2c1CC[NH2+]Cc1ccc(C=CC(O)=NO)cc1,"InChI=1S/C21H23N3O2/c1-15-18(19-4-2-3-5-20(19)23-15)12-13-22-14-17-8-6-16(7-9-17)10-11-21(25)24-26/h2-11,22-23,26H,12-14H2,1H3,(H,24,25)/p+1",1,Panobinostat,Mixed,bw,0.1555058360099792,0.4269187957048416,0.2981866165995598,0.6359590888023376,0.3539938002824783,0.1018252894282341,0.0379013418219983,0.6141817450523377,0.9147221446037292,0.5816051423549652,0.4325205683708191,0.1250885616987943,0.0175425289198756,0.1712621957063675,0.9013912558555603,0.0563150689005851,0.045156268030405,0.7134172081947326,0.16333599537611,0.0749009475111961,0.10460816770792,0.0034982197976205,0.5383055567741394,0.7700586795806885,0.1516619086265564,0.0190771641209721,0.1004223994910717,0.2270524114370346,0.0390523038804531,0.4766040086746216,0.938133180141449,-6.149209801252028,43.162711798649056,22.01018036470705,-10.463929120731802,-12.183132344856944,3.314778161344902,1.231365613098333,86.14000657936488,-1.6105328871744742,11.170776330286596,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Histone deacetylase (HDAC) inhibitors
80,dyanavel xr; dyanavel xr,amphetamine,amphetamine,most,CC([NH3+])Cc1ccccc1,"InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/p+1",1,Amphetamine,Mixed,wp,0.016853681160137,0.9103542447090148,0.7047846794128418,0.0472655748017132,0.0511669110739603,0.0969732478260994,0.0012742985214572,0.5776141375303269,0.4314323842525482,0.2053512185811996,0.0008251341205323,0.0853377170860767,0.0002404654096608,0.0032784777344204,0.9876403570175172,0.0002903181914007,0.0068145785946398,0.0046116890385746,0.000567283930286,0.0029572374885901,0.115177658945322,8.173475715125277e-05,0.7856188774108886,0.0025636798003688,0.0033951430348679,2.746167843952208e-05,0.0017968727050174,0.0017885182867757,6.0583024765037405e-05,0.9164779663085938,0.2210727751255035,-4.155979029501191,64.98438641982656,20.05542888103341,-13.849784471311596,-5.359229697506795,2.2410093968160263,0.805150378162401,42.35826878315943,-0.8718516382067047,0.5790179948700869,NERVOUS SYSTEM,PSYCHOANALEPTICS,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",Centrally acting sympathomimetics
81,xcopri; xcopri maintenance pack; xcopri titration pack,cenobamate,cenobamate,most,NC(=O)OC(Cn1ncnn1)c1ccccc1Cl,"InChI=1S/C10H10ClN5O2/c11-8-4-2-1-3-7(8)9(18-10(12)17)5-16-14-6-13-15-16/h1-4,6,9H,5H2,(H2,12,17)",1,Cenobamate,Arrhythmia,wp,0.6887892991304397,0.9825185537338256,0.983845102787018,0.0488013871014118,0.339158208668232,0.1463025651872158,0.0162278739735484,0.014881241787225,0.003060754443868,0.3333191320300102,0.0332958394661545,0.2803151860833168,0.063870245963335,0.9454527378082276,0.9999834060668944,0.0016790649999165,0.0009077945098397,0.0375337625853717,0.0101319677196443,0.0035384990274906,0.0255611237138509,0.0214925328851677,0.7244222730398178,0.0671758717769989,0.0714529171586036,0.0025841601192951,0.0047689144965261,0.0020191852468997,0.0085204555653035,0.597339802980423,0.0035315546090714,-4.759963213415759,58.90838869167542,37.39596962487904,-0.7230836228046339,-14.147336168529485,2.390026517640808,0.103371556927954,48.66961825704104,-1.725675454117381,-5.064828563417533,NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Other antiepileptics
82,,prenylamine,prenylamine,most,CC(Cc1ccccc1)[NH2+]CCC(c1ccccc1)c1ccccc1,"InChI=1S/C24H27N/c1-20(19-21-11-5-2-6-12-21)25-18-17-24(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,20,24-25H,17-19H2,1H3/p+1",1,Prenylamine,Arrhythmia,Withdraw,0.0322671025991439,0.7011413931846618,0.5102171719074249,0.30702795535326,0.3221542805433273,0.140710000693798,0.0950814969837665,0.503119695186615,0.989484179019928,0.5776946783065796,0.182860891520977,0.0760052857920527,0.003276408574311,0.0164480478968471,0.9617465615272522,0.0031651117140427,0.0048478148411959,0.034455095231533,0.0946496110409498,0.0499464020133018,0.2333124637603759,0.0026298568962374,0.836487638950348,0.4401861131191253,0.1145934835076332,0.0002480651455698,0.0315282069612294,0.3734636425971985,0.0023741400451399,0.872886312007904,0.986185884475708,-5.142395705921112,76.24286483756366,16.81592394205407,-15.1675983051183,-6.184764755644646,2.989183822942862,2.422830087250601,86.62834305645566,-3.596982740930538,12.622464725948737,CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,VASODILATORS USED IN CARDIAC DISEASES,Other vasodilators used in cardiac diseases
83,zykadia,ceritinib,ceritinib,most,Cc1cc(N=c2[n-]cc(Cl)c(=Nc3ccccc3S(=O)(=O)C(C)C)[n-]2)c(OC(C)C)cc1C1CC[NH2+]CC1,"InChI=1S/C28H34ClN5O3S/c1-17(2)37-25-15-21(20-10-12-30-13-11-20)19(5)14-24(25)33-28-31-16-22(29)27(34-28)32-23-8-6-7-9-26(23)38(35,36)18(3)4/h6-9,14-18,20,30H,10-13H2,1-5H3/q-2/p+1",1,Ceritinib,Arrhythmia,wp,0.0938320690765976,0.3717793494462967,0.6647779226303101,0.0315878057852387,0.3879684954881668,0.1911488249897956,0.231852738559246,0.235181114077568,0.1437509730458259,0.921064841747284,0.80559903383255,0.2467553853988647,0.0125350966351106,0.5641951203346253,0.96507830619812,0.0046346666524186,0.008982596732676,0.0753291271626949,0.2886475533246994,0.0379250057041645,0.0509919568896293,0.0173228291794657,0.8046763181686402,0.8823588252067566,0.6223361372947693,0.0084288704209029,0.0984095834195613,0.2278202980756759,0.0214431374333798,0.1621636196970939,0.8496407508850098,-5.544206243368819,4.692208261137116,32.41082950698258,1.5663355711753106,-8.354787664746652,2.824374531526904,1.7794211851549415,86.87519266843279,-2.583019393597513,-1.0673672484892012,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Anaplastic lymphoma kinase (ALK) inhibitors
84,atenolol,atenolol,atenolol,most,CC(C)[NH2+]CC(O)COc1ccc(CC(N)=O)cc1,"InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)/p+1",1,Atenolol,Heart Damage,wp,0.0359858829528093,0.17392158806324,0.5945134580135345,0.0137692288029938,0.0066971062216907,0.061056862026453,0.0009874741968815,0.3447130262851715,0.0729087928310036,0.2528995394706726,0.0015046309650642,0.1044098384678363,0.0038046031899284,0.0050490791210904,0.4526719689369202,0.0193868510890752,0.1058623299002647,0.0043895286740735,0.0012997989862924,0.0083746689837425,0.1451665319502353,0.0005490560191901,0.3755183339118957,0.0058721741312183,0.0055475099477916,0.0004257637367118,0.0010453107373905,0.0005668844558385,0.0006531158709549,0.2516989082098007,0.1428587861359119,-5.361942481181354,7.291687237596551,-23.44571293575728,-14.62785985107188,-15.461024495176549,1.847864042953374,-1.0478975091499825,11.376218575784105,-0.8987992267753653,-3.0359403313484656,CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,"BETA BLOCKING AGENTS;BETA BLOCKING AGENTS AND OTHER DIURETICS;BETA BLOCKING AGENTS AND THIAZIDES;BETA BLOCKING AGENTS, OTHER COMBINATIONS;BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS","Beta blocking agents and calcium channel blockers;Beta blocking agents, selective;Beta blocking agents, selective, and other diuretics;Beta blocking agents, selective, and thiazides;Beta blocking agents, selective, thiazides and other diuretics"
85,nexplanon,etonogestrel,etonogestrel,most,C#CC1(O)CCC2C3CC=C4CC(=O)CCC4C3C(=C)CC21CC,"InChI=1S/C22H28O2/c1-4-21-13-14(3)20-17-9-7-16(23)12-15(17)6-8-18(20)19(21)10-11-22(21,24)5-2/h2,6,17-20,24H,3-4,7-13H2,1H3",1,Etonogestrel,Heart Damage,wp,0.06340605141595,0.8812828779220581,0.8881220817565918,0.0500925029627978,0.7471400499343872,0.3820729613304138,0.5000029295682907,0.1279739674180746,0.1280588269233703,0.7964750170707703,0.7091569542884827,0.1592335497960448,0.0683132898062467,0.1006466373801231,0.9999892950057984,0.2124659538269043,0.6812270641326904,0.0353674218989908,0.0795396193861961,0.3988785207271575,0.7626739501953125,0.0147381308954209,0.980731749534607,0.3082566291093826,0.6443698644638062,0.0098832041257992,0.0699998551979661,0.2643735751509666,0.0380495525896549,0.3035021230578422,0.127485629543662,-4.597754038135695,60.524022802943946,22.693831531766087,-9.759907301119728,-4.412570115952603,2.8044159969211777,4.152065938267018,95.30914268957734,-5.565736525341888,-0.5930894245644509,GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,Progestogens
86,ingrezza,valbenazine,valbenazine tosylate,most,COc1cc2c(cc1OC)C1CC(OC(=O)C([NH3+])C(C)C)C(CC(C)C)C[NH+]1CC2,"InChI=1S/C24H38N2O4/c1-14(2)9-17-13-26-8-7-16-10-21(28-5)22(29-6)11-18(16)19(26)12-20(17)30-24(27)23(25)15(3)4/h10-11,14-15,17,19-20,23H,7-9,12-13,25H2,1-6H3/p+2",1,Valbenazine,Arrhythmia,wp,0.036870627105236,0.408504056930542,0.3131300285458565,0.0025338004837976,0.0340792946517467,0.0347613088786602,0.0054225099040195,0.5787505030632019,0.4922571361064911,0.8564256072044373,0.2359214663505554,0.0225325541570782,0.0031086183851584,0.0327551619149744,0.5967887133359909,0.0041343220276758,0.0278919527307152,0.0299589596688747,0.0121396333910524,0.0301264366135001,0.1121120437979698,0.0004909426970698,0.8970386862754822,0.234298937022686,0.0190450454130768,0.0014105473732342,0.0045550700626336,0.0084089876152575,0.0020704161375761,0.3673439964652061,0.8747167348861694,-5.502798771202342,67.36581864252481,93.71578868053813,-5.66411655004009,-6.501478627336307,2.617578545334041,1.3294196331442845,71.2736452143502,-2.6267896255765657,9.94648843741017,NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,OTHER NERVOUS SYSTEM DRUGS,Other nervous system drugs
87,celecoxib,celecoxib,celecoxib,most,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,"InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)",1,Celecoxib,Heart Damage,bw,0.1245786160230636,0.8156946778297425,0.9465335845947266,0.7532874822616578,0.4758826434612274,0.6811814188957215,0.3430666744709015,0.2790373101830482,0.0770408641546964,0.5674751341342926,0.5186875820159912,0.8637242197990418,0.3340038925409317,0.9544352054595948,0.9992149114608764,0.0934993341565132,0.1087129205465316,0.0458161663264036,0.1398831143975258,0.0432557247579097,0.1193035788834095,0.0525107972323894,0.896368932723999,0.6596756696701049,0.372511476278305,0.0373048730194568,0.0099857151508331,0.315337486565113,0.0584656683728098,0.0824975028634071,0.6055729508399963,-4.889574944565564,24.211046570744195,26.691923274378656,-45.279684957600224,-5.507205799447601,2.378255788577376,2.833419748587678,99.63877629600113,-4.484045488727817,-2.708120520965625,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;CARDIOVASCULAR SYSTEM;GENITO URINARY SYSTEM AND SEX HORMONES;MUSCULO-SKELETAL SYSTEM;NERVOUS SYSTEM,ANALGESICS;ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;ANTINEOPLASTIC AGENTS;CALCIUM CHANNEL BLOCKERS;GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS;OPIOIDS;OTHER ANTINEOPLASTIC AGENTS;SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS",Coxibs;Dihydropyridine derivatives;Opioids in combination with non-opioid analgesics;Other antineoplastic agents;Sulfonamides
88,ciprofloxacin,ciprofloxacin,ciprofloxacin hydrochloride,most,O=C([O-])c1cn(C2CC2)c2cc(N3CC[NH2+]CC3)c(F)cc2c1=O,"InChI=1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24)",1,Ciprofloxacin,Arrhythmia,wp,0.5872264623641967,0.1560010723769664,0.7719585776329041,0.0023713956587016,0.0041305525461211,0.0549740143120288,0.0033363865280989,0.0370252488180995,0.0085908803623169,0.0778039686381816,0.0046991304378025,0.1466979190707206,0.0042130146641284,0.8454781532287597,0.5927527010440826,0.057216277718544,0.0813379801809787,0.0216138139367103,0.0129924738779664,0.0111021414399147,0.1452766016125679,0.001836237956013,0.044476943090558,0.0093302892753854,0.0331890824250876,0.0103065746370702,0.0019443652185145,0.0056782717001624,0.0088517115684226,0.3222836822271347,0.0614881567656993,-4.959090835263234,-1.3727141327457597,-1.690919866588401,-22.04197739040086,-13.131400056639626,2.1936207415601823,-1.3239100931211574,41.51684982546124,-3.0428819207475635,-0.9784214558319958,ANTIINFECTIVES FOR SYSTEMIC USE;SENSORY ORGANS,ANTIBACTERIALS FOR SYSTEMIC USE;OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;OPHTHALMOLOGICALS;OTOLOGICALS,ANTIINFECTIVES;COMBINATIONS OF ANTIBACTERIALS;QUINOLONE ANTIBACTERIALS,Antiinfectives;Combinations of antibacterials;Fluoroquinolones
89,stivarga,regorafenib,regorafenib monohydrate,most,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,"InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)",1,Regorafenib,Heart Damage,wp,0.3215853422880173,0.6593228220939636,0.8921070337295532,0.433518123626709,0.6604785442352294,0.4629434585571289,0.6304135203361512,0.2152945756912231,0.1258408546447754,0.609629213809967,0.5986418485641479,0.6207245647907257,0.3542162895202637,0.9552807688713074,0.9960593700408936,0.0085519189946353,0.0189068192616105,0.2571668714284897,0.1443071335554123,0.0129844942130148,0.0641159899532795,0.0905737221240997,0.6806607484817505,0.757573401927948,0.437948989868164,0.0253482801839709,0.1484300166368484,0.8180395841598511,0.3882057070732116,0.1901821494102478,0.7861979007720947,-5.056717420439497,40.14646371346981,34.843238815329265,137.122668033136,-10.795096718743576,2.945960346022855,3.481723583739707,95.042435382249,-7.067307461591672,4.003548981543302,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors
90,,orciprenaline,orciprenaline,most,CC(C)[NH2+]CC(O)c1cc([O-])cc([O-])c1,"InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3/p-1",1,Orciprenaline,Arrhythmia,Withdraw,0.0097775727743282,0.0571338471956551,0.5062013864517212,0.0396686561405658,0.0029658765764907,0.0856398299336433,0.0012851135252276,0.6761584103107452,0.0877316426485776,0.1307811349630356,0.0012638679472729,0.1555408865213394,0.0006100869402871,0.0062222706153988,0.7458179950714111,0.0058861573750618,0.0735154524445533,0.0178412323351949,0.0007613325346028,0.0037911445950157,0.0988733576610684,0.0001436043703506,0.255602191388607,0.0071660886518657,0.0034254430167493,9.261679306291626e-05,0.0006961135681194,0.0016462723986478,0.0002440903590013,0.5070657074451447,0.1045625895261764,-5.162866821476461,6.453341720169942,-31.23083835237261,-44.29753571686125,-13.127751573746304,1.9712299858494904,-1.0538982347849082,15.005114531064844,-0.3977846427315071,0.2644441447313991,RESPIRATORY SYSTEM,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,"ADRENERGICS FOR SYSTEMIC USE;ADRENERGICS, INHALANTS",Non-selective beta-adrenoreceptor agonists
91,sulindac,sulindac,sulindac,most,CC1=C(CC(=O)[O-])c2cc(F)ccc2C1=Cc1ccc([S+](C)O)cc1,"InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10,24H,11H2,1-2H3",1,Sulindac,Heart Damage,bw,0.1978462651371955,0.7129478335380555,0.9100091457366944,0.4418511092662811,0.3435212016105652,0.4273686110973358,0.4250967681407928,0.0476734403520822,0.0860032498836517,0.39002126455307,0.0777754209935665,0.5043392717838288,0.0554813213646411,0.943665897846222,0.9967347145080566,0.0621175516396761,0.0902012087404728,0.4104412347078323,0.2461644232273102,0.0597039479762315,0.291486918926239,0.4247310221195221,0.574683403968811,0.1876030728220939,0.5742093682289123,0.097134330868721,0.063839141279459,0.3818825304508209,0.144567322731018,0.42355937063694,0.1983602449297904,-4.908358972356784,6.277135283744408,12.771636585232448,21.60587569460149,-8.679063488743104,2.980245908149891,-0.1984430432519842,87.09560394448947,-3.462557056351404,2.747731335120008,MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Acetic acid derivatives and related substances
92,mefenamic acid,mefenamic acid,mefenamic acid,most,Cc1cccc(Nc2ccccc2C(=O)[O-])c1C,"InChI=1S/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18)/p-1",1,Mefenamic acid,Heart Damage,bw,0.2924946174025535,0.5837668657302857,0.9805046558380128,0.3582153350114822,0.1602344185113907,0.3839802712202072,0.2568839490413666,0.1015237361192703,0.0404822723940014,0.178834855556488,0.0399894192814827,0.4198770046234131,0.0063740790821611,0.9148694276809692,0.9997095108032228,0.0035830286797136,0.0433705698698759,0.4681674629449844,0.0196209704503417,0.0102593658026307,0.1670205652713775,0.0598811645060777,0.5329937636852264,0.0125307714799419,0.1039725460112094,0.0359610890969634,0.030773352459073,0.2726241961121559,0.0271269435063004,0.5552879333496094,0.0493640258908271,-4.600672150026438,72.86802086427237,31.5674504897994,-31.97453974268472,-8.28075511050947,2.0570341647285555,0.9281949064654847,78.97799502820052,-3.724406374758393,-5.3032236273643605,MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Fenamates
93,clarithromycin,clarithromycin,clarithromycin,most,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC([NH+](C)C)C2O)C(C)(OC)CC(C)C(=O)C(C)C(O)C1(C)O,"InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/p+1",1,Clarithromycin,Arrhythmia,wp,0.0629208823665976,0.0063380983192473,0.6406534373760223,2.138886829925468e-05,0.0022706352290697,0.0105642652604728,0.0006506185636681,0.006723508820869,0.0006044247149475,0.6435216546058655,0.1972303628921508,0.0374352796003222,0.0016920586349442,0.3920991331338882,0.2907694771885872,0.0083493625046685,0.0192607320845127,0.0020742815861012,0.0128671067766845,0.015174248907715,0.0637449283152818,0.0047000199789181,0.5049221813678741,0.5546641886234284,0.0246162557974457,0.0020029543782584,0.0047430204809643,0.0353675943333655,0.0145596318878233,0.1979137681424617,0.1032806932926178,-5.94695834584474,73.17933542654072,44.56231882302532,-7.488479786594814,-11.465119252659184,2.529718821696749,0.068040622153341,48.60378569016562,-1.7053044498119223,6.769622588819996,ALIMENTARY TRACT AND METABOLISM;ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE;DRUGS FOR ACID RELATED DISORDERS,"DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Combinations for eradication of Helicobacter pylori;Macrolides
94,paliperidone,paliperidone,paliperidone,most,Cc1nc2n(c(=O)c1CC[NH+]1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,"InChI=1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3/p+1",1,Paliperidone,Arrhythmia,wp,0.1164104297757148,0.5048672437667847,0.3393352329730987,0.0034211066085845,0.0036676628049463,0.0339202029630541,0.0019256733939982,0.3673351109027862,0.2656062453985214,0.6668985068798066,0.0274843609891831,0.0821096792817115,0.0186926972121,0.1491445824503898,0.8022246360778809,0.0205840568989515,0.1171132154762744,0.011283762846142,0.0095944111235439,0.008132423646748,0.1929715141654014,0.0001618511505512,0.5962050437927247,0.3966620057821274,0.0157512702047824,0.0006875642167869,0.0012008469726424,0.0029254231369122,0.0011847093934193,0.2292116835713386,0.8922101259231567,-5.492634916908195,-3.289214566322772,1.415331420158708,22.497206527656925,-14.226031254700317,3.4358949687302123,0.6741528523560719,62.05178316937381,-0.8120597789310064,2.8521441975167585,NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics
95,ifosfamide,ifosfamide,ifosfamide,most,O=P1([NH2+]CCCl)OCCC[NH+]1CCCl,"InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)/p+2",1,Ifosfamide,Mixed,wp,0.9911251544952392,0.476290762424469,0.767963969707489,0.0098189642129,0.0443729981823707,0.1380516570061445,0.0021257133572362,0.2376729950308799,0.0096475874459429,0.3613796651363373,0.0046638407744467,0.6030406057834625,0.0161979656606035,0.1416356761008501,0.4888882707804441,0.0081612472888082,0.0025148158718366,0.0173785065242555,0.0038436997596363,0.020344225410372,0.109376411139965,0.0040421576955395,0.4088735193014144,0.0011809319612723,0.097814430296421,0.0073932414408773,0.0036007827176945,0.0020729275491248,0.0560946846380829,0.9736401915550232,0.1746169935911893,-5.262579229638888,30.99276447789752,-21.9231498262073,-28.479612309161062,-10.773421084357292,3.592700094551561,0.3452288889880724,3.218358897029127,-0.1332296555905285,8.192796641479372,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,ALKYLATING AGENTS,Nitrogen mustard analogues
96,multaq,dronedarone,dronedarone,most,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCC[NH+](CCCC)CCCC)cc1,"InChI=1S/C31H44N2O5S/c1-5-8-12-29-30(27-23-25(32-39(4,35)36)15-18-28(27)38-29)31(34)24-13-16-26(17-14-24)37-22-11-21-33(19-9-6-2)20-10-7-3/h13-18,23,32H,5-12,19-22H2,1-4H3/p+1",1,Dronedarone,Mixed,bw,0.1076189666986465,0.2663322150707244,0.3617928355932235,0.469949746131897,0.3199072808027267,0.1556527137756347,0.1822381906211376,0.3497890084981918,0.8558432340621949,0.7997653365135193,0.7494088292121888,0.4405535995960236,0.0110245452262461,0.4033805280923843,0.7487962484359741,0.1041053354740142,0.0898533582687377,0.1286350555717945,0.320692691206932,0.0470006141811609,0.1374150931835174,0.0358334153890609,0.7626377224922181,0.9807893753051756,0.3650685846805572,0.0118286952376365,0.1194769337773323,0.5065259099006653,0.0817197430878877,0.3207458049058914,0.98289475440979,-5.310470730192152,36.76884416994833,79.91739511574988,206.000469513861,-9.202455734667495,3.224425235595242,1.984989350338912,93.65798760261576,-3.0303979020622114,19.52058531331692,CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,"ANTIARRHYTHMICS, CLASS I AND III","Antiarrhythmics, class III"
97,ixempra,ixabepilone,ixabepilone,most,CC(=Cc1csc(C)n1)C1CC2OC2(C)CCCC(C)C(O)C(C)C(=O)C(C)(C)C(O)CC(=O)N1,"InChI=1S/C27H42N2O5S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)29-23(31)13-21(30)26(5,6)25(33)17(3)24(15)32/h11,14-15,17,20-22,24,30,32H,8-10,12-13H2,1-7H3,(H,29,31)",1,Ixabepilone,Mixed,wp,0.1330831550061702,0.1934009954333305,0.7999821424484252,0.0013955763861304,0.0750619493424892,0.1207038410007953,0.0871102143079042,0.0249583261087536,0.0021305075380951,0.7808516383171081,0.5779245853424072,0.160278645157814,0.075699483603239,0.822533655166626,0.9965685844421388,0.0172119942726567,0.07524044662714,0.0544619992375373,0.0464578472077846,0.0140644393861293,0.1225693434476852,0.036060881614685,0.7926828503608704,0.7762295484542847,0.4644112467765808,0.0244376625865697,0.052792222239077,0.1709206148982048,0.1304275661706924,0.0521679491735994,0.1712869331240654,-5.196249650841097,59.72738526567084,76.57662745686241,20.746050382057053,-10.874367060688389,3.496313993351685,2.1825231555831417,83.16446076386698,-3.469206680485091,4.951924670434652,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,Other cytotoxic antibiotics
98,definity rt,perflutren,perflutren,most,FC(F)(F)C(F)(F)C(F)(F)F,"InChI=1S/C3F8/c4-1(5,2(6,7)8)3(9,10)11",1,Perflutren,Mixed,bw,0.0008384050437598,0.9990540027618408,0.7891434490680694,0.0354670610278844,0.6519165635108948,0.0833584934473037,0.0849308520555496,0.0453227867372334,0.0012034089522785,0.6278788417577743,0.0022892023977419,0.741862553358078,1.4898946560748528e-05,0.1284740338800475,0.999981451034546,0.0001697509584118,0.0009721055917907,0.0001643176309016,0.0006110634945343,0.016251862514764,0.0551933359354734,9.802207250686478e-06,0.9559179186820984,0.0044755680050002,0.0109761549567338,3.83715255907191e-05,0.0037926409626379,0.0028702972456812,0.0029501393088139,0.6577920019626617,0.3046179047145415,-4.165042560442799,9.240997558611168,-16.00288470962237,9.38888951837087,3.681683844768075,1.3405367079825132,3.326084444807519,88.05852834284212,-4.005086830465362,5.371434432990034,,,,
99,tibsovo,ivosidenib,ivosidenib,most,N#Cc1ccnc([NH+]2C(=O)CCC2C(=O)[NH+](c2cncc(F)c2)C(C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,"InChI=1S/C28H22ClF3N6O3/c29-21-4-2-1-3-20(21)25(26(40)36-18-11-28(31,32)12-18)37(19-10-17(30)14-34-15-19)27(41)22-5-6-24(39)38(22)23-9-16(13-33)7-8-35-23/h1-4,7-10,14-15,18,22,25H,5-6,11-12H2,(H,36,40)/p+2",1,Ivosidenib,Arrhythmia,wp,0.1193158753216266,0.3132212489843368,0.6251619160175323,0.0117537952959537,0.2872038602828979,0.1228255316615104,0.3105438970029354,0.0482464527711272,0.0468597684055566,0.7343764662742615,0.9564640760421752,0.2206054285168647,0.0213915009051561,0.8738738298416138,0.9885361909866331,0.0147042906843125,0.0130350180901587,0.0150824448093771,0.1645967490971088,0.0156799240969121,0.0420265063643455,0.0116674444172531,0.7115787029266357,0.3298524528741836,0.3596307456493378,0.0064246905269101,0.0207978499587625,0.4886787176132202,0.0842545434832573,0.1994648110121488,0.6739630460739136,-5.808234026063369,36.955585152857886,17.421575477032615,-23.243362058691265,-12.784560934516064,3.880955936518397,1.30437227349183,77.44670364488817,-4.355827962832913,1.9775158427404684,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Other antineoplastic agents
100,potassium acetate,potassium acetate,potassium acetate,most,CC(=O)[O-],"InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)/p-1",1,Potassium acetate,Arrhythmia,wp,0.0474214245565235,0.9793869018554688,0.6653329610824585,0.0010375245023169,0.0113365889061242,0.0642802959308028,0.0007871477602748,0.0141201465390622,0.0089417171606328,0.0982656314969062,1.4597483986023008e-06,0.0718374349176883,0.0014248698600567,0.6978450417518616,0.9482261538505554,0.0002671473383088,0.0038168819155544,0.0004021324464702,1.535919727757573e-05,0.0005276410709484,0.1770868254825472,1.1391294211193782e-05,0.2979687608778477,0.0251846771687269,0.0070760517846792,1.007156802756981e-05,0.0009842985426075,0.0004485284079237,0.0001668457167852,0.2252602040767669,0.0009354941314086,-4.691340921789285,-63.68257719146831,-18.834418512173794,-19.0440594190372,-7.449531419775438,1.089000324301129,-2.929322018328764,34.10886003354474,1.1007220644742537,2.029563418970074,BLOOD AND BLOOD FORMING ORGANS,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,I.V. SOLUTION ADDITIVES,Electrolyte solutions
101,tagrisso,osimertinib,osimertinib,most,C=CC(=O)Nc1cc(N=c2nc(-c3cn(C)c4ccccc34)cc[n-]2)c(OC)cc1N(C)CC[NH+](C)C,"InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H2,29,30,31,32,36)",1,Osimertinib,Mixed,wp,0.4575228452682495,0.507326191663742,0.3979553997516632,0.1929133929312229,0.0874421149492263,0.1487792894244194,0.0097713065333664,0.2893491715192794,0.4186790913343429,0.8571734428405762,0.7724316716194153,0.1490812316536903,0.0474153356626629,0.7561009168624878,0.7826319932937622,0.0609238661825656,0.0278623264282941,0.5217285454273224,0.0970947340130806,0.0532548457384109,0.0508325286209583,0.0066421288996934,0.7737619638442993,0.8249835848808289,0.2199953094124794,0.077176771312952,0.0738989196717739,0.1259565994143486,0.2065326690673828,0.2135139167308807,0.9007099747657776,-5.377133564763919,36.024968949223215,81.06661604120669,38.75969958687428,-12.254736896601724,3.061085412916719,1.667139427536656,77.88231363510087,-1.871295265175993,2.471621890297554,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
102,mirtazapine,mirtazapine,mirtazapine,most,C[NH+]1CC[NH+]2c3ncccc3Cc3ccccc3C2C1,"InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3/p+2",1,Mirtazapine,Arrhythmia,wp,0.0812930215150117,0.7295925974845886,0.2585434734821319,0.0050665950169786,0.0089943704893812,0.1629014447331428,0.000288286383693,0.369126409292221,0.2688316702842712,0.2911034345626831,0.0044256681110709,0.0126650555059313,0.0016588117458923,0.0495700315572321,0.4526441022753715,0.0080171823501586,0.0490910120308399,0.0423476312309503,0.0039644148666411,0.0075900780037045,0.162754824757576,3.566503575740399e-05,0.411387300491333,0.012619068683125,0.0281298520043492,0.0001668578031967,0.0005581622746831,0.0024128128192387,0.000596937611408,0.7566495537757874,0.403788161277771,-5.001385268062167,58.799624524518094,4.430854234034856,-14.637274515214926,-12.915556846645098,3.0160316948892985,0.6094124338572182,42.91947508978773,-1.2211814671963357,14.63149361994483,NERVOUS SYSTEM,PSYCHOANALEPTICS,ANTIDEPRESSANTS,Other antidepressants
103,,astemizole,astemizole,most,COc1ccc(CC[NH+]2CCC(N=c3[n-]c4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,"InChI=1S/C28H30FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3/q-1/p+1",1,Astemizole,Arrhythmia,Withdraw,0.1428719639778137,0.5980525106191635,0.3879947185516357,0.063551877066493,0.1754956439137459,0.0771408081054687,0.0524415384978056,0.6351495623588562,0.9842026948928831,0.8528589129447937,0.6738195836544036,0.0819134719669818,0.029125084169209,0.0897824928164482,0.9684163093566894,0.0029712327523157,0.0070751566439867,0.2495216444134712,0.1721621692180633,0.0123492814600467,0.0677823238074779,0.0018275071779498,0.8222910284996032,0.9493772983551024,0.2084846496582031,0.0020481029408983,0.0651398934423923,0.0475380394607782,0.0047400914598256,0.3677762731909751,0.992994773387909,-5.324346351497138,25.410531775545778,27.15946948370705,-47.701150352682696,-9.299534391002146,2.8648799714806383,2.1755721185899946,87.31560376214833,-2.6625319144292687,2.274272929116067,RESPIRATORY SYSTEM,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,Other antihistamines for systemic use
104,tetrabenazine,tetrabenazine,tetrabenazine,most,COc1cc2c(cc1OC)C1CC(=O)C(CC(C)C)C[NH+]1CC2,"InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/p+1",1,Tetrabenazine,Mixed,wp,0.0631821174174547,0.8219360947608948,0.6413026034832001,0.0122086023446172,0.0180680339224636,0.0638722466304898,0.0018612988875247,0.7992677807807922,0.3107772320508957,0.7373997211456299,0.0138184983283281,0.0183590893633663,0.0020239734614733,0.0389359652996063,0.8609741806983948,0.0040607422124594,0.0237143956124782,0.0782028175890445,0.0079815747682005,0.0089083621278405,0.1231174603104591,0.000510925038543,0.8942895293235779,0.1461512222886085,0.03860396258533,0.0018599820323288,0.0030677083181217,0.0041229176800698,0.0022705263167154,0.3092396840453147,0.6399039983749389,-4.752016931806734,73.39102858472383,40.36262541041943,-9.06433769293137,-6.984413682529514,2.4890594656916973,1.367222936903908,67.28653319889153,-2.601830467870196,8.590135179949446,NERVOUS SYSTEM,OTHER NERVOUS SYSTEM DRUGS,OTHER NERVOUS SYSTEM DRUGS,Other nervous system drugs
105,droperidol,droperidol,droperidol,most,O=C(CCC[NH+]1CC=C(n2c(=O)[n-]c3ccccc32)CC1)c1ccc(F)cc1,"InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)",1,Droperidol,Arrhythmia,bw,0.2517879590392112,0.7412376046180725,0.4620256185531616,0.0715045981109142,0.0665984399616718,0.1084316231310367,0.0279910557903349,0.3973600447177887,0.9303143858909608,0.6006053805351257,0.1331130787730217,0.1904773280024528,0.0229707568883895,0.2040681771934032,0.7639581561088562,0.069990786537528,0.0694787442684173,0.1135418646037578,0.0808258302509784,0.023258939012885,0.1105363711714744,0.0038762827927712,0.4543478071689605,0.8185111522674561,0.1149993136525154,0.0076756512746214,0.0211423736065626,0.0365901409648358,0.0139110879041254,0.3255068212747574,0.884480357170105,-5.306696133269791,53.26852870708177,20.142679625378086,10.367393601071871,-10.863628249176088,2.52804268183015,1.3106666411685464,73.25064628059066,-1.4307156161514516,7.047667687500573,NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Butyrophenone derivatives
106,rozlytrek,entrectinib,entrectinib,most,C[NH+]1CCN(c2ccc(C(=O)N=c3[n-][n-]c4ccc(Cc5cc(F)cc(F)c5)cc34)c([NH2+]C3CCOCC3)c2)CC1,"InChI=1S/C31H32F2N6O2/c1-38-8-10-39(11-9-38)25-3-4-26(29(19-25)34-24-6-12-41-13-7-24)31(40)35-30-27-17-20(2-5-28(27)36-37-30)14-21-15-22(32)18-23(33)16-21/h2-5,15-19,24H,6-14H2,1H3,(H-2,34,35,36,37,40)/q-2/p+2",1,Entrectinib,Mixed,wp,0.1847359880805015,0.1211238596588373,0.5315191805362701,0.0161661284044384,0.1861936926841735,0.1677197605371475,0.0515100251883268,0.191501247882843,0.1848009474575519,0.7415824890136719,0.4449831128120422,0.3604039430618286,0.0221118782646954,0.7856767535209656,0.3447812333703041,0.017238163203001,0.0281619843095541,0.0668726459145546,0.0469212047755718,0.0281439709477126,0.0902221046388149,0.0117414225824177,0.3477585703134537,0.8305693149566651,0.3564038634300231,0.0476229069754481,0.0290806531906127,0.0992301225662231,0.0485262595117092,0.1797331735491752,0.8347586393356323,-5.651978106383936,-7.68259011074362,32.51917560354549,23.17980771759315,-11.083421670320108,2.9575939455153937,1.56927174118704,83.01184846833408,-1.1137791192819997,9.520015255986312,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors
107,fluconazole,fluconazole,fluconazole,most,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,"InChI=1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2",1,Fluconazole,Arrhythmia,wp,0.2142539963126182,0.6673838436603546,0.9739175081253052,0.0441590552218258,0.2791161112487316,0.2310880322009325,0.4118305942974984,0.0296588275581598,0.013143509272777,0.1766620442271232,0.7237915933132172,0.1447168178856372,0.1770983098074793,0.8962567806243896,0.9999828100204468,0.0004707547515863,0.000850733538391,0.070970644056797,0.1234934374690055,0.0016032893385272,0.0032733562286011,0.0010281227270752,0.5881359219551087,0.0113771573509438,0.0229410339146852,0.0001622115782083,0.0023766115104081,0.0014904828451108,0.0007939866569358,0.5905106425285339,0.1142545256763696,-5.01608957890912,20.66217077356533,-2.835297658339634,15.392260245831997,-12.483070845397318,2.5052222408997977,0.0775750941662473,18.845940305280656,-2.312192609994457,-2.8367795519856407,ANTIINFECTIVES FOR SYSTEMIC USE;DERMATOLOGICALS,ANTIBACTERIALS FOR SYSTEMIC USE;ANTIFUNGALS FOR DERMATOLOGICAL USE;ANTIMYCOTICS FOR SYSTEMIC USE,ANTIFUNGALS FOR TOPICAL USE;ANTIMYCOTICS FOR SYSTEMIC USE;COMBINATIONS OF ANTIBACTERIALS,Combinations of antibacterials;Imidazole and triazole derivatives;Triazole and tetrazole derivatives
108,almotriptan,almotriptan,almotriptan malate,most,C[NH+](C)CCc1c[nH]c2ccc(CS(=O)(=O)[NH+]3CCCC3)cc12,"InChI=1S/C17H25N3O2S/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3/p+2",1,Almotriptan,Mixed,wp,0.1485933974385261,0.3736914873123169,0.2742581695318222,0.0550841890275478,0.008341337996535,0.2627140671014786,0.002120934271079,0.611409044265747,0.1194336637854576,0.5336831629276275,0.064884204044938,0.0970329392701387,0.0105822246521711,0.2708378776907921,0.4206009313464164,0.0150300545617938,0.0283336536958813,0.0322321770712733,0.0112773582339286,0.0289424255490303,0.1102158620953559,0.0008806020852716,0.4229102283716202,0.021836607158184,0.017513367254287,0.00081532268523,0.0039647476805839,0.0178455447778105,0.0062340115779079,0.7391374468803406,0.6913702487945557,-5.666190639435163,32.2112641652926,-11.524380647678004,4.022024582337804,-14.685869911149108,3.20427988084888,-0.6446680217810089,42.177509376044085,-1.968775379347829,1.277599072645296,NERVOUS SYSTEM,ANALGESICS,ANTIMIGRAINE PREPARATIONS,Selective serotonin (5HT1) agonists
109,efavirenz,efavirenz,efavirenz,most,O=C1Nc2ccc(Cl)cc2C(C#CC2CC2)(C(F)(F)F)O1,"InChI=1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)",1,Efavirenz,Arrhythmia,wp,0.2760028973221778,0.8821410536766052,0.8160508513450623,0.749556303024292,0.8909170150756835,0.2023079812526703,0.7549483299255371,0.0262253412976861,0.0932164935395121,0.8118486523628234,0.5542188465595246,0.6115866541862488,0.0265813606092706,0.9172082304954527,0.9999776363372804,0.0169735596980899,0.0106025591958314,0.1943967819213867,0.6009325504302978,0.1355142951011657,0.4153624504804611,0.2456838920712471,0.9409236311912536,0.1276658616960048,0.8856343746185302,0.1392614662647247,0.661604642868042,0.9791502237319948,0.8091437458992005,0.8983993053436279,0.2812912777066231,-4.126015824978775,11.824546158623235,7.459743571048537,19.331148858612305,-6.667435968990153,2.5109586667306285,3.5699069836916784,96.87968373486734,-4.936638020469971,-5.709212718657186,ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,"Antivirals for treatment of HIV infections, combinations;Non-nucleoside reverse transcriptase inhibitors"
110,,cisapride,cisapride,most,COc1cc(N)c(Cl)cc1C(=O)NC1CC[NH+](CCCOc2ccc(F)cc2)CC1OC,"InChI=1S/C23H29ClFN3O4/c1-30-21-13-19(26)18(24)12-17(21)23(29)27-20-8-10-28(14-22(20)31-2)9-3-11-32-16-6-4-15(25)5-7-16/h4-7,12-13,20,22H,3,8-11,14,26H2,1-2H3,(H,27,29)/p+1",1,Cisapride,Arrhythmia,Withdraw,0.1688671037554741,0.4388935506343842,0.4765931904315948,0.0155573829077184,0.1621064327657222,0.0480700347572565,0.0381799433380365,0.5369343161582947,0.6570799052715302,0.8169450402259827,0.536695808172226,0.1210475593805313,0.0194008781574666,0.2134444385766983,0.7288802266120911,0.0050045896321535,0.0148319747298955,0.0694189622998237,0.0278625028207898,0.0086688767187297,0.0752215676009655,0.0008791132990154,0.6561418652534485,0.4146341353654861,0.0683849412947893,0.0017855294048786,0.0058685715310275,0.010524152778089,0.0055620699655264,0.2988757699728012,0.969588541984558,-5.517249982698295,52.929582732422055,4.13279502920984,-38.01922085701703,-10.674090248378922,2.362912743114664,1.812203084650848,80.33089604240965,-3.1070859260792547,1.4937648977041975,ALIMENTARY TRACT AND METABOLISM,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,PROPULSIVES,Propulsives
111,tafinlar,dabrafenib,dabrafenib mesylate,most,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2cc[n-]c(=N)n2)s1,"InChI=1S/C23H19F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H-,27,28,29)/q-1",1,Dabrafenib,Heart Damage,wp,0.1377352744340896,0.355502450466156,0.8589075565338135,0.2153883129358291,0.6854936599731445,0.4510928809642792,0.6437363803386689,0.0835841156542301,0.1355578541755676,0.4869737267494202,0.7376292705535888,0.6980456113815308,0.1326048374176025,0.9659196853637696,0.9912927031517028,0.0324229795485735,0.0789271645247936,0.0905717141926288,0.2460868343710899,0.0295210439711809,0.1193138375878334,0.1528587684035301,0.7830465793609619,0.5634299516677856,0.4730882585048676,0.0253039095550775,0.0809858903288841,0.6832604765892029,0.1162454515695571,0.1708927124738693,0.6362446308135986,-5.164416824305535,15.784353449202143,19.645801693685225,105.588744198751,-8.81919899232543,2.1406058821462794,2.3176172088893785,101.68057708780456,-4.837317569729384,-6.019554091187266,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,B-Raf serine-threonine kinase (BRAF) inhibitors
112,daypro,oxaprozin,oxaprozin,most,O=C([O-])CCc1nc(-c2ccccc2)c(-c2ccccc2)o1,"InChI=1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21)/p-1",1,Oxaprozin,Heart Damage,bw,0.0164780303835868,0.6069379985332489,0.9424737095832824,0.2215755999088287,0.3211599618196487,0.6306647598743439,0.255963471531868,0.03148949816823,0.0072413789108395,0.2860905706882476,0.0042076743207871,0.2883912295103073,0.0154239897616207,0.9615363836288452,0.9978326439857484,0.0117977246176451,0.0274380017071962,0.0351053658872842,0.0449651312083005,0.0235959067940711,0.2744792550802231,0.5514245986938476,0.773629343509674,0.156221180409193,0.2319122612476349,0.0215543748810887,0.0257142281159758,0.0114166727755218,0.0066177059430629,0.3651388496160507,0.0177713653072714,-4.777992940952826,21.14748047324923,8.638700371809632,-21.1681473552324,-8.628532680739424,1.8698271156384216,0.5432463603334187,96.56987052308304,-3.0540334271365066,5.152820517994097,MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Propionic acid derivatives
113,exkivity,mobocertinib,mobocertinib,most,C=CC(=O)Nc1cc(N=c2nc(-c3cn(C)c4ccccc34)c(C(=O)OC(C)C)c[n-]2)c(OC)cc1N(C)CC[NH+](C)C,"InChI=1S/C32H39N7O4/c1-9-29(40)34-24-16-25(28(42-8)17-27(24)38(6)15-14-37(4)5)35-32-33-18-22(31(41)43-20(2)3)30(36-32)23-19-39(7)26-13-11-10-12-21(23)26/h9-13,16-20H,1,14-15H2,2-8H3,(H2,33,34,35,36,40,41)",1,Mobocertinib,Mixed,bw,0.3963148981332779,0.3352012008428573,0.2779289782047272,0.222349926829338,0.2191135540604591,0.1506521731615066,0.0663953371345996,0.2228611528873443,0.3588095664978027,0.8433336734771728,0.874009656906128,0.1566864341497421,0.0505573891103267,0.810601818561554,0.7428269386291504,0.0844490937888622,0.0338515505194664,0.4270139396190643,0.1110674872994423,0.0522346660494804,0.0402399186044931,0.0150113526266068,0.8302090287208557,0.8593146443367005,0.2152820363640785,0.1130654007196426,0.0931554701179266,0.2173372536897659,0.2603075742721558,0.2049957752227783,0.913140380382538,-5.012452138307472,78.33071408303722,131.41038387616555,58.441626094832166,-11.89644498792309,3.0622511277109803,2.105445608363457,77.74323713431504,-2.7451621619753817,5.365913829631974,,,,
114,olinvyk,oliceridine,oliceridine,most,COc1ccsc1C[NH2+]CCC1(c2ccccn2)CCOC2(CCCC2)C1,"InChI=1S/C22H30N2O2S/c1-25-18-7-15-27-19(18)16-23-13-10-21(20-6-2-5-12-24-20)11-14-26-22(17-21)8-3-4-9-22/h2,5-7,12,15,23H,3-4,8-11,13-14,16-17H2,1H3/p+1",1,Oliceridine,Mixed,wp,0.2247820079326629,0.8021602392196655,0.4328451991081238,0.1267451390624046,0.2060356184840202,0.0814493469893932,0.0527367604896426,0.5902595937252044,0.924380087852478,0.7970968246459961,0.8744869470596314,0.0199531342368572,0.0586951274424791,0.0380359603092074,0.9930896639823914,0.0068225128343328,0.011039085779339,0.1540291666984558,0.3442807793617248,0.1171935468912124,0.2145687237381935,0.0073595438036136,0.9308400392532348,0.6163484513759613,0.2640319764614105,0.0158505920320749,0.1361232116818428,0.1868010997772216,0.0293565791100263,0.5100003510713578,0.8678433418273925,-5.429634517557014,108.95372052361316,58.74126910799494,-32.212518271124324,-8.409103433747184,3.0616891741468457,1.813208939443203,82.2860277108662,-3.0789451900846907,8.322561362540432,NERVOUS SYSTEM,ANALGESICS,OPIOIDS,Other opioids
115,clozapine,clozapine,clozapine,most,C[NH+]1CCN(C2=[NH+]c3cc(Cl)ccc3Nc3ccccc32)CC1,"InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3/p+2",1,Clozapine,Mixed,bw,0.4649794280529022,0.898725950717926,0.554621571302414,0.6023742496967316,0.0368701099185273,0.2962586104869842,0.0018967670679558,0.6859679698944092,0.8209890007972718,0.5039589107036591,0.0296509229578077,0.1262987032532692,0.0118836450972594,0.6529975831508636,0.8095815420150757,0.0145652181468904,0.0161456950008869,0.1318089112639427,0.0485666781663894,0.0094764463603496,0.0562989726662635,0.0015907522221823,0.681480348110199,0.1768727652728557,0.1086659591645002,0.0012600657209986,0.007372106751427,0.0589121112599968,0.015304410457611,0.8079352259635926,0.9424197196960448,-5.111440817554902,20.4223206825752,-0.2248797312330467,-2.4702383218806268,-12.039233914804294,2.899430114933262,1.6452265821979364,83.05451152335547,-3.23128483395305,21.40809088784557,NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,"Diazepines, oxazepines, thiazepines and oxepines"
116,erleada,apalutamide,apalutamide,most,CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,"InChI=1S/C21H15F4N5O2S/c1-27-17(31)13-4-3-11(8-15(13)22)30-19(33)29(18(32)20(30)5-2-6-20)12-7-14(21(23,24)25)16(9-26)28-10-12/h3-4,7-8,10H,2,5-6H2,1H3,(H,27,31)",1,Apalutamide,Heart Damage,wp,0.4926797360181808,0.8015586972236634,0.8271389722824096,0.0306240827776491,0.2838128983974456,0.1688674062490463,0.5613609790802002,0.0347778175026178,0.0099542872048914,0.6213348209857941,0.4377367615699768,0.3860147267580032,0.3006838083267212,0.9593112349510192,0.9982362270355224,0.0258164849132299,0.0428688049316406,0.0216950599104166,0.4169426083564758,0.0179505258798599,0.0627726845443248,0.0524823922663927,0.9345334649086,0.4499392926692963,0.6253542065620422,0.0849106602370739,0.1327224053442478,0.7773416876792908,0.4701064229011535,0.2753844767808914,0.6915911436080933,-4.729837547093714,27.82022168587212,16.923292341680487,79.92778089731732,-9.972722984854,3.258956617829643,2.9533726393206146,83.95214827196169,-6.114114887578163,4.617858524578546,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-androgens
117,daurismo,glasdegib,glasdegib,most,C[NH+]1CCC(NC(=O)Nc2ccc(C#N)cc2)CC1c1nc2ccccc2[n-]1,"InChI=1S/C21H22N6O/c1-27-11-10-16(24-21(28)23-15-8-6-14(13-22)7-9-15)12-19(27)20-25-17-4-2-3-5-18(17)26-20/h2-9,16,19H,10-12H2,1H3,(H3,23,24,25,26,28)",1,Glasdegib,Arrhythmia,wp,0.0979374911636114,0.6624358177185059,0.3035708397626876,0.0214708727784454,0.0426354458555579,0.1153394512832164,0.0238911525346338,0.4528989970684051,0.1723728597164154,0.6132999360561371,0.0459767095744609,0.0767847768962383,0.0625873930752277,0.373168820142746,0.7457122206687927,0.014066597726196,0.035753421112895,0.2345601350069046,0.0290694091469049,0.0122495187446475,0.0891760170459747,0.0015793404658325,0.5581366658210755,0.1238411821424961,0.080271591246128,0.0087775086984038,0.0081015218049287,0.0553033649921417,0.0388948012143373,0.2249928094446659,0.8650231480598449,-5.417898628819305,14.171075309540452,-15.198199855283718,11.757716566053498,-13.636702831700164,2.5312492959963704,1.3732616055794593,73.992926030064,-3.418128691698448,-3.744889241416733,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,OTHER ANTINEOPLASTIC AGENTS,Hedgehog pathway inhibitors
118,carvedilol,carvedilol,carvedilol,most,COc1ccccc1OCC[NH2+]CC(O)COc1cccc2[nH]c3ccccc3c12,"InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3/p+1",1,Carvedilol,Mixed,wp,0.167696463316679,0.2750712916254997,0.4279084175825119,0.8752546548843384,0.7106036305427551,0.1540692135691642,0.2041101470589637,0.7417373299598694,0.8735008239746094,0.7559370636940003,0.8323752045631408,0.1365211088210344,0.016414594091475,0.3915890753269195,0.9779022693634032,0.0323516953736543,0.0232697388157248,0.7757764101028443,0.414475530385971,0.0299649177119135,0.07577481046319,0.0258461623452603,0.7488024115562439,0.9487533330917358,0.3204068124294281,0.0154600547626614,0.1172266259789466,0.4050003379583359,0.0399581708014011,0.3729356288909912,0.9880890250205994,-5.905969450101529,39.727945286796654,35.280586766598006,-23.225045325842235,-13.759595211564228,2.685197626246195,1.9602287763256137,87.18321756749279,-3.153740340859367,2.634100634929181,CARDIOVASCULAR SYSTEM,BETA BLOCKING AGENTS,"BETA BLOCKING AGENTS;BETA BLOCKING AGENTS, OTHER COMBINATIONS","Alpha and beta blocking agents;Beta blocking agents, other combinations"
119,fanapt,iloperidone,iloperidone,most,COc1cc(C(C)=O)ccc1OCCC[NH+]1CCC(c2noc3cc(F)ccc23)CC1,"InChI=1S/C24H27FN2O4/c1-16(28)18-4-7-21(23(14-18)29-2)30-13-3-10-27-11-8-17(9-12-27)24-20-6-5-19(25)15-22(20)31-26-24/h4-7,14-15,17H,3,8-13H2,1-2H3/p+1",1,Iloperidone,Mixed,wp,0.1018364205956459,0.7911376595497132,0.5342565715312958,0.1115890651941299,0.0482917109504342,0.0503006666898727,0.0188430058769881,0.8169354200363159,0.8785961389541626,0.8103129386901855,0.4481148838996887,0.0506989542394876,0.0226977655664086,0.1453411199152469,0.96227068901062,0.0238619579002261,0.0262586390599608,0.2664429068565369,0.0506961207836866,0.0186888195574283,0.1391518600285053,0.0017656251169682,0.8950835943222046,0.879063880443573,0.1675211787223816,0.0143800944089889,0.0114972890354692,0.0332457788288593,0.0140986803919076,0.1525641024112701,0.946555757522583,-5.003407566877574,56.21993250946905,42.32847540973625,-17.867803763075113,-9.85622067680807,2.7949465200504298,2.027124563090066,87.08474045765834,-2.4191454430332664,8.075262163391434,NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Other antipsychotics
120,ketek,telithromycin,telithromycin,most,CCC1OC(=O)C(C)C(=O)C(C)C(OC2OC(C)CC([NH+](C)C)C2O)C(C)(OC)CC(C)C(=O)C(C)C2[NH+](CCCCn3cnc(-c4cccnc4)c3)C(=O)OC12C,"InChI=1S/C43H65N5O10/c1-12-33-43(8)37(48(41(53)58-43)19-14-13-18-47-23-31(45-24-47)30-16-15-17-44-22-30)27(4)34(49)25(2)21-42(7,54-11)38(28(5)35(50)29(6)39(52)56-33)57-40-36(51)32(46(9)10)20-26(3)55-40/h15-17,22-29,32-33,36-38,40,51H,12-14,18-21H2,1-11H3/p+2",1,Telithromycin,Arrhythmia,wp,0.1675192520022392,0.0137885821983218,0.5635692715644837,0.0001391213999795,0.0092401287984102,0.0180607555434107,0.0151705276686698,0.010316540626809,0.0067500580800697,0.7663534641265869,0.8143268585205078,0.0808770641684532,0.0250830066390335,0.6572668075561523,0.7616648316383362,0.0126750959549099,0.0254180902615189,0.0243842538446187,0.0705635823309421,0.010625500883907,0.051244968175888,0.0028272645082324,0.6077142417430877,0.7399816274642944,0.1033188208937645,0.0078530995175242,0.0042337764170952,0.0996166925877332,0.0583648279309272,0.1118646517395973,0.6948338866233825,-5.715577355647104,70.7561202576607,58.44472870263064,-34.552111522765635,-12.025864020121023,3.0955924216951223,0.3037341250158699,51.53638446269355,-1.3371014731118458,15.39061710477664,ANTIINFECTIVES FOR SYSTEMIC USE,ANTIBACTERIALS FOR SYSTEMIC USE,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",Macrolides
121,ranolazine,ranolazine,ranolazine,most,COc1ccccc1OCC(O)C[NH+]1CC[NH+](CC(=O)Nc2c(C)cccc2C)CC1,"InChI=1S/C24H33N3O4/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3/h4-10,20,28H,11-17H2,1-3H3,(H,25,29)/p+2",1,Ranolazine,Arrhythmia,wp,0.0853307612240314,0.1302384976297617,0.2478030122816562,0.0059140187397133,0.0348724904935806,0.10620300732553,0.0080616673454642,0.3676067262887955,0.4653997242450714,0.5547779977321625,0.0678536085411906,0.2024934060871601,0.0052780537633225,0.0660070568323135,0.2496979376301169,0.0119050343520939,0.0544482316821813,0.0130858088843524,0.0025057686725631,0.0039542271522805,0.0545197755098342,0.0006707586868287,0.4332939326763153,0.3904032737016678,0.0471975181251764,0.0002041252228082,0.0024913416593335,0.00632415197324,0.0009428975230548,0.4528152227401733,0.9546730518341064,-5.7121190307771785,1.9374536426584013,18.6385192481221,-29.0251036287694,-11.268130437823938,2.4527880980963834,-0.3617166044343929,55.44425356533952,-1.0903004412253552,-1.8941586116493443,CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,OTHER CARDIAC PREPARATIONS,Other cardiac preparations
122,rinvoq,upadacitinib,upadacitinib,most,CCC1C[NH+](C(=O)NCC(F)(F)F)CC1c1cnc2cnc3[nH]ccc3n12,"InChI=1S/C17H19F3N6O/c1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15/h3-6,10-11,21H,2,7-9H2,1H3,(H,24,27)/p+1",1,Upadacitinib,Heart Damage,bw,0.2684566974639892,0.6798639178276062,0.6059664905071258,0.1533735014498233,0.0767853550612926,0.1695268467068672,0.0583181759342551,0.3743138939142227,0.0467121083289384,0.4126352339982986,0.1256784252822399,0.2072127021849155,0.0282916853204369,0.552457082271576,0.970999026298523,0.0158706733956933,0.0178873606026172,0.2292397737503052,0.016134737804532,0.0150838233530521,0.2120242521166801,0.0007860352430725,0.415722906589508,0.0552606657147407,0.1843070745468139,0.0419370422139763,0.0056598732247948,0.0223354056477546,0.0171064890921115,0.3204148083925247,0.795988941192627,-5.2851435453831455,-7.723969553387126,-14.30367896119922,-20.34153189437509,-14.016086283235149,3.6726234189144193,1.264991132532146,68.11383894887923,-2.488309074010691,-2.076061119013017,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,Selective immunosuppressants
123,tavalisse,fostamatinib,fostamatinib,most,COc1cc(N=c2nc(N=c3ccc4c([n-]3)N(CO[P](=O)(=O)O)C(=O)C(C)(C)O4)c(F)c[n-]2)cc(OC)c1OC,"InChI=1S/C23H23FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H-2,25,26,27,28,29,32,33,34)/q-2",1,Fostamatinib,Heart Damage,wp,0.3844955474138259,0.6380845367908478,0.8674626827239991,0.0190682233311235,0.1944543540477752,0.2762268781661987,0.4350684285163879,0.0500280566513538,0.029557648464106,0.8399860978126525,0.5727384209632873,0.1502172738313675,0.3201788544654846,0.9449256777763366,0.9642349004745484,0.0087489668861962,0.0138851440511643,0.2321140825748443,0.0665964893996715,0.0228619031608104,0.0297768203541636,0.0184787261299788,0.8265864610671997,0.6265331268310547,0.6829027652740478,0.0728745609521865,0.040960930660367,0.0683875465765595,0.1355997823178768,0.1068660899996757,0.6700452923774719,-4.741028847426247,25.68156320107905,51.35046905468148,113.6182419115033,-9.6434843252194,2.7564568372281464,2.0880899080404296,78.25870074625244,-2.280246320103619,7.048059739929049,BLOOD AND BLOOD FORMING ORGANS,ANTIHEMORRHAGICS,VITAMIN K AND OTHER HEMOSTATICS,Other systemic hemostatics
124,signifor lar,pasireotide,pasireotide,most,[NH3+]CCCCC1NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(c2ccccc2)NC(=O)C2CC(OC(=O)NCC[NH3+])C[NH+]2C(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(OCc3ccccc3)cc2)NC1=O,"InChI=1S/C58H66N10O9/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72)/p+3",1,Pasireotide,Arrhythmia,wp,0.1884661681950092,0.0618106760084629,0.2981753587722778,0.0159047233406454,0.2348690152168274,0.0997560039162635,0.2001408286392688,0.0736024044454097,0.0481640007346868,0.7772399425506592,0.6940560460090637,0.1388893350958824,0.0168831152841448,0.7855668663978577,0.5178351879119873,0.0249033623374998,0.1172500193119049,0.0420555841177701,0.0347770478576421,0.0191578486002981,0.1035602539777755,0.0310958545655012,0.2706141576170921,0.5009833693504333,0.3832545220851898,0.0303298067301511,0.0200118399225175,0.2466499030590057,0.106615374982357,0.1845620542764663,0.8879242539405823,-6.377690889058548,69.85685289421534,75.42620779592713,36.8239782744776,-13.965853480773555,3.37422491416165,0.8824033204091183,90.47788744471464,-3.2672349107179386,1.0937440304234296,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,HYPOTHALAMIC HORMONES,Somatostatin and analogues
125,dipyridamole,dipyridamole,dipyridamole,most,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,"InChI=1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2",1,Dipyridamole,Mixed,wp,0.2814433664083481,0.6339528322219848,0.3457935154438019,0.2406410753726959,0.1502258695662021,0.027791503816843,0.2927374601364135,0.1694008886814117,0.1909980282187461,0.4306939899921417,0.2312812652438879,0.1318969435989856,0.2403194427490234,0.8648363828659058,0.9598912119865416,0.0576008394360542,0.0142130523920059,0.198673503100872,0.2292186975479126,0.0131262175738811,0.0623702563345432,0.0157703122124075,0.8345040917396546,0.1923110216856002,0.5159957706928253,0.1073924645781517,0.0774321116507053,0.4229993999004364,0.6510750353336334,0.4874983131885528,0.9015669226646424,-5.4236107315295845,37.090135052332286,69.05945410986098,40.04196390911657,-10.110888318916516,2.5822137114303656,2.839155011606654,78.08996916138526,-3.10375666693324,11.612264467080069,BLOOD AND BLOOD FORMING ORGANS,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,Platelet aggregation inhibitors excl. heparin
126,cotellic,cobimetinib,cobimetinib fumarate,most,O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)[NH+]1CC(O)(C2CCCC[NH2+]2)C1,"InChI=1S/C21H21F3IN3O2/c22-14-6-5-13(19(18(14)24)27-16-7-4-12(25)9-15(16)23)20(29)28-10-21(30,11-28)17-3-1-2-8-26-17/h4-7,9,17,26-27,30H,1-3,8,10-11H2/p+2",1,Cobimetinib,Heart Damage,wp,0.113021608069539,0.3756095319986343,0.3434435844421387,0.0260598461143672,0.0339736702851951,0.0313948930241167,0.0182185458019375,0.2964086532592773,0.4006498336791992,0.4228235602378845,0.0725502330809831,0.088165901787579,0.0290456191636621,0.1188419371843338,0.3023676648736,0.1445970296859741,0.1425546035170555,0.0368137998506426,0.0182071041315794,0.0199527679942548,0.1536746069788933,0.001981262852496,0.2922112345695495,0.2026863545179367,0.0774128206074237,0.0066358882235363,0.0069128453091252,0.0410960835404694,0.0391649892553687,0.2821468666195869,0.8594213604927063,-5.66714731186088,9.47491133239802,-11.421181766828756,-4.028838409247972,-11.428578032494489,3.1617823213501737,1.4025059896743208,70.22857398762063,-3.0013734729239685,18.915204482366228,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Mitogen-activated protein kinase (MEK) inhibitors
127,xtandi,enzalutamide,enzalutamide,most,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,"InChI=1S/C21H16F4N4O2S/c1-20(2)18(31)28(12-5-4-11(10-26)15(8-12)21(23,24)25)19(32)29(20)13-6-7-14(16(22)9-13)17(30)27-3/h4-9H,1-3H3,(H,27,30)",1,Enzalutamide,Heart Damage,wp,0.314028850197792,0.6553036987781524,0.7052934408187866,0.0662138000130653,0.4989655315876007,0.2148457005620002,0.560203355550766,0.0538226390257477,0.0192164971493184,0.6309181094169617,0.5731609582901,0.6873504400253296,0.1594560943543911,0.9347957611083983,0.992396104335785,0.0159309905022382,0.0232211994007229,0.016266363300383,0.3727565348148346,0.0234117444604635,0.0651710510253906,0.0634915873408317,0.8997156262397766,0.6234809279441833,0.6153133571147918,0.0124139281921088,0.1308688141405582,0.7792401432991027,0.3885454893112182,0.4022527128458023,0.8606573462486267,-4.647600390772999,30.549973110133465,22.69181675795597,91.02746952261484,-8.760277523018663,3.204791392598037,2.877565020431113,87.72311789178406,-6.00202536026522,1.1690242012399787,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ENDOCRINE THERAPY,HORMONE ANTAGONISTS AND RELATED AGENTS,Anti-androgens
128,inlyta,axitinib,axitinib,most,CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)[n-]nc2c1,"InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H2,23,24,25,26,27)/p-1",1,Axitinib,Heart Damage,wp,0.3071280866861343,0.6450859189033509,0.829779839515686,0.5152555286884308,0.7329311370849609,0.5584611773490906,0.6765622973442078,0.2611461728811264,0.2475059419870376,0.4983295559883117,0.7692375421524048,0.3855100214481354,0.3158624172210693,0.9041782140731812,0.9961621522903442,0.0270185386762022,0.0233889020979404,0.5107965052127839,0.1194978818297386,0.0332947503775358,0.1888515964150428,0.1749932706356048,0.8629273176193237,0.7519414782524109,0.5416296482086181,0.1308130159974098,0.3202361404895782,0.4400201678276062,0.1600524052977562,0.3345542579889297,0.4818150162696838,-5.453347936197867,48.301629583081656,56.89027233701993,46.47681352450678,-11.7653393397597,2.3368136279560616,2.67568200097299,95.1611457254586,-3.904352980764915,-8.370932866100638,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
129,nexavar,sorafenib,sorafenib,most,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,"InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)",1,Sorafenib,Mixed,wp,0.3639829844236374,0.7238458156585693,0.9159575462341308,0.4157553017139435,0.772490632534027,0.495219475030899,0.6765206575393676,0.2218591958284378,0.1824836552143097,0.6589803099632263,0.4870960056781769,0.6879673480987549,0.3771282970905304,0.9447482705116272,0.9972055077552796,0.0053603847511112,0.0168654065579175,0.3239669799804687,0.1485662646591663,0.0133105169981718,0.1041726812720298,0.0720959458500146,0.7893349289894104,0.7966759324073791,0.5218243420124054,0.0331362165510654,0.1737328186631202,0.8572465896606445,0.4081830143928527,0.1762470111250877,0.7927430629730224,-5.177996873033028,35.4398691881084,30.09412837038559,96.72507492944136,-11.230020837255164,2.720701960632836,3.4577228070464754,96.8082110490075,-6.955567498946683,-3.4644452043050604,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors
130,fotivda,tivozanib,tivozanib hydrochloride,most,COc1cc2nccc(Oc3ccc(NC(=O)N=c4cc(C)o[n-]4)c(Cl)c3)c2cc1OC,"InChI=1S/C22H19ClN4O5/c1-12-8-21(27-32-12)26-22(28)25-16-5-4-13(9-15(16)23)31-18-6-7-24-17-11-20(30-3)19(29-2)10-14(17)18/h4-11H,1-3H3,(H2,25,26,27,28)/p-1",1,Tivozanib,Heart Damage,wp,0.4336175501346588,0.6432121753692627,0.975327730178833,0.1250165354460478,0.4286095857620239,0.3584571421146393,0.3994530260562897,0.095523502677679,0.0449956567957997,0.832593047618866,0.6678002357482911,0.3244015544652939,0.2761616170406341,0.9770707845687866,0.998913550376892,0.0101245172321796,0.0298626581206917,0.7689081311225892,0.1400141164660454,0.0119092829059809,0.0733947470784187,0.0527115274220705,0.9259125590324402,0.919573140144348,0.7888615965843201,0.2222716182470321,0.0775517679750919,0.5473584592342376,0.3450093567371368,0.0989952407777309,0.6824533820152283,-4.846777944097913,60.99896772806769,56.86950198322844,119.7915780894172,-10.51243384533684,2.856907882457507,3.006655052043574,95.87153707333503,-5.448914634171677,5.550684466541357,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
131,osphena,ospemifene,ospemifene,most,OCCOc1ccc(C(=C(CCCl)c2ccccc2)c2ccccc2)cc1,"InChI=1S/C24H23ClO2/c25-16-15-23(19-7-3-1-4-8-19)24(20-9-5-2-6-10-20)21-11-13-22(14-12-21)27-18-17-26/h1-14,26H,15-18H2",1,Ospemifene,Heart Damage,wp,0.310068079829216,0.2178659737110138,0.6857291698455811,0.634567791223526,0.7258864402770996,0.3355024635791778,0.7322460770606994,0.1883119538426399,0.2724129021167755,0.7404619932174683,0.4859983325004577,0.6345806002616883,0.0249640362337231,0.4827534615993499,0.9988642811775208,0.0189206639304757,0.004737294698134,0.1907086387276649,0.6250909924507141,0.2827462963759899,0.3992925524711609,0.2702427357435226,0.6406093597412109,0.8865071892738342,0.8302620887756348,0.0153515502810478,0.7331598281860352,0.9334278583526612,0.4471337586641312,0.6920752167701721,0.8790276765823364,-4.917446232070772,54.99433578126268,54.20894149767516,20.80235378801286,-7.011301384462567,2.317287553192275,4.288719928337319,104.61336065836768,-6.498820210276392,5.587602879343565,GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,Selective estrogen receptor modulators
132,tradjenta,linagliptin,linagliptin,most,CC#CCn1c(N2CCCC([NH3+])C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,"InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/p+1",1,Linagliptin,Heart Damage,wp,0.369280743598938,0.632093608379364,0.4042516887187958,0.0359220623970031,0.0880048230290412,0.1178292550146579,0.1900107234716415,0.1769834846258163,0.1785733267664909,0.8349254608154297,0.7616084575653076,0.1259100414812564,0.1098877482116222,0.8195072293281556,0.9629174590110778,0.0178200140595436,0.0328859450295567,0.1125962004065513,0.2281597793102264,0.02791044190526,0.0613231629133224,0.0092342064715921,0.910941219329834,0.8172120451927185,0.4948360443115234,0.0313227232545614,0.034040212444961,0.1373357325792312,0.0698791824281215,0.349103569984436,0.9534231424331664,-5.458407278495718,36.67059640977698,52.99507733175974,-20.9589088401154,-10.096292260263867,2.758471853242638,1.552663508991285,71.91015729503302,-2.8311459837357504,6.395500099417871,ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",Combinations of oral blood glucose lowering drugs;Dipeptidyl peptidase 4 (DPP-4) inhibitors
133,,encainide,encainide,most,COc1ccc(C(=O)Nc2ccccc2CCC2CCCC[NH+]2C)cc1,"InChI=1S/C22H28N2O2/c1-24-16-6-5-8-19(24)13-10-17-7-3-4-9-21(17)23-22(25)18-11-14-20(26-2)15-12-18/h3-4,7,9,11-12,14-15,19H,5-6,8,10,13,16H2,1-2H3,(H,23,25)/p+1",1,Encainide,Arrhythmia,Withdraw,0.0836478538811206,0.7825824618339539,0.4223076939582825,0.0359817111864686,0.0115552986273542,0.074014614149928,0.0018027955491561,0.7441967606544495,0.8319987773895263,0.6662020564079285,0.0222682169638574,0.0490295216441154,0.0159726548939943,0.0600426634773612,0.6130743145942688,0.0067640848457813,0.0363629773259162,0.0579814996570348,0.0176401636563241,0.0088100101333111,0.1496538326144218,0.0005751947293902,0.816180419921875,0.3584206938743591,0.0359253570437431,0.0016571639920584,0.0064776699291542,0.0164544640108942,0.0037961652502417,0.3933074861764908,0.9418480873107912,-5.175338560402751,31.941445487464524,-15.589241760822144,-18.352329870367875,-9.255595874850815,2.5146034024475625,0.6543098925193584,63.01642031297986,-2.688301564646935,-4.612611534636472,CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,"ANTIARRHYTHMICS, CLASS I AND III","Antiarrhythmics, class Ic"
134,meloxicam,meloxicam,meloxicam,most,Cc1c[n-]c(=NC(=O)C2C(=O)c3ccccc3S(=O)(=O)[NH+]2C)s1,"InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,11H,1-2H3,(H,15,16,19)",1,Meloxicam,Heart Damage,bw,0.0400418298318982,0.1659130439162254,0.6592689156532288,0.2164144545793533,0.203070293366909,0.6552302122116089,0.0570911597460508,0.0766899362206459,0.0243977155536413,0.3993681788444519,0.1910989642143249,0.1909186601638794,0.001315516768227,0.9751195430755616,0.9822623133659364,0.0413919823244214,0.0832684285938739,0.2938689008355141,0.0124054653570055,0.0149081617593765,0.1916714489459991,0.0160702472086995,0.5412510991096496,0.1120108865201473,0.1938022524118423,0.023552061477676,0.0266086438670754,0.3905527785420418,0.0459214596077799,0.4449225395917892,0.0276219200342893,-4.97684729088639,65.2563429654728,28.06545300261636,-16.74386616435782,-13.265714754860022,2.9626391798739027,-0.3627135922799935,77.9853911692292,-2.729700375740068,-3.878906454647258,MUSCULO-SKELETAL SYSTEM;NERVOUS SYSTEM,ANESTHETICS;ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANESTHETICS, LOCAL;ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Amides;Oxicams
135,,sertindole,sertindole,most,O=C1NCC[NH+]1CC[NH+]1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,"InChI=1S/C24H26ClFN4O/c25-18-1-6-23-21(15-18)22(16-30(23)20-4-2-19(26)3-5-20)17-7-10-28(11-8-17)13-14-29-12-9-27-24(29)31/h1-6,15-17H,7-14H2,(H,27,31)/p+2",1,Sertindole,Arrhythmia,Withdraw,0.3338875502347946,0.5875355720520019,0.343950468301773,0.24717777967453,0.0327525587752461,0.0856384703889489,0.0076623948523774,0.5690578579902649,0.603627610206604,0.6004216134548187,0.1558782324194908,0.1493744634091854,0.04032763983123,0.2620392560958862,0.4040109157562256,0.0891386777162552,0.0670012261718511,0.1724919445812702,0.0259763799607753,0.0590819910168647,0.2182935118675232,0.0016938859371293,0.520208066701889,0.3408208549022674,0.1679776266217231,0.0166665786644443,0.0114834943087771,0.0237987386994063,0.0414548311382532,0.4885632455348968,0.8295441746711731,-5.3589280243758335,-32.76962400595104,-11.689064977081026,44.77502340659681,-11.89474280271698,3.031997164415924,1.8438509947703152,86.06958294589072,-2.4449195248073528,10.05069242199987,NERVOUS SYSTEM,PSYCHOLEPTICS,ANTIPSYCHOTICS,Indole derivatives
136,northera,droxidopa,droxidopa,most,[NH3+]C(C(=O)[O-])C(O)c1ccc([O-])c([O-])c1,"InChI=1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/p-2",1,Droxidopa,Heart Damage,bw,0.0365160338580608,0.0661617305129766,0.703995943069458,0.0016438215156085,0.002416258060839,0.3252977758646011,0.0026663627591915,0.0573837831616401,0.0011499705957248,0.1952114522457123,0.0004474473833397,0.1563131645321846,0.0002698812604648,0.1664689026772975,0.5978419303894043,0.0056436503422446,0.0463510751724243,0.0058617299189791,0.0003533423237968,0.0014540874632075,0.0370624095201492,0.0011659981508273,0.0275327089242637,0.0037302472628653,0.0043024304788559,0.0001482045367083,0.0012752629088936,0.0003021596490725,0.0003215945409465,0.3514073759317398,0.0022971680620685,-5.882730132808054,-22.232590201689863,-36.27196544007355,-34.144781700714965,-15.37474475470016,1.8388328090286856,-3.168752827792862,47.07785405708061,-1.042887058295797,2.066091342467969,CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,Adrenergic and dopaminergic agents
137,sotradecol,tetradecyl hydrogen sulfate (ester),tetradecyl hydrogen sulfate (ester),most,CCCCC(CC)CCC(CC(C)C)OS(=O)(=O)[O-],"InChI=1S/C14H30O4S/c1-5-7-8-13(6-2)9-10-14(11-12(3)4)18-19(15,16)17/h12-14H,5-11H2,1-4H3,(H,15,16,17)/p-1",1,Tetradecyl hydrogen sulfate (ester),Heart Damage,wp,0.0951664566993713,0.9771313428878784,0.9057445764541626,0.22078552916646,0.2552935466170311,0.3587346255779266,0.0928829610347747,0.3131679728627204,0.1118028633296489,0.7171037912368774,0.0353057849220931,0.7842255175113678,0.0249454932287335,0.4386558473110199,0.999731469154358,0.0004630498711776,0.0071117010433226,0.0143136506900191,0.0137837405782192,0.0081428115139715,0.0948383193463087,0.0061392203671857,0.9787523627281188,0.2145900424569845,0.097454559803009,0.0004116785799851,0.0186959982849657,0.1167833667248487,0.0031507322972174,0.8165178418159484,0.5096057534217835,-4.700883127533035,68.64488853794995,45.505652902185325,35.55946870100981,-2.082664464119353,1.9957029186907624,3.1377858160121823,94.75598893990862,-2.8161279319122587,7.415681709645836,,,,
138,lenvima,lenvatinib,lenvatinib,most,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,"InChI=1S/C21H19ClN4O4/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28)",1,Lenvatinib,Mixed,wp,0.6360096633434296,0.887853991985321,0.987182915210724,0.5213253796100616,0.4073955535888672,0.5311845242977142,0.4530230611562729,0.1724511370062828,0.0403502581641078,0.5879182398319245,0.6772891640663147,0.2488442838191986,0.5010259330272675,0.966473352909088,0.999859070777893,0.0181197025813162,0.0283183842897415,0.4638004064559936,0.0653135791420936,0.0151422509923577,0.0785259962081909,0.0646566737443208,0.9044008851051332,0.3000961303710937,0.4658004641532898,0.2656281560659408,0.0779403436928987,0.547464793920517,0.4549916923046112,0.1218596599996089,0.5254791021347046,-4.779492477380785,33.81857458599198,38.177316873949565,45.28563463894321,-14.045311095954023,2.835469969887714,3.4094665404579523,92.24366092609576,-5.758628059826143,-0.5778287092918561,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors
139,dofetilide,dofetilide,dofetilide,most,C[NH+](CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1,"InChI=1S/C19H27N3O5S2/c1-22(13-12-16-4-6-17(7-5-16)20-28(2,23)24)14-15-27-19-10-8-18(9-11-19)21-29(3,25)26/h4-11,20-21H,12-15H2,1-3H3/p+1",1,Dofetilide,Arrhythmia,bw,0.0440995395183563,0.1281786389648914,0.4580612361431121,0.2925901740789413,0.0459920465946197,0.255194678902626,0.013308084430173,0.3328606575727463,0.46290984749794,0.6305485546588898,0.3831229709088802,0.2979876786470413,0.0079029692016774,0.5474718689918519,0.1339636132121086,0.0425039872527122,0.1735943637788295,0.0126896234229207,0.0116493580397218,0.0091750995256006,0.0855797946453094,0.0015606927496264,0.5915928840637207,0.0720771128311753,0.0510026942938566,0.0014332834427477,0.0070812104502692,0.0275813661515712,0.0108287695329636,0.2052147924900055,0.7802424192428589,-6.20164596238825,3.32608197498208,-3.8311570542837097,-24.60979790859789,-10.839593752335444,2.098723614275248,-0.5986966732792895,51.57091506845219,-1.247113335106537,-7.619908687468448,CARDIOVASCULAR SYSTEM,CARDIAC THERAPY,"ANTIARRHYTHMICS, CLASS I AND III","Antiarrhythmics, class III"
140,sodium tetradecyl sulfate,sodium tetradecyl sulfate,sodium tetradecyl sulfate,most,CCCCCCCCCCCCCCOS(=O)(=O)[O-],"InChI=1S/C14H30O4S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18-19(15,16)17/h2-14H2,1H3,(H,15,16,17)/p-1",1,Sodium tetradecyl sulfate,Heart Damage,wp,0.1003123879432678,0.9770533561706544,0.7685117363929749,0.5744284063577652,0.2657455638051033,0.1925338424742221,0.1225146602839231,0.2229107335209846,0.0461587938480079,0.534604960680008,0.0234737068647518,0.7783162295818329,0.0081547539448365,0.5725456893444061,0.9998228549957277,0.0011331603112921,0.0181992882862687,0.0065502303565153,0.0163953052833676,0.0058936555404216,0.1027150519192218,0.0073576890863478,0.9541541576385498,0.4200971558690071,0.083253950625658,0.0008054141653701,0.0157855425029993,0.0357080866582691,0.006503563048318,0.8868775010108948,0.5459095001220703,-4.651978378516847,84.8204077066623,47.34243169088496,51.72503398787943,-3.0730999484499915,2.0044766523478943,3.185677172674285,93.78752360488322,-2.787752069721635,7.182388278205229,CARDIOVASCULAR SYSTEM,VASOPROTECTIVES,ANTIVARICOSE THERAPY,Sclerosing agents for local injection
141,xyosted,testosterone enanthate,testosterone enanthate,most,CCCCCCC(=O)OC1CCC2C3CC=C4CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h9,20-23H,4-8,10-17H2,1-3H3",1,Testosterone enanthate,Heart Damage,bw,0.0449994508177042,0.9638478279113768,0.697558867931366,0.0077336885035037,0.3962322086095809,0.136583861708641,0.2475002497434616,0.1274770352989435,0.1083761479705572,0.8483516812324524,0.2695288598537445,0.1128315851092338,0.023681666702032,0.1247485741972923,0.9999361157417296,0.0595377393066883,0.3690539866685867,0.0134573524817824,0.0239696505479514,0.0639894105494022,0.3262970149517059,0.0136914611794054,0.9846310138702392,0.9494070768356324,0.4308417499065399,0.0037685040384531,0.0756687432527542,0.2220422223210335,0.017498816922307,0.4271551236510277,0.4985509246587753,-4.858388720169164,148.41812488227927,109.2118396216421,9.283845226072415,-1.7928023208490953,2.285953795296217,4.749296547314861,106.84556877444724,-5.927010526660011,-0.2490260413650382,,,,
142,retevmo,selpercatinib,selpercatinib,most,COc1ccc(C[NH+]2C3CC2CN(c2ccc(-c4cc(OCC(C)(C)O)cn5ncc(C#N)c45)cn2)C3)cn1,"InChI=1S/C29H31N7O3/c1-29(2,37)18-39-24-9-25(28-21(10-30)13-33-36(28)17-24)20-5-6-26(31-12-20)34-15-22-8-23(16-34)35(22)14-19-4-7-27(38-3)32-11-19/h4-7,9,11-13,17,22-23,37H,8,14-16,18H2,1-3H3/p+1",1,Selpercatinib,Mixed,wp,0.0494062058627605,0.1422744318842888,0.2641165196895599,0.0127567493123933,0.1166689917445182,0.0551080696284771,0.0977853633463382,0.2782679960131645,0.1243181012570858,0.8307097434997559,0.3757742702960968,0.0871320642530918,0.0591457288712263,0.6753567159175873,0.6724826216697692,0.019303333479911,0.0174153602216392,0.2868808954954147,0.0827134057879448,0.0346299387514591,0.0650046534836292,0.0026082658790983,0.7584216952323913,0.2599292784929276,0.2322663605213165,0.0206087793223559,0.0184368505142629,0.2185587301850318,0.3061619937419891,0.1275822222232818,0.959449827671051,-5.468414835442401,19.463073492998536,76.03205665297511,-59.96444781863397,-11.647011779226288,3.293236528568974,1.62640786737844,82.89855611865582,-3.4597682352270325,6.069090140445835,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors
143,estradiol valerate,estradiol valerate,estradiol valerate,most,CCCCC(=O)OC1CCC2C3CCc4cc([O-])ccc4C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/p-1",1,Estradiol valerate,Heart Damage,bw,0.111017719656229,0.8981159806251526,0.8596866846084594,0.1172965656965971,0.6565436840057373,0.4519137144088745,0.2347778603434562,0.2876478433609009,0.0949125856161117,0.8574510216712952,0.3459708869457245,0.171852208673954,0.0166994534432888,0.1534555673599243,0.9999826669692992,0.0246952580288052,0.2979844480752945,0.0424660038203001,0.0159031923860311,0.1872325524687767,0.566764098405838,0.0142914981115609,0.9788832306861878,0.6857982814311981,0.1939506143331527,0.0134255941957235,0.0497949283570051,0.3070507705211639,0.0218393531627953,0.3658733919262886,0.4370229065418243,-4.587849326472716,114.09404745843632,103.0520674449933,-0.8350620779971415,-2.592564798667296,2.055321644705054,4.935632855171898,105.28962686409878,-6.3406648165746615,0.6916143091374,,,,
144,vimpat,lacosamide,lacosamide,most,COCC(NC(C)=O)C(=O)NCc1ccccc1,"InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)",1,Lacosamide,Arrhythmia,wp,0.6846624314785004,0.956409513950348,0.89259432554245,0.0018545244238339,0.0448610027320683,0.0567128058522939,0.0010022032947745,0.0610038824379444,0.0013095367059577,0.4120315045118332,0.0015828997828066,0.293563237786293,0.0313036981970071,0.0903584841638803,0.9878650307655334,0.0089976176153868,0.0082148584071546,0.0034532856894657,0.0010057325591333,0.0033600595314055,0.0677072472870349,0.0009473871265072,0.66112579703331,0.0022829239664133,0.0233033239841461,0.000879369478207,0.0030708998208865,0.0001720443572594,0.0017812042264267,0.7459428429603576,0.0208646509796381,-4.712017773127331,34.788078319076426,17.554255053441764,-12.332240652275985,-12.685218739743334,1.441167826402031,0.4367330267060271,50.77645133248946,-1.531883159275676,-3.63517161668944,NERVOUS SYSTEM,ANTIEPILEPTICS,ANTIEPILEPTICS,Other antiepileptics
145,testosterone cypionate,testosterone cypionate,testosterone cypionate,most,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3",1,Testosterone cypionate,,,0.0311589404940605,0.8820058584213257,0.706937313079834,0.0110052256146445,0.2754998236894607,0.132240854203701,0.1250547036528587,0.0933517632074654,0.074194586277008,0.7472784996032715,0.2243000730872154,0.101841302216053,0.0280670631676912,0.1524624943733215,0.9996636033058166,0.216057376563549,0.6197120010852813,0.0060240882681682,0.0374254625290632,0.1955753684043884,0.5180092275142669,0.0171079842373728,0.9692797899246216,0.936730706691742,0.4805559575557708,0.0043328922009095,0.0610655520111322,0.1855601876974106,0.0128587139770388,0.4807607293128967,0.4676236987113952,-4.86484205123039,113.44977142002212,104.59199286676696,32.226834632648085,-1.4876740989906545,2.082652255014382,5.086030525054844,103.55712935122524,-5.945830606232315,2.1240264913414224,,,,
146,estradiol,estradiol,estradiol,most,CC12CCC3c4ccc([O-])cc4CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/p-1",1,Estradiol,Heart Damage,bw,0.1605009280145168,0.7955502986907959,0.9102415204048157,0.2562458157539368,0.7088395595550537,0.5933052837848664,0.1551628835499286,0.4406803041696548,0.1444911986589431,0.764947235584259,0.1892768686637282,0.1533076839521527,0.0087935095652937,0.1119624212384224,0.9999812841415404,0.0179159352555871,0.2388044059276581,0.1237609438598155,0.0360986020416021,0.2860372222959995,0.6912803769111633,0.0114417134784162,0.9489378094673157,0.3496128469705581,0.2192224860191345,0.0149596293456852,0.0832881703972816,0.5134607911109924,0.0258401785045862,0.3626299172639847,0.3848072424530983,-4.559951910851889,46.8845914296838,35.63013046830209,-20.10934082792547,-5.642167101635424,1.8032301773700383,3.628710892119977,91.88444457236632,-4.150242304806985,4.19387868801375,"GENITO URINARY SYSTEM AND SEX HORMONES;SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",OTHER GYNECOLOGICALS;PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION;ANTIANDROGENS;CONTRACEPTIVES FOR TOPICAL USE;ESTROGENS;HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;HYPOTHALAMIC HORMONES;PROGESTOGENS AND ESTROGENS IN COMBINATION,"Androgens and estrogens;Anti-gonadotropin-releasing hormones;Antiandrogens and estrogens;Intravaginal contraceptives;Natural and semisynthetic estrogens, plain;Progestogens and estrogens, fixed combinations;Progestogens and estrogens, sequential preparations"
147,januvia,sitagliptin,sitagliptin phosphate,most,[NH3+]C(CC(=O)[NH+]1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,"InChI=1S/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/p+2",1,Sitagliptin,Heart Damage,wp,0.5663229852914811,0.5985026657581329,0.7241138458251953,0.0066899108234792,0.031712268711999,0.0954230166971683,0.0081353086337912,0.1152912214398384,0.1037639621645212,0.6870529413223266,0.0804362222552299,0.5016762495040894,0.0209190542344003,0.3340988397598267,0.5559317588806152,0.0369794856756925,0.0582629300653934,0.0068864077795296,0.0092857341282069,0.0210299853235483,0.1409258052706718,0.0017838725063484,0.4181640893220901,0.0661412820219993,0.1020274199545383,0.0048263548524118,0.0018756514182314,0.0036145960213616,0.0134066681377589,0.4845409333705902,0.4345049381256103,-5.226226187380524,-2.4125876166600384,21.56227733168637,-6.593056442026343,-9.156442817457108,4.0098866790045165,0.8966163997603533,48.6201960127208,-2.5099321353604425,5.817201241742984,ALIMENTARY TRACT AND METABOLISM,DRUGS USED IN DIABETES,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",Combinations of oral blood glucose lowering drugs;Dipeptidyl peptidase 4 (DPP-4) inhibitors
148,,rofecoxib,rofecoxib,most,CS(=O)(=O)c1ccc(-c2coc([O-])c2-c2ccccc2)cc1,"InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-11,18H,1H3/p-1",1,Rofecoxib,Heart Damage,Withdraw,0.0303510854020714,0.7344165325164795,0.8389121770858765,0.8699432611465454,0.8424947500228882,0.657782781124115,0.581110155582428,0.1872957542538643,0.0435037551447749,0.3857247948646545,0.2218546628952026,0.4177260339260101,0.0243306424468755,0.966166615486145,0.9989837765693664,0.0117703502997756,0.04330944865942,0.0499051690101623,0.064957358688116,0.0308127550408244,0.1075635723769664,0.05161136649549,0.8991886258125306,0.4314685255289078,0.2615341454744339,0.0109899747185409,0.0360569145530462,0.1863774985074996,0.0096463485620915,0.163625730574131,0.1983044877648353,-4.504418745025005,16.026950285877728,19.388687011113845,53.20353463945128,-7.665718590432614,2.62973711228468,2.414369123152881,103.84591750201189,-4.3847951546959525,-1.2609788024868642,MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",Coxibs
149,progesterone,progesterone,progesterone,most,CC(=O)C1CCC2C3CC=C4CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,16-19H,5-12H2,1-3H3",1,Progesterone,Heart Damage,bw,0.0351391636766493,0.9823356389999388,0.8931492686271667,0.0049095822847448,0.7125995397567749,0.4297512203454971,0.2420642971992492,0.1640547160059213,0.0305894341319799,0.8333652973175049,0.1210051044821739,0.1212049603462219,0.0243745198473334,0.2178424268960953,0.9999413251876832,0.0141195942298509,0.223268324136734,0.0207851022481918,0.0354053667746484,0.0583263050764799,0.3451957315206527,0.0068801774643361,0.9920874118804932,0.5481024026870728,0.4208644926548004,0.0017882657586596,0.064994727820158,0.201033179461956,0.0062818111153319,0.3786090940237045,0.3101229630410671,-4.59574962573098,82.08042907771413,50.19514433515769,4.579525299183734,-2.745790403458943,2.2635468191777592,4.203710654703506,94.20547297447118,-5.315508147018839,0.8319738576047844,GENITO URINARY SYSTEM AND SEX HORMONES,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,PROGESTOGENS;PROGESTOGENS AND ESTROGENS IN COMBINATION,"Pregnen (4) derivatives;Progestogens and estrogens, fixed combinations"
150,zolmitriptan,zolmitriptan,zolmitriptan,most,C[NH+](C)CCc1c[nH]c2ccc(CC3COC(=O)N3)cc12,"InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/p+1",1,Zolmitriptan,Mixed,wp,0.3692312240600586,0.6352296233177185,0.4096245318651199,0.0540035188198089,0.019956069253385,0.1117841109633445,0.0006785937643144,0.3922720193862915,0.0962806530296802,0.3515252351760864,0.0174437033012509,0.0531324978917837,0.0176235863938927,0.2739741265773773,0.5348358124494552,0.0073782100807875,0.0091937902383506,0.1274329707026481,0.008154230704531,0.0140080011449754,0.2004771217703819,0.0005433191443444,0.3188155885785818,0.0123004920780658,0.0200539771467447,0.0056938868016004,0.0046453960705548,0.0058065680786967,0.0183305449783802,0.8200202941894531,0.3761986434459686,-5.312800782440865,8.652489344757793,-43.25451280449864,-12.339588625613848,-16.09381554251311,2.823149197662733,-0.0861939402039665,47.15264611095791,-1.6136121042264908,6.759487452418384,NERVOUS SYSTEM,ANALGESICS,ANTIMIGRAINE PREPARATIONS,Selective serotonin (5HT1) agonists
151,atazanavir,atazanavir,atazanavir sulfate,most,COC(=O)NC(C(=O)[N-]N(Cc1ccc(-c2ccccn2)cc1)CC(O)C(Cc1ccccc1)NC(=O)C(NC(=O)OC)C(C)(C)C)C(C)(C)C,"InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H4,40,41,42,43,46,47,48,49)/p-1",1,Atazanavir,Arrhythmia,wp,0.0755475662648677,0.1866117380559444,0.6196481704711914,0.0315004189964383,0.8999585032463073,0.4431812584400177,0.9057663321495056,0.0714300502091646,0.1953179985284805,0.8515513777732849,0.97117201089859,0.1924707680940628,0.1022150166332721,0.7641956210136414,0.9979526162147522,0.0019037769525311,0.0028983659343793,0.082352427765727,0.0252907270565629,0.0091957906726747,0.0269294621422886,0.0117297386983409,0.9166702151298524,0.761453104019165,0.2246845319867134,0.0028404375363606,0.025605112593621,0.2260622225701808,0.0178362423554062,0.0775755196809768,0.8911365985870361,-5.133918968058689,49.58941126392199,139.52550368223456,6.671747367309287,-10.335352062899394,3.3169325961051137,3.371327552914792,101.52687846396918,-5.237492604552793,3.025806664539279,ANTIINFECTIVES FOR SYSTEMIC USE,ANTIVIRALS FOR SYSTEMIC USE,DIRECT ACTING ANTIVIRALS,"Antivirals for treatment of HIV infections, combinations;Protease inhibitors"
152,tykerb,lapatinib,lapatinib ditosylate,most,CS(=O)(=O)CC[NH2+]Cc1ccc(-c2ccc3[n-]cnc(=Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,"InChI=1S/C29H25ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3/q-1/p+1",1,Lapatinib,Mixed,wp,0.2647587865591049,0.3442625999450683,0.6308194518089294,0.622896695137024,0.794137465953827,0.2763735502958298,0.428343242406845,0.2890763729810714,0.4018430173397064,0.8448755979537964,0.9653974413871764,0.4093701362609863,0.0167132768779993,0.805085289478302,0.9734466314315796,0.0182112911716103,0.0195735109969973,0.2752984821796417,0.5059153616428376,0.0430355165153741,0.1086751170456409,0.0852430559694767,0.448803699016571,0.9677955746650696,0.7195818901062012,0.0196038331836462,0.2123024001717567,0.2718236833810806,0.0456685148179531,0.1364253848791122,0.9738046407699584,-5.500377323630231,42.31356320690772,36.16537215210623,44.83647897017145,-10.64542777036849,3.444587292315899,2.442379226461719,98.85402540107694,-3.1166154196395164,-1.2298782424637913,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
153,orgovyx,relugolix,relugolix,most,CO[N-]C(=O)Nc1ccc(-c2sc3c(c2C[NH+](C)C)c(=O)n(-c2ccc(OC)nn2)c(=O)n3Cc2c(F)cccc2F)cc1,"InChI=1S/C29H27F2N7O5S/c1-36(2)14-19-24-26(39)38(22-12-13-23(42-3)34-33-22)29(41)37(15-18-20(30)6-5-7-21(18)31)27(24)44-25(19)16-8-10-17(11-9-16)32-28(40)35-43-4/h5-13H,14-15H2,1-4H3,(H2,32,35,40)",1,Relugolix,Arrhythmia,wp,0.6092672646045685,0.3175242632627487,0.6194470882415771,0.0160118888132274,0.1042241618037223,0.2404068917036056,0.153894792869687,0.0982601802796125,0.1044644758105278,0.6298151850700379,0.4229042947292328,0.3933806270360946,0.108056179434061,0.940276563167572,0.2887029618024826,0.0145726908929646,0.0175375101156532,0.0295599907636642,0.0314253306016325,0.0085200923494994,0.0421528499573469,0.0050081909168511,0.5142481803894043,0.7688697934150696,0.2321059316396713,0.032107400894165,0.0087978102266788,0.124088630080223,0.1226956456899643,0.2791156738996506,0.8610233545303345,-5.202348393472564,28.1538693047425,51.14901246180906,102.75493662323063,-12.552496616392794,3.3620864346438752,2.101561112220407,87.48115286514192,-3.6866665053184136,-4.198904019667929,"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",ENDOCRINE THERAPY;PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,HORMONE ANTAGONISTS AND RELATED AGENTS;HYPOTHALAMIC HORMONES,Anti-gonadotropin-releasing hormones;Other hormone antagonists and related agents
154,mekinist,trametinib,trametinib dimethyl sulfoxide,most,CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,"InChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34)",1,Trametinib,Heart Damage,wp,0.1901837348937988,0.6555710554122924,0.9019597291946412,0.0285171024501323,0.0787717230618,0.3379664152860641,0.2369278788566589,0.0471851971000433,0.0242055840790271,0.6552755534648895,0.343250036239624,0.4958058327436447,0.305575942993164,0.9631556153297424,0.9924515843391418,0.0396798383444547,0.0569860458374023,0.0800378084182739,0.0693820793181657,0.0087716954294592,0.0571701806038618,0.0241903286427259,0.7998594403266907,0.606449294090271,0.336634013056755,0.0813954383134842,0.0490019779652357,0.4699135422706604,0.2363555774092674,0.1039062064141035,0.6499655544757843,-4.591577931389887,22.024684732631467,34.94036528029224,127.04228363700808,-11.75785822797149,3.2244651878463912,2.820193383271877,89.70921028310558,-5.7797248659705724,0.1360224996166158,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Mitogen-activated protein kinase (MEK) inhibitors
155,nabumetone,nabumetone,nabumetone,most,COc1ccc2cc(CCC(C)=O)ccc2c1,"InChI=1S/C15H16O2/c1-11(16)3-4-12-5-6-14-10-15(17-2)8-7-13(14)9-12/h5-10H,3-4H2,1-2H3",1,Nabumetone,Heart Damage,bw,0.4167620480060577,0.946489953994751,0.9345086455345154,0.993271827697754,0.6239055573940278,0.4995953142642975,0.1346816822886467,0.818287444114685,0.2150191351771354,0.7811511278152465,0.1554932296276092,0.0787597462534904,0.031735660880804,0.684943687915802,0.9999752044677734,0.017011804645881,0.0529743589460849,0.6934478282928467,0.0558550164103508,0.0526561327278614,0.3883073627948761,0.0279437039047479,0.9916314244270324,0.2823153689503669,0.2071130484342575,0.2306351870298385,0.040504839643836,0.1320945635437965,0.0728400025516748,0.3125061333179474,0.3650380849838257,-4.43656415417787,113.52333905975772,72.67089741067052,-11.232864886320533,-7.150412630077466,1.672602023929572,3.4952752715309123,96.8877546769326,-4.1674638000129205,-1.231840383844797,MUSCULO-SKELETAL SYSTEM,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS","Other antiinflammatory and antirheumatic agents, non-steroids"
156,jakafi,ruxolitinib,ruxolitinib,most,N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,"InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)",1,Ruxolitinib,Heart Damage,wp,0.182171356678009,0.820771586894989,0.913757050037384,0.7627487301826477,0.5701416015625,0.4461296319961548,0.2712969169020652,0.4428689301013946,0.1474157266318798,0.5126312136650085,0.903808057308197,0.0734818123281002,0.3985283434391021,0.6728556632995606,0.999976396560669,0.0044296053471043,0.0118251324631273,0.4368462681770325,0.1637970522046089,0.029534638673067,0.0588903218507766,0.0036516762687824,0.9325628757476808,0.1233624033629894,0.0713728964328765,0.0655848789960145,0.0416803587228059,0.0747984491288662,0.0400021007284522,0.2690025478601455,0.5488096535205841,-5.185341983700321,8.328004738392199,11.42420321047077,-5.929444645450501,-10.815432125661518,2.7713682239787403,2.76281869506807,95.24215675823284,-4.335099763739049,-0.5406138009671316,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Janus-associated kinase (JAK) inhibitors
157,mektovi,binimetinib,binimetinib,most,Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)[N-]OCCO)cc21,"InChI=1S/C17H15BrF2N4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,25H,4-5H2,1H3,(H2,22,23,26)/p-1",1,Binimetinib,Heart Damage,wp,0.9055076003074646,0.6534870088100433,0.8873753070831298,0.2711144357919693,0.1626662909984588,0.1191101126372814,0.1396573886275291,0.0351189706474542,0.0531384412199258,0.5444119274616241,0.2848839223384857,0.3219966143369674,0.192715498805046,0.8375151872634887,0.9995917081832886,0.0496808052062988,0.0396176241338253,0.8026393413543701,0.4489729255437851,0.0263792191632092,0.1072015158832073,0.0331373762339353,0.8215290546417237,0.6935624122619629,0.5752881109714508,0.2158000886440277,0.0565976604819297,0.554435670375824,0.3721081882715225,0.2497767239809036,0.7257476806640625,-5.364952775940578,59.5514682337285,37.64778335574546,79.18474574751107,-12.125878750629518,2.110991208264399,2.457521848662376,90.80384686632786,-3.014915961702895,4.87478253627345,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Mitogen-activated protein kinase (MEK) inhibitors
158,egaten,triclabendazole,triclabendazole,most,CSc1nc2cc(Cl)c(Oc3cccc(Cl)c3Cl)cc2[n-]1,"InChI=1S/C14H8Cl3N2OS/c1-21-14-18-9-5-8(16)12(6-10(9)19-14)20-11-4-2-3-7(15)13(11)17/h2-6H,1H3/q-1",1,Triclabendazole,Arrhythmia,wp,0.5649357080459595,0.8624350070953369,0.8841770887374878,0.9957746028900146,0.9459192633628846,0.205845658481121,0.8201779842376709,0.2248644173145294,0.2152297616004944,0.7118857026100158,0.238355977833271,0.1691819787025451,0.011691925022751,0.9012903809547425,0.9999903917312624,0.0067708265502005,0.0370057046413421,0.9636970520019532,0.479259181022644,0.0478097613900899,0.3578524112701416,0.1013230636715889,0.9736106991767884,0.579624229669571,0.7669071078300476,0.2414973646402359,0.593567967414856,0.7084102272987366,0.2496685862541198,0.6367444157600403,0.472539347410202,-4.359677813441839,93.48857286431384,38.76151421399796,20.05979852650504,-7.728163143376468,2.8273501260857863,3.701158724542261,93.10719653160552,-6.796173131236543,3.688452436370708,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTHELMINTICS,ANTITREMATODALS,Other antitrematodal agents
159,fexinidazole,fexinidazole,fexinidazole,most,CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1,"InChI=1S/C12H13N3O3S/c1-14-11(13-7-12(14)15(16)17)8-18-9-3-5-10(19-2)6-4-9/h3-7H,8H2,1-2H3",1,Fexinidazole,Arrhythmia,wp,0.8822738766670227,0.939779806137085,0.940207815170288,0.8666579604148865,0.839507234096527,0.3231029421091079,0.239358465373516,0.1551449030637741,0.112117313593626,0.7262767910957336,0.1454765740782022,0.1822841331362724,0.0264671487733721,0.8473363518714905,0.9999645471572876,0.0101833312073722,0.007807943271473,0.3486629009246826,0.1995525613427162,0.0851599767804145,0.3109179258346558,0.0434869749471545,0.983640158176422,0.0978018995374441,0.3027146756649017,0.1578506469726562,0.1115217715501785,0.0738932490348815,0.0475134294480085,0.7385199308395386,0.0947803668677806,-4.535892678767628,63.72274461835445,37.95249589336434,-29.121709433419248,-8.550939124353066,1.8903417218324947,1.592030015982426,80.97337585615641,-3.759877265500104,-4.554807391207423,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ANTIPROTOZOALS,AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS,Nitroimidazole derivatives
160,kisqali,ribociclib,ribociclib succinate,most,C[NH+](C)C(=O)c1cc2c[n-]c(=Nc3ccc(N4CC[NH2+]CC4)cn3)nc2n1C1CCCC1,"InChI=1S/C23H30N8O/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28,32)/p+1",1,Ribociclib,Arrhythmia,wp,0.1667496778070926,0.4338762611150741,0.4485316216945648,0.0969240829348564,0.0262107954360544,0.1850423961877823,0.0221017236355692,0.3614486247301102,0.0408267636317759,0.5663708508014679,0.3467993855476379,0.0577668642625212,0.0593566475436091,0.7555214285850524,0.7440286099910736,0.0387436651624739,0.0240011414512991,0.1948140732944011,0.0345692871138453,0.0409002881497144,0.1143744960427284,0.0034005994617473,0.7061355233192443,0.0384994247928261,0.1804106920957565,0.0684663763269782,0.0257548348046839,0.094050320982933,0.1861301273107528,0.2427407979965209,0.6787699222564697,-5.411594948000017,-9.83266321595278,24.948383871883657,-11.780713654870624,-12.16048973565338,3.430757064432831,1.204458982248022,67.11511045844944,-1.5859350649348418,7.826007013722884,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Cyclin-dependent kinase (CDK) inhibitors
161,yondelis,trabectedin,trabectedin,most,COc1cc2c(cc1[O-])CC[NH2+]C21CSC2c3c(OC(C)=O)c(C)c4c(c3C(COC1=O)[NH+]1C(O)C3Cc5cc(C)c(OC)c([O-])c5C(C21)[NH+]3C)OCO4,"InChI=1S/C39H43N3O11S/c1-16-9-20-10-22-37(46)42-23-13-50-38(47)39(21-12-25(48-5)24(44)11-19(21)7-8-40-39)14-54-36(30(42)29(41(22)4)26(20)31(45)32(16)49-6)28-27(23)35-34(51-15-52-35)17(2)33(28)53-18(3)43/h9,11-12,22-23,29-30,36-37,40,44-46H,7-8,10,13-15H2,1-6H3/p+1",1,Trabectedin,Heart Damage,wp,0.0451135768555104,0.0103639646666124,0.3548422873020172,0.0085236095357686,0.2444765329360962,0.1344374999403953,0.040804985538125,0.1564317092299461,0.1837776064872741,0.83385728597641,0.845912230014801,0.0552732937037944,0.0026306370273232,0.7772044777870178,0.4844038337469101,0.0346005544066429,0.0558637402951717,0.0365949502214789,0.0117064780555665,0.0177294824272394,0.0606335952877998,0.0069272482767701,0.4710327744483947,0.5912657558918,0.0659555189311504,0.0037438900675624,0.0044470682973042,0.1385850727558136,0.0358817815780639,0.1493845850229263,0.7880524516105651,-5.6739607158989855,13.732988766830072,95.13047884831104,6.374154607093352,-12.48151323857785,2.3912590835061325,1.6175520470227482,69.67177379292158,-2.4248667840232963,11.218297914108302,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,Other plant alkaloids and natural products
162,isturisa,osilodrostat,osilodrostat phosphate,most,N#Cc1ccc(C2CCc3cncn32)c(F)c1,"InChI=1S/C13H10FN3/c14-12-5-9(6-15)1-3-11(12)13-4-2-10-7-16-8-17(10)13/h1,3,5,7-8,13H,2,4H2",1,Osilodrostat,Arrhythmia,wp,0.3705715179443359,0.937830889225006,0.9424175024032592,0.7836226344108581,0.8664610147476196,0.2015745639801025,0.6159676492214203,0.0849434241652488,0.1214379534125328,0.407060706615448,0.854468822479248,0.03379682675004,0.0575106708332896,0.5398728787899018,0.9999985694885254,0.0035351856204215,0.0241338985040783,0.1842643469572067,0.7413329720497132,0.0403364654630422,0.05516012981534,0.0033000176423229,0.9724608063697816,0.192855759896338,0.047412234544754,0.0203871680423617,0.0091936814133077,0.0113343514502048,0.0156692998250946,0.3582852900028229,0.4437841385602951,-4.341239027092406,38.08024877057839,17.365772353798427,-0.0983886904936376,-10.801074272409306,2.6527101682720167,1.7299161455402576,44.59958322514871,-2.1217440803104965,-6.57454379566307,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",CORTICOSTEROIDS FOR SYSTEMIC USE,ANTIADRENAL PREPARATIONS,Anticorticosteroids
163,caprelsa,vandetanib,vandetanib,most,COc1cc2c(=Nc3ccc(Br)cc3F)[n-]cnc2cc1OCC1CC[NH+](C)CC1,"InChI=1S/C22H23BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3/q-1/p+1",1,Vandetanib,Mixed,bw,0.0935193043202161,0.854134202003479,0.7277910351753235,0.106155289709568,0.0438604922965168,0.0924047589302063,0.0073405030183494,0.6996506452560425,0.3858692169189453,0.7594088435173034,0.3592543512582778,0.0790879897773265,0.0291678812354803,0.4131262719631195,0.9495990991592408,0.011276130657643,0.0276109687983989,0.2771944791078568,0.0385250799357891,0.0129755776375532,0.0815595522522926,0.0011708529083989,0.8867677330970765,0.6059847891330719,0.1004521697759628,0.0187889652326703,0.0123399994336068,0.0213844100944697,0.0141226741019636,0.1390494436025619,0.8857273101806641,-4.888360696964749,6.792958660544284,18.61776501889924,-13.405602510845256,-9.979635218667749,3.091326174072764,1.7147576302614844,85.16147341544709,-2.3433591381322345,2.5390684030144013,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Other protein kinase inhibitors
164,calcium gluconate,calcium gluconate,calcium gluconate monohydrate,most,O=C(C(O)C(O)O)C(O)C(O)CO,"InChI=1S/C6H12O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-3,5-9,11-13H,1H2",1,Calcium gluconate,Arrhythmia,wp,0.0797767835669219,0.2527040228247642,0.4494348496198654,0.0212177814559254,0.0303033461270388,0.0607544402591884,0.0036775881908397,0.0150088872294873,0.0013700780749104,0.0706223129294812,7.913755856132631e-05,0.1629450879991054,0.0103073183039668,0.0518684295937419,0.3978963375091552,0.0357408189214766,0.0062562563456594,0.0043335480575024,0.0005237567852873,0.0145252796719432,0.0463775217533111,0.0007698682157524,0.1117273098207078,0.0049667206272715,0.0973561347927898,0.0003828357722568,0.0018861031887354,0.0195646632849275,0.0049614310677497,0.2160365737974643,0.0040617741373353,-5.873534552209887,53.70854712721528,8.841646976495026,-0.6267388159822531,-19.60833075483189,1.358481164071746,0.2632299517881434,23.208149975656305,0.2532354720053241,-2.43230599507568,ALIMENTARY TRACT AND METABOLISM;DERMATOLOGICALS,MINERAL SUPPLEMENTS;OTHER DERMATOLOGICAL PREPARATIONS,CALCIUM;OTHER DERMATOLOGICAL PREPARATIONS,Calcium;Other dermatologicals
165,piroxicam,piroxicam,piroxicam,most,C[NH+]1C(C(=O)N=c2cccc[n-]2)C(=O)c2ccccc2S1(=O)=O,"InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,13H,1H3,(H,16,17,20)",1,Piroxicam,Heart Damage,bw,0.0419074520468711,0.2357087329030037,0.6562552571296691,0.0851813800632953,0.0471851680427789,0.6412934541702271,0.0220758197829127,0.0786431632936,0.0198606220073997,0.3574795603752136,0.0301838221028447,0.2074150875210762,0.0029671758238691,0.9486130595207214,0.9515566229820251,0.0391639620065689,0.0533714145421981,0.1067867144942283,0.0086255233269184,0.0116902150679379,0.0927077338099479,0.0074192906264215,0.4692854255437851,0.0738887567073106,0.0889396272599697,0.0136059625539928,0.0123438310809433,0.199158925563097,0.0344167767092585,0.3287056237459183,0.027499413723126,-4.893722853209676,62.87862823450153,16.807295457847736,-12.378178766246412,-14.23407166897189,3.0002002137805435,-0.2254037454604043,70.11803269162353,-2.7505250817006344,-0.909302610602348,MUSCULO-SKELETAL SYSTEM;SENSORY ORGANS,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;OPHTHALMOLOGICALS;TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,"ANTIINFLAMMATORY AGENTS;ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS;TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN","Antiinflammatory agents, non-steroids;Antiinflammatory preparations, non-steroids for topical use;Oxicams"
166,indomethacin,indomethacin,indomethacin,most,COc1ccc2c(c1)c(CC(=O)[O-])c(C)n2C(=O)c1ccc(Cl)cc1,"InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)/p-1",1,Indomethacin,Mixed,ar,0.0487362079322338,0.7199349522590637,0.9719440460205078,0.1297161772847175,0.2847432374954223,0.5911243081092834,0.3537486284971237,0.0441377295181155,0.0087093125097453,0.6319636821746826,0.1003791011869907,0.1956548288464546,0.0333793811500072,0.9810127854347228,0.9969692230224608,0.0133223596960306,0.0417956633493304,0.1570338353514671,0.0640778787434101,0.0167497595772147,0.0815312281250953,0.1935771703720092,0.8743016362190247,0.1127564284950494,0.0774181731045246,0.0228337786160409,0.0165497268550097,0.0147556603886187,0.0441114513203501,0.0721401453018188,0.0612495072185993,-4.647586244109656,16.208580998055044,6.740128819606158,11.637871146612152,-9.914011677334887,3.341959924556188,0.2728230155863166,90.83635373274078,-4.193372805331437,0.0009080134523921,CARDIOVASCULAR SYSTEM;MUSCULO-SKELETAL SYSTEM;SENSORY ORGANS,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;CARDIAC THERAPY;OPHTHALMOLOGICALS;TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,"ANTIINFLAMMATORY AGENTS;ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS;OTHER CARDIAC PREPARATIONS;TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN","Acetic acid derivatives and related substances;Antiinflammatory agents, non-steroids;Antiinflammatory agents, non-steroids and antiinfectives in combination;Antiinflammatory preparations, non-steroids for topical use;Other cardiac preparations"
167,koselugo,selumetinib,selumetinib,most,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)[N-]OCCO)cc21,"InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,25H,4-5H2,1H3,(H2,22,23,26)/p-1",1,Selumetinib,Heart Damage,wp,0.8443079710006713,0.6242869198322296,0.8822754383087158,0.3628121346235275,0.2633789241313934,0.1187098175287246,0.2407433897256851,0.0365968350321054,0.0734718423336744,0.6193116307258606,0.4358680963516235,0.305762580037117,0.1960469201207161,0.8664608359336853,0.9997534990310668,0.035862785950303,0.0313616052269935,0.8770696759223938,0.590222316980362,0.0378344583325088,0.1147364053875207,0.050728116929531,0.889992105960846,0.7799893379211426,0.6736770033836365,0.2115510046482086,0.1055660486221313,0.7006333649158478,0.4559944450855255,0.2296730756759643,0.7178232192993164,-5.267929141024427,58.93037231787781,42.51437335994647,92.76574884342008,-11.75522991188829,2.1681411038539347,2.5895898616505515,92.46775335263152,-3.509713456775432,10.975066232602597,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ANTINEOPLASTIC AGENTS,PROTEIN KINASE INHIBITORS,Mitogen-activated protein kinase (MEK) inhibitors
